
<html lang="en"     class="pb-page"  data-request-id="1249ac18-8ce8-4d60-adb3-02ec7a995b5c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.5b01376;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors" /></meta><meta name="dc.Creator" content="Teng  Ai" /></meta><meta name="dc.Creator" content="Daniel J.  Wilson" /></meta><meta name="dc.Creator" content="Swati S.  More" /></meta><meta name="dc.Creator" content="Jiashu  Xie" /></meta><meta name="dc.Creator" content="Liqiang  Chen" /></meta><meta name="dc.Description" content="Derived from our previously reported human sirtuin 2 (SIRT2) inhibitors that were based on a 5-aminonaphthalen-1-yloxy nicotinamide core structure, 5-((3-amidobenzyl)oxy)nicotinamides offered excel..." /></meta><meta name="Description" content="Derived from our previously reported human sirtuin 2 (SIRT2) inhibitors that were based on a 5-aminonaphthalen-1-yloxy nicotinamide core structure, 5-((3-amidobenzyl)oxy)nicotinamides offered excel..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 25, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01376" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01376" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01376" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01376" /></link>
        
    
    

<title>5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01376" /></meta><meta property="og:title" content="5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0020.jpeg" /></meta><meta property="og:description" content="Derived from our previously reported human sirtuin 2 (SIRT2) inhibitors that were based on a 5-aminonaphthalen-1-yloxy nicotinamide core structure, 5-((3-amidobenzyl)oxy)nicotinamides offered excellent activity against SIRT2 and high isozyme selectivity over SIRT1 and SIRT3. Selected compounds also exhibited generally favorable in vitro absorption, distribution, metabolism, and excretion properties. Kinetic studies revealed that a representative SIRT2 inhibitor acted competitively against both NAD+ and the peptide substrate, an inhibitory modality that was supported by our computational study. More importantly, two selected compounds exhibited significant protection against α-synuclein aggregation-induced cytotoxicity in SH-SY5Y cells. Therefore, 5-((3-amidobenzyl)oxy)nicotinamides represent a new class of SIRT2 inhibitors that are attractive candidates for further lead optimization in our continued effort to explore selective inhibition of SIRT2 as a potential therapy for Parkinson’s disease." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01376"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01376">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01376&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01376&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01376&amp;href=/doi/10.1021/acs.jmedchem.5b01376" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2928-2941</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b02025" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01416" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teng++Ai">Teng Ai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Wilson">Daniel J. Wilson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Swati+S.++More">Swati S. More</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiashu++Xie">Jiashu Xie</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liqiang++Chen">Liqiang Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Center for Drug Design, Academic Health Center, University of Minnesota, 516 Delaware Street SE, Minneapolis, Minnesota 55455, United States</span></div><div class="corresp-info"><strong>*</strong>Tel.: 612-624-2575. Fax: 612-624-8154. E-mail: <a href="/cdn-cgi/l/email-protection#d0b3b8b5bea8e4e6e290a5bdbefeb5b4a5"><span class="__cf_email__" data-cfemail="37545f52594f03010577425a5919525342">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01376&amp;href=/doi/10.1021%2Facs.jmedchem.5b01376" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2928–2941</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 16, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 September 2015</li><li><span class="item_label"><b>Published</b> online</span>25 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01376" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01376</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2928%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTeng%2BAi%252C%2BDaniel%2BJ.%2BWilson%252C%2BSwati%2BS.%2BMore%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D7%26contentID%3Dacs.jmedchem.5b01376%26title%3D5-%2528%25283-Amidobenzyl%2529oxy%2529nicotinamides%2Bas%2BSirtuin%2B2%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2941%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01376"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1842</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01376" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Teng&quot;,&quot;last_name&quot;:&quot;Ai&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Wilson&quot;},{&quot;first_name&quot;:&quot;Swati&quot;,&quot;last_name&quot;:&quot;S. More&quot;},{&quot;first_name&quot;:&quot;Jiashu&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Liqiang&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;2928-2941&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01376&quot;},&quot;abstract&quot;:&quot;Derived from our previously reported human sirtuin 2 (SIRT2) inhibitors that were based on a 5-aminonaphthalen-1-yloxy nicotinamide core structure, 5-((3-amidobenzyl)oxy)nicotinamides offered excellent activity against SIRT2 and high isozyme selectivity over SIRT1 and SIRT3. Selected compounds also exhibited generally favorable in vitro absorption, distribution, metabolism, and excretion properties. Kinetic studies revealed that a representative SIRT2 inhibitor acted competitively against both NAD+ and the peptide substrate, an inhibitory modality that was supported by our computational study. More importantly, two selected compounds exhibited significant protection against α-synuclein aggregation-induced cytotoxicity in SH-SY5Y cells. Therefore, 5-((3-amidobenzyl)oxy)nicotinamides represent a new class of SIRT2 inhibitors that are attractive candidates for further lead optimization in our continued effort to explore selective inhibition of SIRT2 as a potential therapy for Parkinson’s disease.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01376&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01376" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01376&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01376" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01376&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01376" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01376&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01376&amp;href=/doi/10.1021/acs.jmedchem.5b01376" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01376" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01376" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01376%26sid%3Dliteratum%253Aachs%26pmid%3D26982234%26genre%3Darticle%26aulast%3DAi%26date%3D2016%26atitle%3D5-%2528%25283-Amidobenzyl%2529oxy%2529nicotinamides%2Bas%2BSirtuin%2B2%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D2928%26epage%3D2941%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0020.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Derived from our previously reported human sirtuin 2 (SIRT2) inhibitors that were based on a 5-aminonaphthalen-1-yloxy nicotinamide core structure, 5-((3-amidobenzyl)oxy)nicotinamides offered excellent activity against SIRT2 and high isozyme selectivity over SIRT1 and SIRT3. Selected compounds also exhibited generally favorable in vitro absorption, distribution, metabolism, and excretion properties. Kinetic studies revealed that a representative SIRT2 inhibitor acted competitively against both NAD<sup>+</sup> and the peptide substrate, an inhibitory modality that was supported by our computational study. More importantly, two selected compounds exhibited significant protection against α-synuclein aggregation-induced cytotoxicity in SH-SY5Y cells. Therefore, 5-((3-amidobenzyl)oxy)nicotinamides represent a new class of SIRT2 inhibitors that are attractive candidates for further lead optimization in our continued effort to explore selective inhibition of SIRT2 as a potential therapy for Parkinson’s disease.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sirtuin 2 (SIRT2) is a member of the mammalian sirtuin (NAD<sup>+</sup>-dependent histone deacetylase) family that comprises SIRT1–7.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> SIRT2 is the only sirtuin that predominantly resides in the cytosol even though it is localized in the nucleus during mitosis. Interestingly, an alternatively spliced isoform has been reported to permanently reside in the nucleus. As the most abundant sirtuin homologue in the brain,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> SIRT2 has emerged as an important regulator in brain physiology and pathology.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Several studies have suggested that selective pharmacological inhibition of SIRT2 is a promising therapeutic approach for Parkinson’s disease (PD). Overexpression of SIRT2 induced neuronal apoptosis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In contrast, blocking SIRT2 protected cells from neurotoxicity induced by α-synuclein, a risk factor associated with familial PD, in cellular and fruit fly models of PD.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Furthermore, SIRT2 exacerbated the nigrostriatal neurotoxicity induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), whereas genetic deletion<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> or pharmacological inhibition<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> of SIRT2 prevented MPTP-induced neurodegeneration in mice. Moreover, as a major deacetylase of α-tubulin,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> SIRT2 decreased the acetylation level of microtubules, enhancing their association with pathologically mutated leucine-rich kinase 2 (LRRK2) in the Roc-COR domain (R1441C and Y1699C). Although this strengthened association impaired axonal transport, genetic knockdown of SIRT2 restored both axonal transport and locomotion in fruit flies.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Besides PD, blocking SIRT2 may also provide protection against other neurodegenerative diseases. Inhibition of SIRT2 had a protective effect in a cellular model of multiple system atrophy,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which is a form of synucleinopathy similar to PD. In granule cells obtained from slow Wallerian degeneration (Wld(s)) mice, genetic knockdown of SIRT2 enhanced resistance to axonal degeneration, whereas overexpression of SIRT2 abrogated the resistance.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Furthermore, inhibiting SIRT2 offered neuroprotection in flies, worms, and primary striatal neuron models of Huntington’s disease, likely by reducing sterol biosynthesis,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> although the therapeutic potential still remains to be unequivocally defined. Moreover, SIRT2 inhibitors have been explored for their potential therapeutic applications in mouse models of tauopathies, such as Alzheimer’s disease (AD),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and frontotemporal dementia.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Lastly, a neurotoxic role of SIRT2 in AD has been recently proposed.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Taken together, these studies suggest that optimized SIRT2 inhibitors will have a broad impact on the treatment of neurodegenerative diseases.</div><div class="NLM_p">SIRT2’s potential therapeutic applications in neurodegenerative diseases as well as cancers<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> have generated a growing interest in the discovery of potent and selective SIRT2 inhibitors,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> leading to compounds that are exemplified by those shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. AGK2 (<b>1</b>), a commonly used SIRT2 inhibitor, has been shown to mitigate the neurotoxicity induced by α-synuclein in models of Parkinson’s disease,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> even though it only possesses modest activity and selectivity against SIRT2. AK-1 (<b>2</b>) and its analogues have been tested for their therapeutic application in Huntington’s disease and PD, and further extensive structural modifications have been reported.<a onclick="showRef(event, 'ref12 ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref12 ref14 ref18">(12, 14, 18)</a> Compound <b>3</b>, which was developed by structural optimization of an anilinobenzamide chemotype, displays high anti-SIRT2 activity and excellent (>200-fold) selectivity over SIRT1 and SIRT3.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Inhibitor <b>4</b> and its analogues, which are based on a chroman-4-one core structure, are low micromolar inhibitors of SIRT2 with high isozyme selectivity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A series of thieno[3,2-<i>d</i>]pyrimidine-6-carboxamides, such as compound <b>5</b>, has been shown to possess low nanomolar activity against SIRT2; however, their selectivity over SIRT1 and SIRT3 still needs to be improved.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> More recently, a potent and selective SIRT2 inhibitor <b>6</b>, which was built on a new 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one scaffold, has been reported to prevent neuronal cell death triggered by lactacystin in an in vitro model of PD.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Also remarkable, a new class of highly selective SIRT2 inhibitors, including SirReal2 (<b>7</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), has been reported.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Through crystallographic studies, SirReal2’s selectivity has been attributed to a ligand-induced structural rearrangement of the enzyme active site, which reveals a new binding pocket that accommodates SirReal2 and can be exploited for further design of selective SIRT2 inhibitors. Furthermore, varied chemotypes such as tenovins,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> macrocyclic peptides equipped with a mechanism-based warhead,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> isoxazol-5-one cambinol analogues,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and tetrahydro-1H-pyrido[4,3-<i>b</i>]indoles<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> have also been reported as SIRT2 inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected SIRT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, we have reported potent and selective SIRT2 inhibitors based on a 5-aminonaphthalen-1-yloxy nicotinamide core structure as exemplified by compound <b>8</b> in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In our continued efforts to discover novel SIRT2 inhibitors, we have designed inhibitors based on a 3-aminobenzyloxy nicotinamide core structure as represented by compound <b>9</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Herein, we focus on our structure–activity relationship (SAR) studies on ring A that have revealed key structural features that lead to enhanced enzymatic activity against SIRT2 as well as selectivity over SIRT1 and SIRT3. We also report our preliminary efforts on evaluating selected compounds for their in vitro ADME properties. Our initial testing of selected SIRT2 inhibitors in a cellular model of PD is also discussed.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of SIRT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> SAR Studies</h3><div class="NLM_p">Compound <b>8</b> showed excellent anti-SIRT2 activity and selectivity over SIRT1 and SIRT3. However, its inefficient chemical synthesis hampered further SAR exploration. Therefore, we proceeded to search for structural replacements for the naphthalene core in compound <b>8</b>. To this end, we explored new SIRT2 inhibitors in which the 5-aminonaphthalen-1-yloxy nicotinamide core structure in compound <b>8</b> was simplified to yield a scaffold that allows for expedient chemical manipulation and subsequent detailed SAR studies.</div><div class="NLM_p">To test the viability of 3-aminobenzyloxy nicotinamide as a new core structure for SIRT2 inhibitors, we first prepared compound <b>10</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) in which a 3-methyl-4-nitrobenzamide functionality was appended to the 3-aminobenzyloxy nicotinamide core structure. A similar chemical modification was previously used in our investigation of SIRT2 inhibitors based on 5-aminonaphthalen-1-yloxy nicotinamide. Gratifyingly, compound <b>10</b> showed nanomolar anti-SIRT2 activity together with good (>50-fold) selectivity over SIRT1 and SIRT3. Encouraged by this finding, we proceeded to conduct detailed SAR studies, which mainly focused on the benzamide functionality as shown in compound <b>10</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activity of 5-((3-Amidobenzyl)oxy)nicotinamides: Aromatic Rings<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Inhibitory activities were determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> values were determined in a 10-dose mode with a 3-fold serial dilution starting at 200 μM in singlet.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values reported in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</p></div></div><div></div></div><div class="NLM_p">First, we investigated whether an aromatic ring and/or conjugation within the amide functionality was required for activity against SIRT2. To that end, compound <b>11</b>, which contained an acetyl group, showed only modest anti-SIRT2 activity; however, compounds <b>12</b> and <b>13</b> with a more bulky cyclohexyl and adamantly group, respectively, exhibited improved anti-SIRT2 activity. When a double bond that led to a conjugated carbonyl system was introduced in compound <b>14</b>, its inhibitory activity against SIRT2 was significantly enhanced when compared with that of compound <b>12</b>. This observation indicated that a conjugated carbonyl system was preferred, a SAR trend that was also observed in compound <b>15</b>, which featured an unsubstituted benzamide functionality. Compound <b>15</b> possessed nanomolar anti-SIRT2 activity and good isozyme selectivity (>40-fold), highlighting the importance of a conjugated aromatic ring system. Compound <b>15</b> is structurally identical to compound <b>8</b> except that the naphthalene ring in compound <b>8</b> has been simplified to give the benzyl linker present in compound <b>15</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Therefore, loss of activity (∼5-fold) against SIRT2 by compound <b>5</b> clearly resulted from this structural simplification. Judged by our studies on inhibition mode and computational modeling (vide infra), compound <b>15</b> was mainly competitive against NAD<sup>+</sup> and competitive with respect to the peptide substrate; therefore, it most likely shared a binding mode very similar to that of compound <b>86</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). In contrast, compound <b>8</b> has been shown to behave as a noncompetitive inhibitor against NAD<sup>+</sup> and a competitive inhibitor against the peptide substrate.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> These findings indicated that the structural simplification performed on compound <b>8</b> caused a shift in inhibition mode (against NAD<sup>+</sup>), which could account for the loss of activity exhibited by compound <b>15</b>. This difference in inhibition mode also explained the fact that compound <b>15</b> was amenable to chemical modifications at position 4, as judged by our following SAR studies, whereas a similar modification performed on compound <b>8</b> led to significant loss of activity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">The importance of an aromatic ring was further confirmed in compound <b>16</b> in which the phenyl ring in compound <b>15</b> was replaced with a thiophene ring without loss of activity. To further explore the amide functionality, we prepared compounds <b>17</b> and <b>18</b>, which contained a methylene and ethylene spacer, respectively, and therefore lack a conjugate system within the amide functionality. The reduced anti-SIRT2 activity of compounds <b>17</b> and <b>18</b>, when compared with the parent compound <b>15</b>, could be attributable to the loss of a conjugated system. When a conjugated system was reinstalled as seen in compound <b>19</b>, its activity against SIRT2 was restored, leading to a nanomolar IC<sub>50</sub> value against SIRT2 and an excellent selectivity profile (>100-fold over SIRT1 and SIRT3). Taken together, our initial SAR exploration as listed in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> clearly demonstrated that a conjugated aromatic system was preferred for both activity and selectivity in inhibitors based on 3-aminobenzyloxy nicotinamide.</div><div class="NLM_p">Having established the importance of a conjugated aromatic system, we proceeded to evaluate fused aromatic rings as a potential replacement of the phenyl ring in compound <b>15</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). 1-Naphthalene (<b>20</b>) resulted in a reduction of anti-SIRT activity; however, 2-naphthalene (<b>21</b>) led to markedly enhanced activity compared with parent compound <b>15</b>, suggesting that the position of attachment was critical. Similarly, incorporation of 2-benzo[<i>b</i>]thiophene (<b>22</b>), 2-benzofuan (<b>23</b>), and 2-indole (<b>24</b>) gave rise to compounds that showed excellent inhibitory activity toward SIRT2. Nonetheless, 2-benzothiazole (<b>25</b>) failed to improve potency beyond that of compound <b>15</b>. The position of attachment was also important in heterocyclic-fused aromatic rings. For instance, 3-benzo[<i>b</i>]thiophene (<b>26</b>) was markedly less potent than its corresponding regioisomer (<b>22</b>), whereas 3-indole (<b>27</b>) showed anti-SIRT2 activity very similar to that of isomer <b>24</b>. When 6-indole was adopted, the resulting compound <b>28</b> was slightly more active than compound <b>27</b>. The anti-SIRT2 activity was further improved when 6-indazole (<b>29</b>) was used even though the anti-SIRT1 activity was also enhanced, leading to a modest isozyme selectivity over SIRT1. In short, we identified fused aromatic/heteroaromatic rings that elicited superb anti-SIRT2 activity even though the selectivity profile still needs to be improved.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activity of 5-((3-Amidobenzyl)oxy)nicotinamides: Fused Aromatic Rings<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0009.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0010.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Inhibitory activities were determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> values were determined in a 10-dose mode with a 3-fold serial dilution starting at 200 μM in singlet.</p></div></div><div></div></div><div class="NLM_p">In addition to fused aromatic rings, we also systematically explored substituents on the phenyl ring in compound <b>15</b>. As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Table S1</a>, Supporting Information, we studied electron-donating methyl (Me) and methoxy (OMe) groups as well as electron-withdrawing chloro (Cl), nitro (NO<sub>2</sub>), and cyano (CN) groups, substituents that are structurally simple and commonly used in SAR studies. Furthermore, to assess the effect of each group at different positions, we installed each substituent on position 2 (R<sup>1</sup>), 3 (R<sup>2</sup>), or 4 (R<sup>4</sup>). When a methyl scan was performed on position 2, 3, or 4, the resulting compounds <b>30</b>, <b>31</b>, and <b>32</b>, respectively, showed sequentially enhanced activity toward SIRT2, indicating that position 4 was the preferred modification site. A similar SAR trend was observed for substituents like OMe (<b>33</b>–<b>35</b>), Cl (<b>36</b>–<b>38</b>), NO<sub>2</sub> (<b>39</b>–<b>41</b>), and CN (<b>42</b>–<b>44</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Table S1</a>). Furthermore, compounds <b>31</b>, <b>35</b>, <b>38</b>, <b>41</b>, and <b>44</b>, which contained one of these substituents on position 4, showed comparable anti-SIRT2 activities, indicating that the electron-donating or -withdrawing nature of these substituents did not appear to play a critical role. Taken together, we demonstrated that substitution on position 4 was desired for augmented activity, and simple substituents of different electronic nature could all be beneficial.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Activity of 5-((3-Amidobenzyl)oxy)nicotinamides: Substituents at Different Positions<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0011.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">SIRT1</th><th class="colsep0 rowsep0" align="center" char=".">SIRT2</th><th class="colsep0 rowsep0" align="center" char=".">SIRT3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="char" char=".">0.252</td><td class="colsep0 rowsep0" align="char" char=".">11.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">192</td><td class="colsep0 rowsep0" align="char" char=".">4.15</td><td class="colsep0 rowsep0" align="char" char=".">19.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">30.4</td><td class="colsep0 rowsep0" align="char" char=".">0.580</td><td class="colsep0 rowsep0" align="char" char=".">9.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">8.54</td><td class="colsep0 rowsep0" align="char" char=".">0.111</td><td class="colsep0 rowsep0" align="char" char=".">5.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">30.2</td><td class="colsep0 rowsep0" align="char" char=".">0.288</td><td class="colsep0 rowsep0" align="char" char=".">2.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">10.1</td><td class="colsep0 rowsep0" align="char" char=".">0.0754</td><td class="colsep0 rowsep0" align="char" char=".">3.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">4.19</td><td class="colsep0 rowsep0" align="char" char=".">0.0368</td><td class="colsep0 rowsep0" align="char" char=".">2.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">31.4</td><td class="colsep0 rowsep0" align="char" char=".">0.277</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">7.97</td><td class="colsep0 rowsep0" align="char" char=".">0.0418</td><td class="colsep0 rowsep0" align="char" char=".">1.56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Inhibitory activities were determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> values were determined in a 10-dose mode with a 3-fold serial dilution starting at 200 μM in singlet.</p></div></div></div><div class="NLM_p">Besides the simple substituents shown above, we also explored the addition of a fluoro (F) group (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), which is frequently used in medicinal chemistry even though its effect is difficult to generalize. When a fluoro scan was performed on position 2, 3, or 4, the resulting compounds <b>45</b>, <b>46</b>, and <b>47</b>, respectively, showed a SAR trend that mirrored the one observed for simple substituents as listed in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Table S1</a>. Interestingly, the activity enhancement was more pronounced, leading to compounds with low nanomolar IC<sub>50</sub> values against SIRT2 together with good isozyme selectivity. Intrigued by this finding, we retained a fluoro group at position 4 and then placed an additional fluoro group on either position 2 or 3 to give compounds <b>48</b> and <b>49</b>, respectively (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Compound <b>48</b> showed an anti-SIRT2 activity almost identical to that of compound <b>45</b>, suggesting that a fluoro group at position 2 was dispensable and was able to offset the beneficial effect elicited by a fluoro group at position 4. In contrast, an additional fluoro group at position 3 in compound <b>49</b> had minimal influence on the inhibition of SIRT2. Because we could demonstrate the beneficial effect of simple substituents such as Me, OMe, and Cl at position 4 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Table S1</a>), we also explored combining a simple substituent at position 4 in conjunction with an additional fluoro group at position 2 or 3 (<b>50</b>–<b>55</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Table S2</a>, Supporting Information). A synergistic effect on anti-SIRT2 activity and selectivity was observed for compounds <b>53</b> (vs <b>35</b>) and <b>55</b> (vs <b>38</b>), which contained a methoxy and chloro group, respectively, at position 4. In summary, our SAR study on the effect of a fluoro group at different positions revealed that a properly positioned fluoro could significantly improve anti-SIRT2 activity and selectivity over SIRT1 and SIRT3; therefore, a fluoro group, especially one at position 3, should be explored in future SAR studies.</div><div class="NLM_p">Because we demonstrated that position 4 was a constructive modification site, we opted to conduct extensive SAR studies at this position (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). To expand on the beneficial effect incurred by a methyl group as seen in compound <b>32</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), we prepared compounds <b>56</b>–<b>59</b>, which featured an increasingly bulky alkyl group. Compared with compound <b>32</b>, there was no significant improvement in anti-SIRT2 activity. However, when a phenyl group was appended at position 4 to give compound <b>60</b>, a remarkable boost in anti-SIRT2 activity was realized, which led to a low nanomolar IC<sub>50</sub> value. A similar effect was observed for compound <b>61</b>, which contained an isosteric thiophene ring. Also importantly, both compounds <b>60</b> and <b>61</b> now exhibited more than 1000-fold selectivity over SIRT1 and SIRT3. These findings suggested that an aromatic ring at position 4 conferred greatly enhanced activity and selectivity, a SAR trend that was further tested by introducing varied heterocyclic aromatic rings as seen in compounds <b>62</b>–<b>69</b>. In compound <b>62</b>, a 2-thioazole at position 4 resulted in a SIRT2 IC<sub>50</sub> comparable with that of compound <b>61</b>, albeit with reduced isozyme selectivity. However, an N-pyrrole in compound <b>63</b> caused a significant loss of anti-SIRT2 activity, which was regained with an N-pyrazole (<b>64</b>). Noticeably, both compounds <b>63</b> and <b>64</b> possessed markedly lower selectivity in comparison with compound <b>61</b>. The selectivity was further eroded in compound <b>65</b>, which contained an N-imidazole. As a result, compound <b>65</b> showed similar submicromolar activity against SIRT1–3, exhibiting nearly no selectivity. When an N-triazole was used, a gain of activity against SIRT2 was observed for compound <b>66</b>; nonetheless, its activity against SIRT1 and SIRT3 still remained submicromolar, leading to a low selectivity. Our SAR study with heterocyclic aromatic rings in compounds <b>62</b>–<b>66</b> suggested that nitrogen atoms in the ring had a detrimental effect on the isozyme selectivity. This intriguing SAR trend was further confirmed in pyridine-derived compounds <b>67</b>–<b>69</b>, in which a nitrogen atom was incorporated at position 2, 3 or 4, respectively. Although the anti-SIRT2 activity remained essentially identical, the selectivity deteriorated when compared with compound <b>60</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activity of 5-((3-Amidobenzyl)oxy)nicotinamides: Substituents at Position 4<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0012.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0013.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Inhibitory activities were determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> values were determined in a 10-dose mode with a 3-fold serial dilution starting at 200 μM in singlet.</p></div></div><div></div></div><div class="NLM_p">We also attempted to find clues for significant erosion of isozyme selectivity seen in compounds <b>63</b>–<b>69</b>. Our studies on inhibition mode and computational modeling (vide infra) showed our new SIRT2 inhibitors most likely adopted a binding mode so that ring A and its substituent at position 4 interacted with the residues in the substrate binding site. A previous sequence analysis of SIRT1–3 has shown high similarity in the residues surrounding the substrate binding site,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> suggesting that it would be difficult to pinpoint residues that were responsible for decreasing isozyme selectivity. Nevertheless, SIRT3 substrate specificity has been examined,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> revealing that positively charged residues in the substrate are preferred for tight SIRT3 binding. Because the basic amines present in compounds <b>64</b>–<b>69</b> are expected to be at least partially protonated under physiological conditions, the resultant positive charge might account for their higher affinity for SIRT3 and hence reduced isozyme selectivity. It is also possible that selectivity against SIRT1 deteriorates via a similar mechanism. Further studies are clearly needed to pinpoint factors that affect isozyme selectivity of our new SIRT2 inhibitors.</div><div class="NLM_p">Having recognized that nitrogen atoms decreased the selectivity, we chose to explore acetylene as an isosteric but less bulky replacement of a phenyl group. Resulting compound <b>70</b> showed excellent inhibitory activity against SIRT2 even though the selectivity profile was still suboptimal. In summary, our investigation of substituents at position 4 clearly indicated that a nonbasic aromatic ring was preferred for high activity and selectivity.</div><div class="NLM_p">We then proceeded to investigate various functional groups, including ester, acid, amide, ether, and amine, at position 4 (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Compound <b>71</b> with a methyl ester showed high anti-SIRT2 activity even though a carboxylic acid (<b>72</b>) was not tolerated. A primary amide (<b>73</b>) led to an IC<sub>50</sub> value of less than 50 nM. N-Methylation (<b>74</b>) further enhanced the activity; however, N-dimethylation (<b>75</b>) caused a significant loss of activity against SIRT2. On the other hand, a reversed methyl amide (<b>76</b>) was well-tolerated, whereas a methyl ketone (<b>77</b>) reduced activity. Notably, even though primary and monosubstituted amides as well as a monosubstituted reversed amide at position 4 conferred excellent anti-SIRT2 activity, compounds that contained these functional groups generally possessed relatively low selectivity, especially relative to those with nonbasic aromatic rings. When a phenoxy (<b>78</b>) or benzoxy (<b>79</b>) was attached, the resulting compounds showed anti-SIRT2 activity comparable to that of parent compound <b>15</b>; however, a significant boost in selectivity was attained, suggesting that a properly substituted ether functionality could be installed to improve the selectivity profile.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Activity of 5-((3-Amidobenzyl)oxy)nicotinamides: Functional Groups at Position 4<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0014.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0015.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Inhibitory activities were determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> values were determined in a 10-dose mode with a 3-fold serial dilution starting at 200 μM in singlet.</p></div></div><div></div></div><div class="NLM_p">We also explored amines at position 4 (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Although compound <b>80</b> harboring a methylamino group showed an anti-SIRT2 activity comparable to that of parent compound <b>15</b>, an ethylamino group (<b>81</b>) caused a minor increase in activity. When the amino group was dimethylated (<b>82</b>), a marked enhancement in the activity and selectivity (>250-fold) was observed. Surprisingly, a bulkier diethylamino group (<b>83</b>) led to a significant loss of activity compared to that of compound <b>82</b>. These findings suggested that a disubstituted amine was desirable at position 4 even though larger groups might not be tolerated. In addition to acyclic amines, we also investigated cyclic amines as potential substituents at position 4. When compared with compound <b>15</b>, compound <b>84</b> with an <i>N</i>-pyrrolidine ring showed slightly improved anti-SIRT2 activity; however, a piperidine ring (<b>85</b>) had a negligible impact. When a morpholine ring was introduced, resultant compound <b>86</b> exhibited a low nanomolar IC<sub>50</sub> value against SIRT2 together with more than 300- and 100-fold selectivity over SIRT1 and SIRT3, respectively. In contrast, an <i>N</i>-methylpiperazine (<b>87</b>) resulted in a drastic decrease in the anti-SIRT2 activity. Also noticeable, the isozyme selectivity was significantly lowered, which was reminiscent of a similar loss of selectivity in compounds that contained basic heterocyclic rings as listed in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. Taken together, we showed that disubstituted amines were beneficial at position 4 even though their steric and electronic nature should be taken into account to obtain desired activity and selectivity.</div><div class="NLM_p">Because we discovered that a properly substituted amine enhanced anti-SIRT2 activity, we continued to explore amines with an extra carbon spacer as depicted in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Table S3</a>, Supporting Information (compounds <b>88</b>–<b>99</b>). Briefly, we showed that cycloalkylamino groups with a methylene spacer generally had reduced anti-SIRT2 activity relative to their analogues without a spacer; however, introduction of fluoro groups on the cycloalkylamines might offer an opportunity to improve the activity against SIRT2 as seen in compounds <b>98</b> and <b>99</b>.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, a nitrogen atom, depending on its position, appeared to have a profound impact on anti-SIRT2 activity and selectivity. To test whether a similar effect existed in ring A, we first investigated compounds <b>100</b>–<b>106</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). When a nitrogen atom was placed at position 2 (<b>100</b>), a significant reduction in anti-SIRT2 activity was observed. A nitrogen atom at position 3 (<b>101</b>) was tolerated, and one at position 4 (<b>102</b>) markedly increased the anti-SIRT2 activity. Second, we investigated a combined effect of two nitrogen atoms at various positions (<b>103</b>–<b>106</b>), which again revealed the detrimental effect of a nitrogen atom at position 2 in compounds <b>103</b>, <b>105</b>, and <b>106</b>. In addition, the beneficial effect of a nitrogen atom at position 4 was abrogated by that of a nitrogen atom at position 3 as seen in <b>104</b>. In addition to compounds <b>100</b>–<b>106,</b> which were based on compound <b>15</b>, we also explored incorporating a nitrogen atom in the phenyl of the cinnamic amide moiety of compound <b>19</b> by preparing compounds <b>107</b>–<b>109</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). In those compounds, changing the location of the nitrogen atom among positions 2, 3, and 4 produced increasingly higher inhibition against SIRT2, a SAR trend that was very similar to that observed in compounds <b>100</b>–<b>102</b>. The SAR study in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> clearly indicated that a nitrogen atom at position 4 was constructive, whereas one at position 3 was merely tolerated.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Inhibitory Activity of 5-((3-Amidobenzyl)oxy)nicotinamides: Heteroaromatic Rings<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0016.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0017.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">Inhibitory activities were determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> values were determined in a 10-dose mode with a 3-fold serial dilution starting at 200 μM in singlet.</p></div></div><div></div></div><div class="NLM_p">The latter finding coupled with our previous observation that a substituent at position 4 was preferred prompted us to study compounds <b>110</b>–<b>114</b> (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). In those compounds, an aromatic ring was introduced at position 4 because a similar modification generally offered significantly enhanced activity and selectivity as described above (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In compound <b>110</b>, a phenyl group led to excellent anti-SIRT2 activity and selectivity, whereas a 2-thiophene ring (<b>111</b>) resulted in similar activity and extraordinary selectivity. Similarly, 2-furan, <i>N</i>-pyrrole, and <i>N</i>-pyrazole attached at position 4 yielded SIRT2 inhibitors <b>112</b>, <b>113</b>, and <b>114</b>, respectively, with comparable activities. Furthermore, we also probed a fluoro group at position 3 in compounds <b>115</b>–<b>117</b> because a fluoro group could be beneficial as demonstrated in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Table S2</a>. Compound <b>115</b>, in which a phenyl group was incorporated, showed excellent anti-SIRT2 activity and selectivity. A 3-pyridine and 4-pyridine in compounds <b>116</b> and <b>117</b>, respectively, also offered extremely high activity even though their isozyme selectivity was reduced, which is a SAR trend similar to the one seen with compounds <b>67</b>–<b>69</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Taken together, for ring A, a nitrogen atom or a fluoro group was well-tolerated, thereby expanding the structural diversity of our SIRT2 inhibitors.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Inhibitory Activity of 5-((3-Amidobenzyl)oxy)nicotinamides: Pyridine Ring and Fluorine<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0018.gif" alt="" id="fx12" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0019.gif" alt="" id="fx13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">Inhibitory activities were determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> values were determined in a 10-dose mode with a 3-fold serial dilution starting at 200 μM in singlet.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Additional Biochemical Evaluation</h3><div class="NLM_p">To accurately assess the relative isozyme activity of selected SIRT2 inhibitors, we tested these compounds in our newly established in-house sirtuin inhibitory assays in which the concentrations of NAD<sup>+</sup> and the peptide substrate were used at the <i>K</i><sub>M</sub> values determined for each enzyme. Compounds <b>61</b>, <b>86</b>, <b>101</b>, and <b>102</b> were selected because of their excellent activities and selectivities as well as structural diversity. Compound <b>61</b> had a lipophilic thiophene group at position 4, and inhibitor <b>86</b> contained a more hydrophilic morpholino group. Compounds <b>101</b> and <b>102</b> were chosen because they contained a pyridine A ring in contrast to a phenyl A ring in compounds <b>61</b> and <b>86</b>. These four selected compounds all showed excellent activity against SIRT2 and selectivity over SIRT1 and SIRT3 (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>), generally mirroring the profiles obtained using the initial sirtuin inhibitory assays. Among these selected SIRT2 inhibitors, compound <b>61</b> displayed the highest isozyme selectivity, highlighting the importance of an aromatic ring at position 4. Compounds <b>86</b>, <b>101</b>, and <b>102</b> were also tested against human SIRT5 and all exhibited outstanding selectivity, suggesting that our newly discovered 5-((3-amidobenzyl)oxy)nicotinamides are devoid of SIRT5 inhibition.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Inhibitory Activity of Selected Compounds<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±"><i>K</i><sub>i</sub><sup>app</sup> (μM)</th><th class="colsep0 rowsep0" align="center" char=" "> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">SIRT1</th><th class="colsep0 rowsep0" align="center" char="±">SIRT2</th><th class="colsep0 rowsep0" align="center" char="±">SIRT3</th><th class="colsep0 rowsep0" align="center" char=" ">SIRT5 IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char="±"> >100</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±"> >100</td><td class="colsep0 rowsep0" align="char" char=" "> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">0.073 ± 0.011</td><td class="colsep0 rowsep0" align="char" char="±">5.4 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=" "> >200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="char" char="±">20 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.26 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=" "> >200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b></td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=" "> >200</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Inhibitory activities against SIRT1–3 were determined in duplicate as described in <a class="ref internalNav" href="#sec4_3" aria-label="In-House SIRT1–3 Biochemical Assays">In-House SIRT1–3 Biochemical Assays</a>, whereas the inhibitory activity against SIRT5 was determined as described in <a class="ref internalNav" href="#sec4_2" aria-label="Initial SIRT1–3 and SIRT5 Biochemical Assays">Initial SIRT1–3 and SIRT5 Biochemical Assays</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Inhibition Mode</h3><div class="NLM_p">To characterize the inhibition mode of SIRT2 inhibitors based on a 5-((3-amidobenzyl)oxy)nicotinamide core structure, we selected compound <b>86</b> because of its excellent anti-SIRT2 activity and selectivity over SIRT1, SIRT3, and SIRT5. Accordingly, compound <b>86</b>’s IC<sub>50</sub> values were determined against NAD<sup>+</sup> and the peptide substrate. A secondary plot of IC<sub>50</sub> values versus [<i>S</i>]/<i>K</i><sub>M</sub> was analyzed using the tight binding versions of the Cheng–Prusoff equations.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> As depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, a plot of IC<sub>50</sub> values versus the concentrations of NAD<sup>+</sup> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) indicated that compound <b>86</b> was competitive against NAD<sup>+</sup>. Furthermore, a plot of IC<sub>50</sub> values versus the concentrations of the peptide substrate (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B) showed that compound <b>86</b> was also a competitive inhibitor with respect to the peptide substrate.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of SIRT2 by compound <b>86</b>. IC<sub>50</sub> values are plotted against either NAD<sup>+</sup> (A) or the peptide substrate (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To examine whether a substituent at position 4 influenced an inhibitor’s inhibition mode, we also tested compound <b>61</b> in which a hydrophobic thiophene, in contrast to compound <b>86</b>’s basic and hydrophilic morpholino group, was placed at position 4. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Figure S1</a>, Supporting Information, an initial examination of a plot of IC<sub>50</sub> values versus the concentrations of NAD<sup>+</sup> suggested that compound <b>61</b> was likely to be competitive against NAD<sup>+</sup>. However, when the data was fitted to a noncompetitive inhibition modality (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Figure S1A</a>; IC<sub>50</sub> = ([<i>S</i>] + <i>K</i><sub>M</sub>)/[(<i>K</i><sub>M</sub>/<i>K</i><sub>i</sub>) + ([<i>S</i>]/α<i>K</i><sub>i</sub>)] + [<i>E</i>]<sub>T</sub>/2), α = 6.2 was obtained. Because a classical noncompetitive inhibitor displays α = 1,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> our result indicated that compound <b>61</b> was mainly competitive against NAD<sup>+</sup>; however, it also exhibited certain features of a noncompetitive inhibitor. Furthermore, a plot of IC<sub>50</sub> values versus the concentrations of the peptide substrate (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Figure S1B</a>, Supporting Information) showed that compound <b>61</b> was a competitive inhibitor with respect to the peptide substrate.</div><div class="NLM_p last">Notably, the inhibition modes of compounds <b>86</b> and <b>61</b> differed from that of compound <b>8</b>, a lead compound previously reported by us.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Like compound <b>8</b>, both compounds <b>86</b> and <b>61</b> were competitive against the peptide substrate. Nevertheless, compound <b>8</b> was most likely a noncompetitive inhibitor with respect to NAD<sup>+</sup>. In contrast, compound <b>86</b> was competitive against NAD<sup>+</sup>, and compound <b>61</b> mainly displayed characteristics of a competitive inhibitor with respect to NAD<sup>+</sup>. This difference suggested that compounds <b>86</b> and <b>61</b> might represent a new class of SIRT2 inhibitors distinct from compound <b>8</b>. Also remarkable, the slightly different inhibition mode exhibited by compound <b>86</b> relative to that of compound <b>61</b> suggested that a substituent at position 4 had a certain impact on their inhibition mode against NAD<sup>+</sup>. However, it was difficult to pinpoint the structural features, such as lipophilicity or basicity, that led to such a discrepancy. It is expected that future structural studies of compounds in complex with SIRT2 will provide clues about different inhibition modes exhibited by these seemingly close analogues.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Computational Modeling</h3><div class="NLM_p last">In an attempt to explore the potential binding modes of compound <b>86</b>, it was docked into human SIRT2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f">1j8f</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Our docking study revealed a major potential binding mode (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) in which the nicotinamide moiety (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, ring C) of compound <b>86</b> interacted with the C-site of the NAD<sup>+</sup> binding pocket. The primary amide functionality in ring C formed two hydrogen bonds with the backbone NH of Ile 169 and the side chain carboxylate of Asp170. The middle ring B was engaged in π–π interactions with Phe 119 and His 187. As a result, ring A (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) extended into the peptide substrate binding pocket, forming a π–π interaction with Phe 235. The observation that compound <b>86</b> occupied both the C-site of the NAD<sup>+</sup> binding pocket and the peptide binding channel might well account for the competitive nature of compound <b>86</b> versus both NAD<sup>+</sup> and the peptide substrate. This binding mode also explained our finding that position 4 was the preferred modification site because position 4 was relatively less hindered. Therefore, a range of substituents, including a morpholino group in compound <b>86</b> and a phenyl group in compound <b>61</b>, were well-tolerated. Interestingly, a similar binding mode was also envisioned for compound <b>8</b>; nevertheless, compound <b>8</b> had another potential binding mode in which the naphthalene and benzamide moieties occupied a mainly hydrophobic pocket that was almost perpendicular to the peptide binding channel. Whether this latter binding mode led to a shift in the inhibition modality of compound <b>8</b> relative to that of <b>86</b> remains to be investigated.<figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed binding mode and interactions of compound <b>86</b> docked into the crystal structure of human SIRT2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f">1j8f</a>). (A) A potential binding mode of compound <b>86</b> (green) in the active site of SIRT2 (surface representation). (B) Potential interactions between compound <b>86</b> and SIRT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vitro Metabolic Stability and Permeability</h3><div class="NLM_p">To obtain preliminary data on the ADME properties of our new SIRT2 inhibitors, we evaluated selected compounds (<b>86</b>, <b>101</b>, and <b>102</b>) for their stability in plasma and liver microsomes from both mouse and human (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). These three compounds were chosen because of their confirmed activity and selectivity (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Furthermore, they also had a relatively low molecular weight and possessed a basic functionality in ring A, both of which are generally preferred for CNS-targeting drugs.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Although all three compounds exhibited excellent stability in human plasma, their stability in mouse plasma was compromised to varied extents. Compounds <b>86</b> and <b>101</b> remained relatively stable in the mouse plasma, but compound <b>102</b> showed modest albeit acceptable stability. An interspecies variance was also observed for microsomal stability. Compound <b>86</b> showed good stability in human liver microsomes but low stability in mouse liver microsomes. Compounds <b>101</b> and <b>102</b> displayed a similar interspecies variance. Nevertheless, they exhibited excellent human microsomal stability together with good stability in the mouse liver microsomes. To estimate whether our selected compounds have desired in vivo BBB permeation, a property that is required for a therapeutic application in PD, we tested our compounds using the Madin–Darby Canine Kidney (MDCKII) cell monolayer assay.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Although compound <b>86</b> showed moderate MDCK permeability, compounds <b>101</b> and <b>102</b> possessed very good permeability (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). In comparison, compound <b>8</b> displayed relatively low MDCK permeability.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. In Vitro ADME Properties of Selected Compounds<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="/">plasma stability (% remaining, 6 h/24 h)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">microsomal stability (<i>t</i><sub>1/2</sub>, min)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MDCK (<i>P</i><sub>app</sub>, ×10<sup>–6</sup> cm/sec)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="/">mouse</th><th class="colsep0 rowsep0" align="center" char="/">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">A to B</th><th class="colsep0 rowsep0" align="center" char=".">B to A</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="char" char="/">74/35</td><td class="colsep0 rowsep0" align="char" char="/">98/98</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="char" char="/">78/25</td><td class="colsep0 rowsep0" align="char" char="/">99/97</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char=".">330</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b></td><td class="colsep0 rowsep0" align="char" char="/">63/7.9</td><td class="colsep0 rowsep0" align="char" char="/">97/99</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">408</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Plasma and microsomal stabilities were determined in triplicate as described in the <a class="ref internalNav" href="#sec4_6" aria-label="Plasma Stability Assay">Plasma Stability Assay</a> and <a class="ref internalNav" href="#sec4_7" aria-label="Microsomal Stability Assay">Microsomal Stability Assay</a> sections, respectively, and the MDCK apparent permeability coefficients were measured as described in <a class="ref internalNav" href="#sec4_9" aria-label="Directional Transport Across MDCKII Cell Monolayers">Directional Transport Across MDCKII Cell Monolayers</a> in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. <i>P</i><sub>app</sub>, apparent permeability coefficient.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cellular Model of α-Synuclein Toxicity</h3><div class="NLM_p">Neuroprotection mediated by SIRT2 inhibition has been investigated in various cellular models of PD.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> We chose to use a cellular model of PD induced by an extracellular supply of aggregated α-synuclein<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> because there has been growing evidence to support the notion that these α-synuclein aggregates are capable of self-propagation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Lower order aggregates of α-synuclein are soluble and capable of permeating into neuronal cells.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Exposure of primary mesencephalic neuroglia and human neuroblastoma cells to aggregated but soluble α-synuclein leads to cytotoxicity, mirroring the mechanism of the spread of synucleinopathies such as PD.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Furthermore, even exogenous α-synuclein fibrils are able to seed the formation of Lewy body (LB)-like intracellular inclusions, leading to synaptic dysfunction, neuron death, and a rapidly progressive neurodegenerative α-synucleinopathy in mice.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> More recently, in both mice and monkeys, inoculations of PD patient-derived LB extracts resulted in progressive nigrostriatal neurodegeneration.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> These observations clearly suggest that α-synuclein aggregation-induced cytotoxicity in SH-SY5Y cells is a reasonable model to gauge protective effects by our SIRT2 inhibitors.</div><div class="NLM_p">Compounds <b>86</b> and <b>102</b> were chosen because they possessed relatively good MDCK permeabilities. In addition, compound <b>61</b> was also included due to its remarkable isozyme selectivity. Furthermore, compound <b>1</b>, a commonly used SIRT2 inhibitor, and compound <b>8</b>, which was reported by us and served as a starting point for this current study, were also included as reference compounds.</div><div class="NLM_p">Because a freshly prepared solution of α-synuclein failed to cause any significant toxicity to SH-SY5Y cells, we generated oligomeric α-synuclein by maintaining the peptide stock solution at 37 °C for 7 days. Compounds <b>86</b> and <b>102</b> were chosen because they possessed excellent activity and relatively good MDCK permeability. In addition, compound <b>1</b>,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> a commonly used SIRT2 inhibitor, was included as a reference compound. When evaluated for their protective effect, both compounds <b>86</b> and <b>102</b> showed statistically significant protection in the low micromolar range (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Protection was indicated by a significant increase in cell growth when compared to the control cells in the presence of α-synuclein (black bars). Furthermore, compounds <b>86</b> and <b>102</b> were not toxic toward SH-SY5Y cells at the concentrations used in this assay (white bars). In comparison, compound <b>1</b> exhibited relatively less protection when used at the same concentration and appeared to be toxic at a higher concentration.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Protection against oligomeric α-synuclein toxicity by selected SIRT2 inhibitors. <sup>≠</sup><i>p</i> < 0.001 vs control cells without α-synuclein treatment; *** <i>p</i> < 0.0001, ** <i>p</i> < 0.001, and * <i>p</i> < 0.05 vs control cells with α-synuclein treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We also evaluated the protective effect by compounds <b>86</b>, <b>102</b>, and <b>61</b> with compound <b>8</b> rather than compound <b>1</b> as a reference compound. Compound <b>61</b> was included due to its remarkable isozyme selectivity. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">Figure S2</a>, Supporting Information, compound <b>86</b> offered statistically significant protection at both 1 and 10 μM, whereas compound <b>102</b> showed significant protection only at 10 μM. Lack of a protective effect at 1 μM was also evident for compound <b>61</b> even though it elicited statistically significant protection at 10 μM. In contrast, compound <b>8</b> provided no significant protection at either concentration. These results indicated that compound <b>86</b> offered improved protection in comparison with compounds <b>61</b> or <b>8</b>. Because the latter two compounds possess excellent anti-SIRT2 and isozyme selectivity, reduced protection might be due to their inferior permeability and/or in vitro metabolic stability.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemical Synthesis</h3><div class="NLM_p">The synthesis of 5-((3-amidobenzyl)oxy)nicotinamide SIRT2 inhibitors was straightforward (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Treatment of commercially available bromide <b>118</b> with methyl 5-hydroxynicotinate gave nitrate <b>119</b>, which was reduced with NaBH<sub>4</sub> in the presence of NiCl<sub>2</sub> to afford amine <b>120</b>. The methyl ester in compound <b>120</b> was converted to the corresponding primary amide <b>121</b> in excellent yield using methanolic ammonia aided by CaCl<sub>2</sub>. Key intermediate <b>121</b> was then used to prepare 5-((3-amidobenzyl)oxy)nicotinamide SIRT2 inhibitors as represented by <b>122</b>. Amide formation was accomplished in varied yields using an acyl chloride, <i>N,N,N</i>′<i>,N</i>′-tetramethyl-<i>O-</i>(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU), <i>N</i>-ethyl-<i>N</i>′-(3-(dimethylamino)propyl)carbodiimide (EDC)/1-hydroxybenzotriazole (HOBt), or EDC alone, as exemplified by the syntheses of compounds <b>10</b>, <b>14</b>, <b>22</b>, and <b>42</b>, respectively.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. SIRT2 Inhibitor Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 5-hydroxynicotinate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 75%; (b) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 80%; (c) NH<sub>3</sub>, CaCl<sub>2</sub>, MeOH, 90%; (d) RCOCl, base; or RCOOH, coupling agents, 1–94%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In our continued efforts to discover novel SIRT2 inhibitors, we have designed compounds based on a 5-((3-aminobenzyl)oxy)nicotinamide core structure (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Our extensive SAR studies have revealed several key structural features that convey excellent activity against SIRT2 and high selectivity over SIRT1 and SIRT3. We have identified position 4 of benzamide ring A as the most rewarding modification site, leading to a number of potent and selective SIRT2 inhibitors. Selected compounds also showed selectivity over SIRT5. Kinetic studies of the representative SIRT2 inhibitor <b>86</b> revealed that it was competitive against both NAD<sup>+</sup> and the peptide substrate, an inhibitory modality that was supported by computational modeling. When evaluated for their in vitro ADME properties, selected compounds exhibited generally favorable properties, including metabolic stability and permeability. This finding prompted us to test compounds <b>86</b> and <b>102</b> in an α-synuclein aggregation-induced cytotoxicity model in SH-SY5Y cells in which a protective effect against α-synuclein toxicity was observed for both compounds. Taken together, excellent anti-SIRT2 activity, high isozyme selectivity, a generally favorable in vitro ADME profile, significant protection against α-synuclein toxicity, and facile syntheses make 5-((3-amidobenzyl)oxy)nicotinamides not only a new class of SIRT2 inhibitors but also attractive candidates for further lead optimization. Optimized SIRT2 inhibitors will be tested for efficacy in animal models of PD in our future studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemical Synthesis</h3><div class="NLM_p">All commercial reagents were used as provided unless otherwise indicated. An anhydrous solvent dispensing system (J. C. Meyer) using 2 packed columns of neutral alumina was used for drying THF, Et<sub>2</sub>O, and CH<sub>2</sub>Cl<sub>2,</sub> whereas 2 packed columns of molecular sieves were used to dry DMF. Solvents were dispensed under argon. Flash chromatography was performed with Ultra Pure silica gel (Silicycle) or with RediSep R<sub>f</sub> silica gel columns on a Teledyne ISCO CombiFlash R<sub>f</sub> system using the solvents as indicated. Nuclear magnetic resonance spectra were recorded on a Varian 600 MHz with Me<sub>4</sub>Si or signals from residual solvent as the internal standard for <sup>1</sup>H. Chemical shifts are reported in ppm, and signals are described as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), bs (broad singlet), and dd (double doublet). Values given for coupling constants are first order. High resolution mass spectra were recorded on an Agilent TOF II TOF/MS instrument equipped with a multimode source (ESI or APCI). Analysis of sample purity was performed on an Agilent 1200 Infinity series HPLC system with a Phenomenex Gemini C18 column (5 μ, 4.6 × 250 mm). HPLC conditions were as follows: solvent A = water, solvent B = MeCN or MeOH, and flow rate = 2.0 mL/min. Compounds were eluted with a gradient of 10–100% MeCN/water or 10–100% MeOH/water in 15 min. Purity was determined by the absorbance at 254 nm. All tested compounds have a purity of ≥95%.</div><div class="NLM_p">Representative procedures for the preparation of SIRT2 inhibitors using aniline <b>121</b>.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5-((3-(4-Methyl-3-nitrobenzamido)benzyl)oxy)nicotinamide (<b>10</b>)</h4><div class="NLM_p last">To a solution of amine <b>121</b> (52 mg, 0.21 mmol) and DIPEA (80 μL, 0.46 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and DMF (1 mL) was added 4-methyl-3-nitrobenzoyl chloride (50 μL, 0.34 mmol), and the mixture was allowed to stir at rt for 24 h. After the solvents were removed, the residue was diluted with EtOAc (30 mL), H<sub>2</sub>O (10 mL), and saturated NaHCO<sub>3</sub> (10 mL). After separation, the organic layer was washed with brine (20 mL) and concentrated. The residue was purified by flash column chromatography (0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give compound <b>10</b> as a white solid (51 mg, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 10.54 (s, 1H), 8.65 (s, 1H), 8.58 (s, 1H), 8.50 (d, <i>J</i> = 3.0 Hz, 1H), 8.22 (d, <i>J</i> = 7.8 Hz, 1H), 8.14 (s, 1H), 7.91 (s, 1H), 7.86 (s, 1H), 7.77 (d, <i>J</i> = 7.8 Hz, 1H), 7.68 (d, <i>J</i> = 7.8 Hz, 1H), 7.62 (s, 1H), 7.41 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.24 (d, <i>J</i> = 7.2 Hz, 1H), 5.26 (s, 2H), 2.60 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 166.6, 163.7, 154.7, 149.2, 141.4, 141.0, 139.4, 137.3, 136.8, 134.1, 133.5, 132.6, 130.8, 129.4, 124.0, 123.8, 120.6, 120.5, 120.1, 70.2, 20.0; HRMS (ESI<sup>+</sup>) calcd for C<sub>21</sub>H<sub>19</sub>N<sub>4</sub>O<sub>5</sub> (M + H)<sup>+</sup> 407.1350, found 407.1353.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-((3-(Cyclohex-1-enecarboxamido)benzyl)oxy)nicotinamide (<b>14</b>)</h4><div class="NLM_p last">To a solution of cyclohex-1-ene-1-carboxylic acid (61.8 mg, 0.49 mmol), HBTU (186 mg, 0.49 mmol), and DIPEA (0.21 mL, 1.23 mmol) in THF (10 mL) was added amine <b>121</b> (100 mg, 0.41 mmol), and the mixture was allowed to stir at rt for 12 h. After the solvents were removed, the residue was diluted with EtOAc (30 mL), H<sub>2</sub>O (10 mL), and saturated NaHCO<sub>3</sub> (10 mL). After separation, the organic layer was washed with brine (20 mL) and concentrated. The residue was purified by flash column chromatography (0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give compound <b>14</b> as a white solid (120 mg, 84%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 9.65 (s, 1H), 8.64 (s, 1H), 8.47 (d, <i>J</i> = 3.0 Hz, 1H), 8.14 (s, 1H), 7.85–7.82 (m, 1H), 7.81 (s, 1H), 7.65–7.57 (m, 2H), 7.32 (dd, <i>J</i> = 8.1, 8.1 Hz, 1H), 7.14 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 6.65 (s, 1H), 5.20 (s, 2H), 2.27–2.22 (m, 2H), 2.20–2.14 (m, 2H), 1.66–1.60 (m, 2H), 1.60–1.54 (m, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 167.5, 166.6, 154.7, 141.4, 141.0, 141.1, 137.0, 134.4, 133.5, 130.8, 129.1, 122.9, 120.4, 120.2, 119.6, 70.2, 25.3, 24.4, 22.2, 21.7; HRMS (ESI<sup>+</sup>) calcd for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 352.1656, found 352.1669.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-((3-(Benzo[<i>b</i>]thiophene-2-carboxamido)benzyl)oxy)nicotinamide (<b>22</b>)</h4><div class="NLM_p last">To a solution of benzo[<i>b</i>]thiophene-2-carboxylic acid (37 mg, 0.21 mmol), HOBt (28 mg, 0.21 mmol), and EDC (28 mg, 0.21 mmol) in DCM (15 mL) was added amine <b>121</b> (50 mg, 0.21 mmol), and the mixture was allowed to stir at rt for 16 h. After the solvents were removed, the residue was diluted with EtOAc (30 mL), H<sub>2</sub>O (10 mL), and saturated NaHCO<sub>3</sub> (10 mL). After separation, the organic layer was washed with brine (20 mL) and concentrated. The residue was purified by flash column chromatography (0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give compound <b>22</b> as a pale solid (48 mg, 57%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 10.58 (s, 1H), 8.66 (s, 1H), 8.51 (d, <i>J</i> = 3.0 Hz, 1H), 8.38 (s, 1H), 8.14, (s, 1H), 8.06 (d, <i>J</i> = 8.4 Hz, 1H), 8.01 (d, <i>J</i> = 7.2 Hz, 1H), 7.91 (s, 1H), 7.87 (s, 1H), 7.76 (d, <i>J</i> = 9.6 Hz, 1H), 7.61 (s, 1H), 7.52–7.45 (m, 2H), 7.42 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.24 (d, <i>J</i> = 7.2 Hz, 1H) 5.27 (s, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 166.6, 160.8, 154.7, 141.5, 141.0, 141.0, 140.4, 139.6, 139.3, 137.4, 130.8, 129.4, 126.9, 126.4, 125.9, 125.5, 123.7, 123.5, 120.5, 120.4, 119.8, 70.2; HRMS (ESI<sup>+</sup>) calcd for C<sub>22</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 404.1063, found 404.1064.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-((3-(2-Cyanobenzamido)benzyl)oxy)nicotinamide (<b>42</b>)</h4><div class="NLM_p last">To a solution of 2-cyanobenzoic acid (22 mg, 0.25 mmol) and EDC (47 mg, 0.25 mmol) in DMF/DCM (1:1, 10 mL) was added amine <b>121</b> (50 mg, 0.21 mmol), and the mixture was allowed to stir at rt for 12 h. After the solvents were removed, the residue was diluted with EtOAc (30 mL), H<sub>2</sub>O (10 mL), and saturated NaHCO<sub>3</sub> (10 mL). After separation, the organic layer was washed with brine (20 mL) and concentrated. The residue was purified by flash column chromatography (0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give compound <b>42</b> as a pale solid (10 mg, 13%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 10.29 (s, 1H), 8.66 (s, 1H), 8.51 (d, <i>J</i> = 2.4 Hz, 1H), 8.27 (d, <i>J</i> = 7.2 Hz, 1H), 8.14 (s, 1H), 7.92–7.85 (m, 3H), 7.82–7.78 (m, 1H), 7.64–7.52 (m, 4H), 7.45 (d, <i>J</i> = 7.8 Hz, 1H), 5.30 (s, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 167.3, 166.6, 159.7, 154.7, 141.5, 141.0, 137.3, 134.2, 133.0, 131.7, 130.8, 130.4, 129.2, 128.4, 127.9, 127.4, 123.3, 123.2, 120.5, 110.0, 69.9; HRMS (ESI<sup>+</sup>) calcd for C<sub>21</sub>H<sub>17</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 373.1295, found 373.1302.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 5-((3-Nitrobenzyl)oxy)nicotinate (<b>119</b>)</h4><div class="NLM_p last">To a solution of 3-nitrobenzyl bromide (<b>118</b>, 9.50 g, 44 mmol) in DMF (80 mL) were added methyl 5-hydroxynicotinate (6.12 g, 40 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (26.1 g, 80 mmol), and the mixture was allowed to stir at rt for 12 h. After water (200 mL) was added, the precipitate was filtered, washed with hexanes, and dried in vacuo to yield compound <b>119</b> as a light yellow solid (8.64 g, 75%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 8.89 (d, <i>J</i> = 1.2 Hz, 1H), 8.58 (d, <i>J</i> = 3.0 Hz, 1H), 8.35 (s, 1H), 8.24 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (dd, <i>J</i> = 3.0, 1.8, Hz, 1H), 7.79 (d, <i>J</i> = 7.2 Hz, 1H), 6.61 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 5.25 (s, 2H), 3.97 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 165.6, 149.3, 143.2, 142.5, 142.5, 137.0, 129.4, 121.3, 121.3, 115.4, 114.1, 113.2, 70.7, 52.9; HRMS (ESI<sup>+</sup>) calcd for C<sub>14</sub>H<sub>13</sub>N<sub>2</sub>O<sub>5</sub> (M + H)<sup>+</sup> 289.0819, found 289.0820.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 5-((3-Aminobenzyl)oxy)nicotinate (<b>120</b>)</h4><div class="NLM_p last">To a solution of compound <b>119</b> (8.64 g, 30 mmol) and NiCl<sub>2</sub>·6H<sub>2</sub>O (14.3 g, 44 mmol) in MeOH (100 mL) was slowly added NaBH<sub>4</sub> (4.8 g, 120 mmol), and the mixture was allowed to stir at rt for 3 h. The reaction was quenched with saturated NH<sub>4</sub>Cl (50 mL), and the mixture was extracted with EtOAc. The organic phase was washed with water and brine, dried over anhydrous K<sub>2</sub>CO<sub>3,</sub> and concentrated in vacuo. The residue was purified by flash column chromatography (0–60% EtOAc/hexanes) to afford compound <b>120</b> as a light yellow solid (6.19 g, 80%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 8.83 (d, <i>J</i> = 1.8 Hz, 1H), 8.53 (d, <i>J</i> = 3.0 Hz, 1H), 8.83 (dd, <i>J</i> = 2.4, 1.8, Hz, 1H), 7.18 (d, <i>J</i> = 7.8 Hz, 1H), 6.80 (d, <i>J</i> = 7.8 Hz, 1H), 6.76 (s, 1H), 6.66 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 5.30 (s, 2H), 5.06 (s, 2H), 3.95 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 165.6, 153.8, 148.3, 143.3, 142.9, 138.9, 134.7, 130.6, 130.6, 123.5, 122.7, 121.4, 69.0, 53.0; HRMS (ESI<sup>+</sup>) calcd for C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 259.1077, found 259.1080.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-((3-Aminobenzyl)oxy)nicotinamide (<b>121</b>)</h4><div class="NLM_p last">A solution of methyl ester <b>120</b> (6.19 g, 24 mmol) and CaCl<sub>2</sub> (2.66 g, 24 mmol) in NH<sub>3</sub>/MeOH (∼7 N, 20 mL) in a sealed tube was heated at 70 °C for 24 h. After the solvent was evaporated in vacuo, the residue was dissolved in EtOAc (150 mL), and the resulting solution was washed with H<sub>2</sub>O (150 mL) and brine (100 mL). After the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, the filtrate was concentrated, and the residue was purified by flash column chromatography (0–5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford compound <b>121</b> as a light yellow solid (5.25 g, 90%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz) δ 8.63 (s, 1H), 8.44 (d, <i>J</i> = 3.0 Hz, 1H), 8.12 (s, 1H), 7.81 (s, 1H), 7.60 (s, 1H), 7.02 (dd, <i>J</i> = 7.5, 7.5 Hz, 1H), 6.63 (s, 1H), 6.57 (d, <i>J</i> = 7.8 Hz, 1H), 6.52 (d, <i>J</i> = 7.8 Hz, 1H), 5.13 (s, 2H), 5.07 (s, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz) δ 166.6, 154.8, 149.3, 141.2, 141.0, 137.2, 130.8, 129.4, 120.3, 115.4, 114.0, 113.3, 70.6; HRMS (ESI<sup>+</sup>) calcd for C<sub>13</sub>H<sub>14</sub>N<sub>3</sub>O<sub>2</sub> (M + H)<sup>+</sup> 244.1081, found 244.1082.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Initial SIRT1–3 and SIRT5 Biochemical Assays</h3><div class="NLM_p last">Initial biochemical assays against human SIRT1–3 were performed at Reaction Biology Corporation (RBC) (Malvern, PA, USA, <a href="http://www.reactionbiology.com" class="extLink">http://www.reactionbiology.com</a>) as reported previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The activity against SIRT5 was measured under conditions similar to those used for SIRT1–3. Briefly, human SIRT5 (UniProt ID: Q9NXA8, amino acids 37–310 with N-terminal His-tag, MW = 32.3 kDa) was expressed in <i>E. coli</i> and purified. Ac-Lys(Succ.)-AMC (50 μM) was used as a fluorogenic SIRT5 substrate in conjunction with NAD<sup>+</sup> (500 μM). After the deacetylation reaction was allowed to proceed at 30 °C for 2 h, the mixture was developed, and the fluorescence intensity was measured at 360/460 ex/em. Compounds were tested in a 10-dose mode with a 3-fold serial dilution starting at 200 μM (200 μM to 10.2 nM) in singlet. The IC<sub>50</sub> values were then calculated from the resulting sigmoidal dose–response curves using GraphPad Prism.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In-House SIRT1–3 Biochemical Assays</h3><div class="NLM_p">Human SIRT1–3 proteins were expressed and purified as reported previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Plasmids for the expression of SIRT1 (SIRT1.1, Addgene plasmid 13735) and SIRT3 (SIRT3L-12, Addgene plasmid 13736) were gifts from John Denu.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The enzymatic assays were performed according to the following conditions under which the concentrations of NAD and the peptide substrate were used at the <i>K</i><sub>M</sub> values determined for each enzyme to accurately assess a compound’s selectivity against SIRT1–3 (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Enzymatic Assay Conditions</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center">SIRT1</th><th class="colsep0 rowsep0" align="center">SIRT2</th><th class="colsep0 rowsep0" align="center">SIRT3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NAD (mM)</td><td class="colsep0 rowsep0" align="center">0.26</td><td class="colsep0 rowsep0" align="center">0.20</td><td class="colsep0 rowsep0" align="center">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peptide substrate (mM)</td><td class="colsep0 rowsep0" align="center">0.45</td><td class="colsep0 rowsep0" align="center">0.30</td><td class="colsep0 rowsep0" align="center">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">enzyme (μM)</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center">0.10</td><td class="colsep0 rowsep0" align="center">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">reaction time (min)</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">60</td></tr></tbody></table></div></div><div class="NLM_p last">Compounds were aliquoted (0.5 μL) in duplicate into a black 384-well nonbinding surface plate (Corning). A master mix containing assay buffer (50 mM Tris pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>, 1 mM DTT, and 1 mg/mL BSA) and NAD<sup>+</sup> was added to at least two wells to serve as a negative control. Enzyme was added to the remaining master mix, and the resulting solution was then aliquoted into the remaining wells. The plate was mixed for 30 s at 1,500 rpm on a MixMate (Eppendorf) and left at 25 °C for 10 min. The reactions were initiated by the addition of the peptide substrate (Ac)RHKK(Ac)-AMC (to a final volume of 50 μL) followed by mixing of the plate as described above. The reaction was allowed to proceed at 37 °C for the desired time and then quenched by the addition of 10 μL developing buffer (12 mM nicotinamide and 30,000 U/mL trypsin in water). The plate was mixed and then developed for 20 min at 37 °C before the fluorescence intensity was measured using an excitation at 355 nm and an emission at 460 nm. The data were analyzed using either the Morrison equation (SIRT2) or the four-parameter dose response equation (SIRT1 and 3) in GraphPad Prism.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Determination of Inhibition Modality by Compounds <b>86</b> and <b>61</b> against SIRT2</h3><div class="NLM_p last">The mode of inhibition assay was performed using the peptide substrate (Ac)RHKK(Ac)-AMC in a manner similar to that described previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The assay was carried out using 100 nM recombinant SIRT2 protein (concentration determined by active site titration) in 50 μL of assay buffer. The concentration of NAD<sup>+</sup> was either held constant at 0.35 mM with variable peptide concentrations (0.015, 0.044, 0.133, 0.400, 1.20, and 3.60 mM) or varied (0.044, 0.133, 0.400, 1.20, and 3.60 mM) with a constant peptide concentration (0.52 mM). The concentration of compound <b>86</b> or <b>61</b> was varied from 0.0206 to 5.00 μM (3-fold serial dilution) with 100 μM included as a negative control. Reactions were initiated by the addition of the peptide substrate and incubated at 37 °C for 20 min. The reactions were then stopped, developed, and detected as described above. The IC<sub>50</sub> value was calculated by using GraphPad Prism software to fit the data to the log (inhibitor) vs response with a variable slope (four parameters). Secondary plots of IC<sub>50</sub> as a function of the substrate concentration over K<sub>M</sub> were used to determine binding modality by fitting to the Cheng–Prusoff tight binding equations and selecting the mode that afforded the best fit.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Molecular Modeling</h3><div class="NLM_p last">The modeling study was carried out as described previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Plasma Stability Assay</h3><div class="NLM_p last">The plasma stability assay was performed in triplicate by incubating a compound in normal mouse and human plasma at 37 °C. At 0, 1, 3, 6, and 24 h, aliquots of the plasma mixture were taken and quenched with 3 volumes of acetonitrile containing an appropriate internal standard. The samples were then vortexed and centrifuged at 14,000 rpm for 5 min. The supernatants were collected and analyzed by LC-MS/MS to determine the remaining percentage at various time points.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Microsomal Stability Assay</h3><div class="NLM_p last">The in vitro microsomal stability assay was conducted in triplicate in mouse and human liver microsomal systems. In a typical incubation, a compound (typically 1 μM final concentration) was spiked into the reaction mixture containing 0.5 mg/mL of liver microsomal protein and 1 mM of NADPH in 0.1 M potassium phosphate buffer (pH 7.4) at 37 °C. At various time points, 1 volume of reaction aliquot was taken and quenched with 3 volumes of acetonitrile with an appropriate internal standard. The samples were then vortexed and centrifuged at 14,000 rpm for 5 min. The supernatants were collected and analyzed by LC-MS/MS to determine the in vitro metabolic half-life (<i>t</i><sub>1/2</sub>) and intrinsic clearance (CL<sub>int</sub>). Verapamil was used as a positive control.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> LC-MS/MS Bioanalysis</h3><div class="NLM_p last">Quantification and analysis of compounds in biological samples were carried out on an AB Sciex QTrap 5500 mass spectrometer coupled with an Agilent 1260 Infinity HPLC. The chromatographic separation of compounds was achieved using a Phenomenex Kinetex C18 column (50 × 2.1 mm, 2.6 μm), and MS/MS analysis was conducted using an ESI ion source with MRM detection. The MS/MS detection parameters including declustering potential (DP), entrance potential (EP), collision energy (CE), and collision cell exit potential (CXP) were optimized for each compound.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Directional Transport across MDCKII Cell Monolayers</h3><div class="NLM_p last">The transport experiments were performed under conditions described previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The recovery of compound was >90% at the end of the experiment.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Protection against α-Synuclein Toxicity</h3><div class="NLM_p last">SH-SY5Y cells were seeded in a 96-well plate at a density of 20,000 cells/well. On the next day, the cells were treated with SIRT2 inhibitors at varied concentrations at 37 °C for 30 min, followed by the addition of media containing oligomeric α-synuclein to a final concentration of 10 μM. The oligomeric α-synuclein was generated by maintaining an α-synuclein (rPeptide) stock solution (100 μM in water) at 37 °C for 7 days. The cells were then incubated for 72 h. The media containing compounds was replaced with fresh media, and cell viability was then determined through MTT assay.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Data were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett’s posthoc comparison test with the significance level held at 0.05 (95% confidence intervals).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01376">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"> Table S1–S3 and Figure S1–S2. The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01376" class="ext-link">10.1021/acs.jmedchem.5b01376</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Chemical characterization data of compounds <b>11−13</b>, <b>15−21</b>, <b>23−41</b>, and <b>43−117</b>; inhibitory activity of 5-((3-amidobenzyl)oxy)nicotinamides (compounds <b>33−44</b>, <b>50−55</b>, and <b>88−99</b>); inhibition of SIRT2 by compound <b>61</b>, and protection against oligomeric α-synuclein toxicity by selected SIRT2 inhibitors (<b>8</b>, <b>61</b>, <b>86</b>, and <b>102</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">IC<sub>50</sub> values of the compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf">jm5b01376_si_001.pdf (455.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_002.csv">jm5b01376_si_002.csv (10.29 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01376" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liqiang Chen</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic
Health Center, University of Minnesota, 516 Delaware Street SE, Minneapolis, Minnesota 55455, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#05666d606b7d3133374570686b2b606170"><span class="__cf_email__" data-cfemail="e6858e83889ed2d0d4a6938b88c8838293">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teng Ai</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic
Health Center, University of Minnesota, 516 Delaware Street SE, Minneapolis, Minnesota 55455, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Wilson</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic
Health Center, University of Minnesota, 516 Delaware Street SE, Minneapolis, Minnesota 55455, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swati S. More</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic
Health Center, University of Minnesota, 516 Delaware Street SE, Minneapolis, Minnesota 55455, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiashu Xie</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Design, Academic
Health Center, University of Minnesota, 516 Delaware Street SE, Minneapolis, Minnesota 55455, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d79e3386-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the Center for Drug Design in the Academic Health Center of the University of Minnesota. We thank Dr. Huaqing Cui for the preparation of compounds <b>11</b>–<b>13</b>, <b>15</b>–<b>21</b>, <b>28</b>–<b>41</b>, <b>45</b>–<b>55</b>, <b>56</b>–<b>58</b>, <b>60</b>, <b>79</b>, <b>84</b>–<b>87</b>, and <b>100</b>–<b>106</b> from intermediate <b>121</b>. The University of Minnesota Supercomputing Institute provided all of the necessary computational resources.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> Abbreviations Used</h2><tr><td class="NLM_term">SIRT2</td><td class="NLM_def"><p class="first last">Sirtuin 2</p></td></tr><tr><td class="NLM_term">NAD<sup>+</sup></td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">AMC</td><td class="NLM_def"><p class="first last">7-amino-4-methylcoumarin</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby Canine Kidney</p></td></tr><tr><td class="NLM_term">A to B</td><td class="NLM_def"><p class="first last">from the apical to basolateral side</p></td></tr><tr><td class="NLM_term">B to A</td><td class="NLM_def"><p class="first last">from the basolateral to apical side</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability coefficient</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>N,N,N</i>′<i>,N</i>′-tetramethyl-<i>O-</i>(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-<i>N</i>′-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Houtkooper, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span> </span><span class="NLM_article-title">Sirtuins as regulators of metabolism and healthspan</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span><span class="refDoi"> DOI: 10.1038/nrm3293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fnrm3293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22395773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=225-238&author=R.+H.+Houtkooperauthor=E.+Pirinenauthor=J.+Auwerx&title=Sirtuins+as+regulators+of+metabolism+and+healthspan&doi=10.1038%2Fnrm3293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins as regulators of metabolism and healthspan</span></div><div class="casAuthors">Houtkooper, Riekelt H.; Pirinen, Eija; Auwerx, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-238</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the beginning of the century, the mammalian sirtuin protein family (comprising SIRT1-SIRT7) has received much attention for its regulatory role, mainly in metab. and ageing.  Sirtuins act in different cellular compartments: they deacetylate histones and several transcriptional regulators in the nucleus, but also specific proteins in other cellular compartments, such as in the cytoplasm and in mitochondria.  As a consequence, sirtuins regulate fat and glucose metab. in response to physiol. changes in energy levels, thereby acting as crucial regulators of the network that controls energy homeostasis and as such dets. healthspan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGF2VZDiGC9LVg90H21EOLACvtfcHk0lj6aToaS1B3QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOktbw%253D&md5=3e7e0a6b23e8d7d4ad7be32bdce28d96</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3293%26sid%3Dliteratum%253Aachs%26aulast%3DHoutkooper%26aufirst%3DR.%2BH.%26aulast%3DPirinen%26aufirst%3DE.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DSirtuins%2520as%2520regulators%2520of%2520metabolism%2520and%2520healthspan%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D225%26epage%3D238%26doi%3D10.1038%2Fnrm3293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pandithage, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilischkis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harting, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedamzik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscher-Firzlaff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoorts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasonder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscher, B.</span><span> </span><span class="NLM_article-title">The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span><span class="refDoi"> DOI: 10.1083/jcb.200707126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1083%2Fjcb.200707126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=18332217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlKmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=915-929&author=R.+Pandithageauthor=R.+Lilischkisauthor=K.+Hartingauthor=A.+Wolfauthor=B.+Jedamzikauthor=J.+Luscher-Firzlaffauthor=J.+Vervoortsauthor=E.+Lasonderauthor=E.+Kremmerauthor=B.+Knollauthor=B.+Luscher&title=The+regulation+of+SIRT2+function+by+cyclin-dependent+kinases+affects+cell+motility&doi=10.1083%2Fjcb.200707126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility</span></div><div class="casAuthors">Pandithage, Ruwin; Lilischkis, Richard; Harting, Kai; Wolf, Alexandra; Jedamzik, Britta; Luescher-Firzlaff, Juliane; Vervoorts, Joerg; Lasonder, Edwin; Kremmer, Elisabeth; Knoell, Bernd; Luescher, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">915-929</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (Cdks) fulfill key functions in many cellular processes, including cell cycle progression and cytoskeletal dynamics.  A limited no. of Cdk substrates have been identified with few demonstrated to be regulated by Cdk-dependent phosphorylation.  We identify on protein expression arrays novel cyclin E-Cdk2 substrates, including SIRT2, a member of the Sirtuin family of NAD+-dependent deacetylases that targets α-tubulin.  We define Ser-331 as the site phosphorylated by cyclin E-Cdk2, cyclin A-Cdk2, and p35-Cdk5 both in vitro and in cells.  Importantly, phosphorylation at Ser-331 inhibits the catalytic activity of SIRT2.  Gain- and loss-of-function studies demonstrate that SIRT2 interfered with cell adhesion and cell migration.  In postmitotic hippocampal neurons, neurite outgrowth and growth cone collapse are inhibited by SIRT2.  The effects provoked by SIRT2, but not those of a nonphosphorylatable mutant, are antagonized by Cdk-dependent phosphorylation.  Collectively, our findings identify a posttranslational mechanism that controls SIRT2 function, and they provide evidence for a novel regulatory circuitry involving Cdks, SIRT2, and microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Zr24RfU0OrVg90H21EOLACvtfcHk0ljUxZYnVyhfOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlKmtbg%253D&md5=3cfb57c6e7556f30a055ddd674d61262</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200707126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200707126%26sid%3Dliteratum%253Aachs%26aulast%3DPandithage%26aufirst%3DR.%26aulast%3DLilischkis%26aufirst%3DR.%26aulast%3DHarting%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DJedamzik%26aufirst%3DB.%26aulast%3DLuscher-Firzlaff%26aufirst%3DJ.%26aulast%3DVervoorts%26aufirst%3DJ.%26aulast%3DLasonder%26aufirst%3DE.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DKnoll%26aufirst%3DB.%26aulast%3DLuscher%26aufirst%3DB.%26atitle%3DThe%2520regulation%2520of%2520SIRT2%2520function%2520by%2520cyclin-dependent%2520kinases%2520affects%2520cell%2520motility%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D915%26epage%3D929%26doi%3D10.1083%2Fjcb.200707126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Harting, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, B.</span><span> </span><span class="NLM_article-title">SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology</span> <span class="citation_source-journal">Eur. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1016/j.ejcb.2009.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ejcb.2009.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20004495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2010&pages=262-269&author=K.+Hartingauthor=B.+Knoll&title=SIRT2-mediated+protein+deacetylation%3A+An+emerging+key+regulator+in+brain+physiology+and+pathology&doi=10.1016%2Fj.ejcb.2009.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2-mediated protein deacetylation: an emerging key regulator in brain physiology and pathology</span></div><div class="casAuthors">Harting, Kai; Knoell, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">262-269</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Protein function is considerably altered by posttranslational modification.  In recent years, cycles of acetylation/deacetylation emerged as fundamental regulators adjusting biol. activity of many proteins.  Particularly, protein deacetylation by Sirtuins, a family of atypical histone deacetylases (HDACs), was demonstrated to regulate fundamental cell biol. processes including gene expression, genome stability, mitosis, nutrient metab., aging, mitochondrial function and cell motility.  Given this wealth of biol. functions, perhaps not unexpectedly then, pharmacol. compds. targeting Sirtuin activity are now prime therapeutic agents for alleviating severity of major diseases encompassing diabetes, cancer, cardiovascular and neurodegenerative disorders in many organs.  In this review, we will focus on the brain and its physiol. and pathol. processes governed by Sirtuin-mediated deacetylation.  Besides discussing Sirtuin function in neurodegenerative diseases, emphasis will be given on the mounting evidence deciphering key developmental brain functions for Sirtuins in neuronal motility, neuroprotection and oligodendrocyte differentiation.  In this respect, we will particularly highlight functions of the unconventional family member SIRT2 in postmitotic neurons and glial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd7fhGWNOt5bVg90H21EOLACvtfcHk0ljUxZYnVyhfOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFSksbc%253D&md5=a5c27ac7529590c28162c51479aa5d2d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2009.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2009.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DHarting%26aufirst%3DK.%26aulast%3DKnoll%26aufirst%3DB.%26atitle%3DSIRT2-mediated%2520protein%2520deacetylation%253A%2520An%2520emerging%2520key%2520regulator%2520in%2520brain%2520physiology%2520and%2520pathology%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2010%26volume%3D89%26spage%3D262%26epage%3D269%26doi%3D10.1016%2Fj.ejcb.2009.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Pfister, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Mello, S. R.</span><span> </span><span class="NLM_article-title">Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e4090</span><span class="refDoi"> DOI: 10.1371/journal.pone.0004090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1371%2Fjournal.pone.0004090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e4090&author=J.+A.+Pfisterauthor=C.+Maauthor=B.+E.+Morrisonauthor=S.+R.+D%E2%80%99Mello&title=Opposing+effects+of+sirtuins+on+neuronal+survival%3A+SIRT1-mediated+neuroprotection+is+independent+of+its+deacetylase+activity&doi=10.1371%2Fjournal.pone.0004090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004090%26sid%3Dliteratum%253Aachs%26aulast%3DPfister%26aufirst%3DJ.%2BA.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DD%25E2%2580%2599Mello%26aufirst%3DS.%2BR.%26atitle%3DOpposing%2520effects%2520of%2520sirtuins%2520on%2520neuronal%2520survival%253A%2520SIRT1-mediated%2520neuroprotection%2520is%2520independent%2520of%2520its%2520deacetylase%2520activity%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De4090%26doi%3D10.1371%2Fjournal.pone.0004090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathearn, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1126/science.1143780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1126%2Fscience.1143780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=17588900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1143780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease</span></div><div class="casAuthors">Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5837</span>),
    <span class="NLM_cas:pages">516-519</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging.  We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued α-synuclein toxicity and modified inclusion morphol. in a cellular model of Parkinson's disease.  Genetic inhibition of SIRT2 via small interfering RNA similarly rescued α-synuclein toxicity.  Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease.  The results suggest a link between neurodegeneration and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm5psHCGzkkLVg90H21EOLACvtfcHk0lht8mIZZbzIPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D&md5=4b8914c34ad0f45fb51b94701609bfa6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1143780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1143780%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519%26doi%3D10.1126%2Fscience.1143780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peritore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donmez, G.</span><span> </span><span class="NLM_article-title">SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway</span> <span class="citation_source-journal">Front. Aging Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="refDoi"> DOI: 10.3389/fnagi.2014.00184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.3389%2Ffnagi.2014.00184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25157229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Flt1Cisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=184&author=L.+Liuauthor=A.+Arunauthor=L.+Ellisauthor=C.+Peritoreauthor=G.+Donmez&title=SIRT2+enhances+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+%28MPTP%29-induced+nigrostriatal+damage+via+apoptotic+pathway&doi=10.3389%2Ffnagi.2014.00184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway</span></div><div class="casAuthors">Liu Lei; Arun Anirudh; Ellis Lakia; Peritore Carina; Donmez Gizem</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in aging neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">184</span>
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    </div><div class="casAbstract">Sirtuins are NAD-dependent protein deacetylases that were shown to have protective effects against different age-related diseases.  SIRT2 is a strong deacetylase that is highly expressed in brain.  It has been associated with neurodegenerative diseases.  MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a dopaminergic neurotoxin that displays clinical features of Parkinson's Disease (PD).  MPTP leads to the degeneration of nigrostriatal dopaminergic pathway after its systemic administration.  Chronic administration of MPTP induces lesion via apoptosis.  We show here that SIRT2 deacetylates Foxo3a, increases RNA and protein levels of Bim, and as a result enhances apoptosis in the MPTP model of PD.  We also show that neurodegeneration induced by chronic MPTP regimen is prevented by genetic deletion of SIRT2 in mouse.  Deletion of SIRT2 leads to the reduction of apoptosis due to an increase in acetylation of Foxo3a and a decrease in Bim levels.  We demonstrate that SIRT2 deacetylates Foxo3a, activates Bim, and induces apoptosis only in MPP(+)-treated cells.  Therefore, designing SIRT2 inhibitors might be helpful in developing effective treatments for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-tLqy8t8LFrZpSb_XWfMrfW6udTcc2ea_DejAI1lPX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Flt1Cisg%253D%253D&md5=6f00800f5c19d8c33fa8dae8dffdea25</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2014.00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2014.00184%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DArun%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DPeritore%26aufirst%3DC.%26aulast%3DDonmez%26aufirst%3DG.%26atitle%3DSIRT2%2520enhances%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520%2528MPTP%2529-induced%2520nigrostriatal%2520damage%2520via%2520apoptotic%2520pathway%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2014%26volume%3D6%26spage%3D184%26doi%3D10.3389%2Ffnagi.2014.00184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herisson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauf, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayata, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116919</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1371%2Fjournal.pone.0116919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25608039" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116919&author=X.+Chenauthor=P.+Walesauthor=L.+Quintiauthor=F.+Zuoauthor=S.+Moniotauthor=F.+Herissonauthor=N.+A.+Raufauthor=H.+Wangauthor=R.+B.+Silvermanauthor=C.+Ayataauthor=M.+M.+Maxwellauthor=C.+Steegbornauthor=M.+A.+Schwarzschildauthor=T.+F.+Outeiroauthor=A.+G.+Kazantsev&title=The+sirtuin-2+inhibitor+AK7+is+neuroprotective+in+models+of+Parkinson%E2%80%99s+disease+but+not+amyotrophic+lateral+sclerosis+and+cerebral+ischemia&doi=10.1371%2Fjournal.pone.0116919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116919%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWales%26aufirst%3DP.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DF.%26aulast%3DMoniot%26aufirst%3DS.%26aulast%3DHerisson%26aufirst%3DF.%26aulast%3DRauf%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DAyata%26aufirst%3DC.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DThe%2520sirtuin-2%2520inhibitor%2520AK7%2520is%2520neuroprotective%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520but%2520not%2520amyotrophic%2520lateral%2520sclerosis%2520and%2520cerebral%2520ischemia%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116919%26doi%3D10.1371%2Fjournal.pone.0116919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borra, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00038-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2FS1097-2765%2803%2900038-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=12620231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=437-444&author=B.+J.+Northauthor=B.+L.+Marshallauthor=M.+T.+Borraauthor=J.+M.+Denuauthor=E.+Verdin&title=The+human+Sir2+ortholog%2C+SIRT2%2C+is+an+NAD%2B-dependent+tubulin+deacetylase&doi=10.1016%2FS1097-2765%2803%2900038-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase</span></div><div class="casAuthors">North, Brian J.; Marshall, Brett L.; Borra, Margie T.; Denu, John M.; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The silent information regulator 2 protein (Sir2p) of Saccharomyces cerevisiae is an NAD-dependent histone deacetylase that plays a crit. role in transcriptional silencing.  Here, we report that a human ortholog of Sir2p, sirtuin type 2 (SIRT2), is a predominantly cytoplasmic protein that colocalizes with microtubules.  SIRT2 deacetylates lysine-40 of α-tubulin both in vitro and in vivo.  Knockdown of SIRT2 via siRNA results in tubulin hyperacetylation.  SIRT2 colocalizes and interacts in vivo with HDAC6, another tubulin deacetylase.  Enzymic anal. of recombinant SIRT2 in comparison to a yeast homolog of Sir2 protein (Hst2p) shows a striking preference of SIRT2 for acetylated tubulin peptide as a substrate relative to acetylated histone H3 peptide.  These observations establish SIRT2 as a bona fide tubulin deacetylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorrA4k4bpBlrVg90H21EOLACvtfcHk0lhB60EyVZCHbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D&md5=622e6bf7b48be1ec6afedf403c56350c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900038-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900038-8%26sid%3Dliteratum%253Aachs%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%2BL.%26aulast%3DBorra%26aufirst%3DM.%2BT.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DThe%2520human%2520Sir2%2520ortholog%252C%2520SIRT2%252C%2520is%2520an%2520NAD%252B-dependent%2520tubulin%2520deacetylase%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D437%26epage%3D444%26doi%3D10.1016%2FS1097-2765%2803%2900038-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Godena, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes-Hocking, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oswald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sancho, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitworth, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, K. J.</span><span> </span><span class="NLM_article-title">Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5245</span><span class="refDoi"> DOI: 10.1038/ncomms6245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fncomms6245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25316291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVersbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5245&author=V.+K.+Godenaauthor=N.+Brookes-Hockingauthor=A.+Mollerauthor=G.+Shawauthor=M.+Oswaldauthor=R.+M.+Sanchoauthor=C.+C.+Millerauthor=A.+J.+Whitworthauthor=K.+J.+De+Vos&title=Increasing+microtubule+acetylation+rescues+axonal+transport+and+locomotor+deficits+caused+by+LRRK2+Roc-COR+domain+mutations&doi=10.1038%2Fncomms6245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations</span></div><div class="casAuthors">Godena, Vinay K.; Brookes-Hocking, Nicholas; Moller, Annekathrin; Shaw, Gary; Oswald, Matthew; Sancho, Rosa M.; Miller, Christopher C. J.; Whitworth, Alexander J.; De Vos, Kurt J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5245</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of Parkinson's disease.  LRRK2 is a multifunctional protein affecting many cellular processes and has been described to bind microtubules.  Defective microtubule-based axonal transport is hypothesized to contribute to Parkinson's disease, but whether LRRK2 mutations affect this process to mediate pathogenesis is not known.  Here we find that LRRK2 contg. pathogenic Roc-COR domain mutations (R1441C, Y1699C) preferentially assocs. with deacetylated microtubules, and inhibits axonal transport in primary neurons and in Drosophila, causing locomotor deficits in vivo.  In vitro, increasing microtubule acetylation using deacetylase inhibitors or the tubulin acetylase αTAT1 prevents assocn. of mutant LRRK2 with microtubules, and the deacetylase inhibitor trichostatin A (TSA) restores axonal transport.  In vivo knockdown of the deacetylases HDAC6 and Sirt2, or administration of TSA rescues both axonal transport and locomotor behavior.  Thus, this study reveals a pathogenic mechanism and a potential intervention for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW55dshiT0xbVg90H21EOLACvtfcHk0lhB60EyVZCHbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVersbk%253D&md5=c4ce7dd4af3f46d8e03aeadde4436705</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fncomms6245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6245%26sid%3Dliteratum%253Aachs%26aulast%3DGodena%26aufirst%3DV.%2BK.%26aulast%3DBrookes-Hocking%26aufirst%3DN.%26aulast%3DMoller%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DG.%26aulast%3DOswald%26aufirst%3DM.%26aulast%3DSancho%26aufirst%3DR.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BC.%26aulast%3DWhitworth%26aufirst%3DA.%2BJ.%26aulast%3DDe%2BVos%26aufirst%3DK.%2BJ.%26atitle%3DIncreasing%2520microtubule%2520acetylation%2520rescues%2520axonal%2520transport%2520and%2520locomotor%2520deficits%2520caused%2520by%2520LRRK2%2520Roc-COR%2520domain%2520mutations%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5245%26doi%3D10.1038%2Fncomms6245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugeno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span> </span><span class="NLM_article-title">Role of TPPP/p25 on alpha-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span><span class="refDoi"> DOI: 10.1016/j.neuint.2010.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.neuint.2010.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20849899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2010&pages=857-866&author=T.+Hasegawaauthor=T.+Babaauthor=M.+Kobayashiauthor=M.+Konnoauthor=N.+Sugenoauthor=A.+Kikuchiauthor=Y.+Itoyamaauthor=A.+Takeda&title=Role+of+TPPP%2Fp25+on+alpha-synuclein-mediated+oligodendroglial+degeneration+and+the+protective+effect+of+SIRT2+inhibition+in+a+cellular+model+of+multiple+system+atrophy&doi=10.1016%2Fj.neuint.2010.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy</span></div><div class="casAuthors">Hasegawa, Takafumi; Baba, Toru; Kobayashi, Michiko; Konno, Masatoshi; Sugeno, Naoto; Kikuchi, Akio; Itoyama, Yasuto; Takeda, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">857-866</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Multiple system atrophy (MSA) is a progressive neurodegenerative disorder presenting variable combinations of parkinsonism, cerebellar ataxia, corticospinal and autonomic dysfunction.  Alpha-synuclein (α-SYN)-immunopos. glial cytoplasmic inclusions (GCIs) represent the neuropathol. hallmark of MSA, and tubulin polymn. promoting protein (TPPP)/p25 in oligodendroglia has been known as a potent stimulator of α-SYN aggregation.  To gain insight into the mol. pathomechanisms of GCI formation and subsequent oligodendroglial degeneration, we ectopically expressed α-SYN and TPPP in HEK293T and oligodendroglial KG1C cell lines.  Here we showed that TPPP specifically accelerated α-SYN oligomer formation and co-immunopptn. anal. revealed the specific interaction of TPPP and α-SYN.  Moreover, phosphorylation of α-SYN at Ser-129 facilitated the TPPP-mediated α-SYN oligomerization.  TPPP facilitated α-SYN-pos. cytoplasmic perinuclear inclusions mimicking GCI in both cell lines; however, apoptotic cell death was only obsd. in KG1C cells.  This apoptotic cell death was partly rescued by sirtuin 2 (SIRT2) inhibition.  Together, our results provide further insight into the mol. pathogenesis of MSA and potential therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphVqU7ySXle7Vg90H21EOLACvtfcHk0lhB60EyVZCHbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLvF&md5=87d077904be8f19f325e5f525628465b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DKonno%26aufirst%3DM.%26aulast%3DSugeno%26aufirst%3DN.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DItoyama%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26atitle%3DRole%2520of%2520TPPP%252Fp25%2520on%2520alpha-synuclein-mediated%2520oligodendroglial%2520degeneration%2520and%2520the%2520protective%2520effect%2520of%2520SIRT2%2520inhibition%2520in%2520a%2520cellular%2520model%2520of%2520multiple%2520system%2520atrophy%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D57%26spage%3D857%26epage%3D866%26doi%3D10.1016%2Fj.neuint.2010.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span> </span><span class="NLM_article-title">Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.04.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.neuroscience.2007.04.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2007&pages=599-612&author=K.+Suzukiauthor=T.+Koike&title=Mammalian+Sir2-related+protein+%28SIRT%29+2-mediated+modulation+of+resistance+to+axonal+degeneration+in+slow+Wallerian+degeneration+mice%3A+a+crucial+role+of+tubulin+deacetylation&doi=10.1016%2Fj.neuroscience.2007.04.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.04.059%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DT.%26atitle%3DMammalian%2520Sir2-related%2520protein%2520%2528SIRT%2529%25202-mediated%2520modulation%2520of%2520resistance%2520to%2520axonal%2520degeneration%2520in%2520slow%2520Wallerian%2520degeneration%2520mice%253A%2520a%2520crucial%2520role%2520of%2520tubulin%2520deacetylation%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D147%26spage%3D599%26epage%3D612%26doi%3D10.1016%2Fj.neuroscience.2007.04.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffitt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokce, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7927</span><span class="NLM_x">–</span> <span class="NLM_lpage">7932</span><span class="refDoi"> DOI: 10.1073/pnas.1002924107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.1002924107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20378838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7927-7932&author=R.+Luthi-Carterauthor=D.+M.+Taylorauthor=J.+Pallosauthor=E.+Lambertauthor=A.+Amoreauthor=A.+Parkerauthor=H.+Moffittauthor=D.+L.+Smithauthor=H.+Runneauthor=O.+Gokceauthor=A.+Kuhnauthor=Z.+Xiangauthor=M.+M.+Maxwellauthor=S.+A.+Reevesauthor=G.+P.+Batesauthor=C.+Neriauthor=L.+M.+Thompsonauthor=J.+L.+Marshauthor=A.+G.+Kazantsev&title=SIRT2+inhibition+achieves+neuroprotection+by+decreasing+sterol+biosynthesis&doi=10.1073%2Fpnas.1002924107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span></div><div class="casAuthors">Luthi-Carter, Ruth; Taylor, David M.; Pallos, Judit; Lambert, Emmanuel; Amore, Allison; Parker, Alex; Moffitt, Hilary; Smith, Donna L.; Runne, Heike; Gokce, Ozgun; Kuhn, Alexandre; Xiang, Zhongmin; Maxwell, Michele M.; Reeves, Steven A.; Bates, Gillian P.; Neri, Christian; Thompson, Leslie M.; Marsh, J. Lawrence; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7927-7932, S7927/1-S7927/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Huntington's disease (HD), an incurable neurodegenerative disorder, has a complex pathogenesis including protein aggregation and the dysregulation of neuronal transcription and metab.  Here, we demonstrate that inhibition of sirtuin 2 (SIRT2) achieves neuroprotection in cellular and invertebrate models of HD.  Genetic or pharmacol. inhibition of SIRT2 in a striatal neuron model of HD resulted in gene expression changes including significant down-regulation of RNAs responsible for sterol biosynthesis.  Whereas mutant huntingtin fragments increased sterols in neuronal cells, SIRT2 inhibition reduced sterol levels via decreased nuclear trafficking of SREBP-2.  Importantly, manipulation of sterol biosynthesis at the transcriptional level mimicked SIRT2 inhibition, demonstrating that the metabolic effects of SIRT2 inhibition are sufficient to diminish mutant huntingtin toxicity.  These data identify SIRT2 inhibition as a promising avenue for HD therapy and elucidate a unique mechanism of SIRT2-inhibitor-mediated neuroprotection.  Furthermore, the ascertainment of SIRT2's role in regulating cellular metab. demonstrates a central function shared with other sirtuin proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl8YT_ra15oLVg90H21EOLACvtfcHk0ljxprq85h7C3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D&md5=8b4798da04f14888acbcd64d1670d503</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002924107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002924107%26sid%3Dliteratum%253Aachs%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DPallos%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DE.%26aulast%3DAmore%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DMoffitt%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRunne%26aufirst%3DH.%26aulast%3DGokce%26aufirst%3DO.%26aulast%3DKuhn%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DReeves%26aufirst%3DS.%2BA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DNeri%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DMarsh%26aufirst%3DJ.%2BL.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSIRT2%2520inhibition%2520achieves%2520neuroprotection%2520by%2520decreasing%2520sterol%2520biosynthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D7927%26epage%3D7932%26doi%3D10.1073%2Fpnas.1002924107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balabadra, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowden, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1021/cb100376q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100376q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVCgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=540-546&author=D.+M.+Taylorauthor=U.+Balabadraauthor=Z.+Xiangauthor=B.+Woodmanauthor=S.+Meadeauthor=A.+Amoreauthor=M.+M.+Maxwellauthor=S.+Reevesauthor=G.+P.+Batesauthor=R.+Luthi-Carterauthor=P.+A.+Lowdenauthor=A.+G.+Kazantsev&title=A+brain-permeable+small+molecule+reduces+neuronal+cholesterol+by+inhibiting+activity+of+sirtuin+2+deacetylase&doi=10.1021%2Fcb100376q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase</span></div><div class="casAuthors">Taylor, David M.; Balabadra, Uma; Xiang, Zhongmin; Woodman, Ben; Meade, Sarah; Amore, Allison; Maxwell, Michele M.; Reeves, Steven; Bates, Gillian P.; Luthi-Carter, Ruth; Lowden, Philip A. S.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuin 2 (SIRT2) deacetylase-dependent inhibition mediates neuroprotective redn. of cholesterol biosynthesis in an in vitro Huntington's disease model.  This study sought to identify the first brain-permeable SIRT2 inhibitor and to characterize its cholesterol-reducing properties in neuronal models.  Using biochem. sirtuin deacetylation assays, we screened a brain-permeable in silico compd. library, yielding 3-(1-azepanylsulfonyl)-N-(3-bromphenyl)benzamide as the most potent and selective SIRT2 inhibitor.  Pharmacokinetic studies demonstrated brain-permeability but limited metabolic stability of the selected candidate.  In accordance with previous observations, this SIRT2 inhibitor stimulated cytoplasmic retention of sterol regulatory element binding protein-2 and subsequent transcriptional downregulation of cholesterol biosynthesis genes, resulting in reduced total cholesterol in primary striatal neurons.  Furthermore, the identified inhibitor reduced cholesterol in cultured naive neuronal cells and brain slices from wild-type mice.  The outcome of this study provides a clear opportunity for lead optimization and drug development, targeting metabolic dysfunctions in CNS disorders where abnormal cholesterol homeostasis is implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0djexnD8mDLVg90H21EOLACvtfcHk0lgtlj5L_AN2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVCgsrc%253D&md5=2b04e3894350051c26a8ee24399774c3</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fcb100376q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100376q%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DBalabadra%26aufirst%3DU.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DMeade%26aufirst%3DS.%26aulast%3DAmore%26aufirst%3DA.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DReeves%26aufirst%3DS.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DLowden%26aufirst%3DP.%2BA.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DA%2520brain-permeable%2520small%2520molecule%2520reduces%2520neuronal%2520cholesterol%2520by%2520inhibiting%2520activity%2520of%2520sirtuin%25202%2520deacetylase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D540%26epage%3D546%26doi%3D10.1021%2Fcb100376q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Green, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Coria, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Nicotinamide restores cognition in Alzheimer’s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">11500</span><span class="NLM_x">–</span> <span class="NLM_lpage">11510</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3203-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1523%2FJNEUROSCI.3203-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=18987186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=11500-11510&author=K.+N.+Greenauthor=J.+S.+Steffanauthor=H.+Martinez-Coriaauthor=X.+Sunauthor=S.+S.+Schreiberauthor=L.+M.+Thompsonauthor=F.+M.+LaFerla&title=Nicotinamide+restores+cognition+in+Alzheimer%E2%80%99s+disease+transgenic+mice+via+a+mechanism+involving+sirtuin+inhibition+and+selective+reduction+of+Thr231-phosphotau&doi=10.1523%2FJNEUROSCI.3203-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau</span></div><div class="casAuthors">Green, Kim N.; Steffan, Joan S.; Martinez-Coria, Hilda; Sun, Xuemin; Schreiber, Steven S.; Thompson, Leslie Michels; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11500-11510</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or delay its onset are urgently needed.  Effective preventive strategies likely offer the greatest and most widespread benefits.  Histone deacetylase (HDAC) inhibitors increase histone acetylation and enhance memory and synaptic plasticity.  We evaluated the efficacy of nicotinamide, a competitive inhibitor of the sirtuins or class III NAD+-dependent HDACs in 3xTg-AD mice, and found that it restored cognitive deficits assocd. with pathol.  Nicotinamide selectively reduces a specific phospho-species of tau (Thr231) that is assocd. with microtubule depolymn., in a manner similar to inhibition of SirT1.  Nicotinamide also dramatically increased acetylated α-tubulin, a primary substrate of SirT2, and MAP2c, both of which are linked to increased microtubule stability.  Reduced phospho Thr231-tau was related to a redn. of monoubiquitin-conjugated tau, suggesting that this posttranslationally modified form of tau may be rapidly degraded.  Overexpression of a Thr231-phospho-mimic tau in vitro increased clearance and decreased accumulation of tau compared with wild-type tau.  These preclin. findings suggest that oral nicotinamide may represent a safe treatment for AD and other tauopathies, and that phosphorylation of tau at Thr231 may regulate tau stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Lz--7nBKTrVg90H21EOLACvtfcHk0lgtlj5L_AN2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt77N&md5=f1e2b0d0da681f441eec1be2cb62baa3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3203-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3203-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DSteffan%26aufirst%3DJ.%2BS.%26aulast%3DMartinez-Coria%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DSchreiber%26aufirst%3DS.%2BS.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DNicotinamide%2520restores%2520cognition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520mice%2520via%2520a%2520mechanism%2520involving%2520sirtuin%2520inhibition%2520and%2520selective%2520reduction%2520of%2520Thr231-phosphotau%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D11500%26epage%3D11510%26doi%3D10.1523%2FJNEUROSCI.3203-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Spires-Jones, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozkalne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitstick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="refDoi"> DOI: 10.3389/fphar.2012.00042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.3389%2Ffphar.2012.00042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22416232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=42&author=T.+L.+Spires-Jonesauthor=L.+M.+Foxauthor=A.+Rozkalneauthor=R.+Pitstickauthor=G.+A.+Carlsonauthor=A.+G.+Kazantsev&title=Inhibition+of+sirtuin+2+with+sulfobenzoic+acid+derivative+AK1+is+non-toxic+and+potentially+neuroprotective+in+a+mouse+model+of+frontotemporal+dementia&doi=10.3389%2Ffphar.2012.00042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of Frontotemporal dementia</span></div><div class="casAuthors">Spires-Jones, Tara L.; Fox, Leora M.; Rozkalne, Anete; Pitstick, Rose; Carlson, George A.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">42</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Tauopathies including tau-assocd. Frontotemporal dementia (FTD) and Alzheimer's disease are characterized pathol. by the formation of tau-contg. neurofibrillary aggregates and neuronal loss, which contribute to cognitive decline.  There are currently no effective treatments to prevent or slow this neural systems failure.  The rTg4510 mouse model, which expresses a mutant form of the tau protein assocd. with FTD with Parkinsonism-17, undergoes dramatic hippocampal and cortical neuronal loss making it an ideal model to study treatments for FTD-related neuronal loss.  Sirtuins are a family of proteins involved in cell survival that have the potential to modulate neuronal loss in neurodegenerative disorders.  Here we tested the hypothesis that sirtuin 2 (SIRT2) inhibition would be non-toxic and prevent neurodegeneration in rTg4510 brain.  In this study we delivered SIRT2 inhibitor AK1 directly to the hippocampus with an osmotic minipump and confirmed that it reached the target region both with histol. assessment of delivery of a dye and with a pharmacodynamic marker, ABCA1 transcription, which was upregulated with AK1 treatment.  AK1 treatment was found to be safe in wild-type mice and in the rTg4510 mouse model and further, it provided some neuroprotection in the rTg4510 hippocampal circuitry.  This study provides proof-of-concept for therapeutic benefits of SIRT2 inhibitors in both tau-assocd. FTD and Alzheimer's disease and suggests that development of potent, brain permeable SIRT2 inhibitors is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxj4KrfzR49rVg90H21EOLACvtfcHk0lgtlj5L_AN2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qt78%253D&md5=54aefece47f5189e19b61cafed6d9e34</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00042%26sid%3Dliteratum%253Aachs%26aulast%3DSpires-Jones%26aufirst%3DT.%2BL.%26aulast%3DFox%26aufirst%3DL.%2BM.%26aulast%3DRozkalne%26aufirst%3DA.%26aulast%3DPitstick%26aufirst%3DR.%26aulast%3DCarlson%26aufirst%3DG.%2BA.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DInhibition%2520of%2520sirtuin%25202%2520with%2520sulfobenzoic%2520acid%2520derivative%2520AK1%2520is%2520non-toxic%2520and%2520potentially%2520neuroprotective%2520in%2520a%2520mouse%2520model%2520of%2520frontotemporal%2520dementia%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D42%26doi%3D10.3389%2Ffphar.2012.00042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Theendakara, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters Libeu, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpot, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Descamps, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poksay, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cailing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredesen, D. E.</span><span> </span><span class="NLM_article-title">Neuroprotective Sirtuin ratio reversed by ApoE4</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">18303</span><span class="NLM_x">–</span> <span class="NLM_lpage">18308</span><span class="refDoi"> DOI: 10.1073/pnas.1314145110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.1314145110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=18303-18308&author=V.+Theendakaraauthor=A.+Patentauthor=C.+A.+Peters+Libeuauthor=B.+Philpotauthor=S.+Floresauthor=O.+Descampsauthor=K.+S.+Poksayauthor=Q.+Zhangauthor=G.+Cailingauthor=M.+Hartauthor=V.+Johnauthor=R.+V.+Raoauthor=D.+E.+Bredesen&title=Neuroprotective+Sirtuin+ratio+reversed+by+ApoE4&doi=10.1073%2Fpnas.1314145110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314145110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314145110%26sid%3Dliteratum%253Aachs%26aulast%3DTheendakara%26aufirst%3DV.%26aulast%3DPatent%26aufirst%3DA.%26aulast%3DPeters%2BLibeu%26aufirst%3DC.%2BA.%26aulast%3DPhilpot%26aufirst%3DB.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DDescamps%26aufirst%3DO.%26aulast%3DPoksay%26aufirst%3DK.%2BS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DCailing%26aufirst%3DG.%26aulast%3DHart%26aufirst%3DM.%26aulast%3DJohn%26aufirst%3DV.%26aulast%3DRao%26aufirst%3DR.%2BV.%26aulast%3DBredesen%26aufirst%3DD.%2BE.%26atitle%3DNeuroprotective%2520Sirtuin%2520ratio%2520reversed%2520by%2520ApoE4%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D18303%26epage%3D18308%26doi%3D10.1073%2Fpnas.1314145110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span> </span><span class="NLM_article-title">Sirtuin inhibitors as anticancer agents</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span><span class="refDoi"> DOI: 10.4155/fmc.14.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.4155%2Ffmc.14.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=24962284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=945-966&author=J.+Huauthor=H.+Jingauthor=H.+Lin&title=Sirtuin+inhibitors+as+anticancer+agents&doi=10.4155%2Ffmc.14.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin inhibitors as anticancer agents</span></div><div class="casAuthors">Hu, Jing; Jing, Hui; Lin, Hening</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">945-966</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Sirtuins are a class of enzymes with NAD (NAD)-dependent protein lysine deacylase function.  By deacylating various substrate proteins, including histones, transcription factors, and metabolic enzymes, sirtuins regulate various biol. processes, such as transcription, cell survival, DNA damage and repair, and longevity.  Small mols. that can inhibit sirtuins have been developed and many of them have shown anticancer activity.  Here, we summarize the major biol. findings that connect sirtuins to cancer and the different types of sirtuin inhibitors developed.  Interestingly, biol. data suggest that sirtuins have both tumor-suppressing and tumor-promoting roles.  However, most pharmacol. studies with small-mol. inhibitors suggest that inhibiting sirtuins has anticancer effects.  We discuss possible explanations for this discrepancy and suggest possible future directions to further establish sirtuin inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosZVnK8lSr27Vg90H21EOLACvtfcHk0lisfBdJEuOPOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemsr3O&md5=1ec5a806a221048984a0c5e18b7d9f12</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.44%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%26atitle%3DSirtuin%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D945%26epage%3D966%26doi%3D10.4155%2Ffmc.14.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of sirtuin inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.2174/092986711795590057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.2174%2F092986711795590057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=21517778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1936-1946&author=L.+Chen&title=Medicinal+chemistry+of+sirtuin+inhibitors&doi=10.2174%2F092986711795590057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of sirtuin inhibitors</span></div><div class="casAuthors">Chen, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1936-1946</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As members of Class III histone deacetylases (HDACs), sirtuins use stoichiometric NAD (NAD+) to remove the acetyl group from N-acetyl-lysines of histones or non-histone proteins.  Sirtuins have been implicated in metabolic diseases, cancer, and neurodegenerative diseases, constituting a promising target for drug discovery.  While the early sirtuin inhibitors mimicked NAD+ or substrate peptides, high-throughput and in silico screenings have identified a wide range of core structures, many of which have been subjected to medicinal chem. efforts.  This review outlines inhibitor chemotypes, and their chem. modifications and biol. evaluations, highlighting strategies to enhance inhibitory activity and selectivity among isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfXcQnFvuWkLVg90H21EOLACvtfcHk0lisfBdJEuOPOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFehuro%253D&md5=13b27b3be14e31b97d501f4a06a7c408</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.2174%2F092986711795590057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795590057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26atitle%3DMedicinal%2520chemistry%2520of%2520sirtuin%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1936%26epage%3D1946%26doi%3D10.2174%2F092986711795590057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cen, Y.</span><span> </span><span class="NLM_article-title">Sirtuins inhibitors: the approach to affinity and selectivity</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1644</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2009.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.bbapap.2009.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=19931429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlaltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=1635-1644&author=Y.+Cen&title=Sirtuins+inhibitors%3A+the+approach+to+affinity+and+selectivity&doi=10.1016%2Fj.bbapap.2009.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins inhibitors: The approach to affinity and selectivity</span></div><div class="casAuthors">Cen, Yana</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1635-1644</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence has indicated the importance of sirtuins (class III histone deacetylases) in various biol. processes.  Their potential roles in metabolic and neurodegenerative diseases have encouraged scientists to seek potent and selective sirtuin inhibitors to investigate their biol. functions with a view to eventual new therapeutic treatments.  Here, the author surveys current knowledge of sirtuin inhibitors including those discovered via high-throughput screening or via mechanism-based drug design from synthetic or natural sources.  Their inhibitory affinity, selectivities, and possible inhibition mechanisms are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkOq-kDRaJbVg90H21EOLACvtfcHk0lgI8MpPWSyM4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlaltbw%253D&md5=3eb521cf151c8e3772244e2e4e3b861a</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DCen%26aufirst%3DY.%26atitle%3DSirtuins%2520inhibitors%253A%2520the%2520approach%2520to%2520affinity%2520and%2520selectivity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D1635%26epage%3D1644%26doi%3D10.1016%2Fj.bbapap.2009.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2789</span><span class="NLM_x">–</span> <span class="NLM_lpage">2793</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.bmcl.2012.02.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2789-2793&author=S.+H.+Choiauthor=L.+Quintiauthor=A.+G.+Kazantsevauthor=R.+B.+Silverman&title=3-%28N-arylsulfamoyl%29benzamides%2C+inhibitors+of+human+sirtuin+type+2+%28SIRT2%29&doi=10.1016%2Fj.bmcl.2012.02.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3D3-%2528N-arylsulfamoyl%2529benzamides%252C%2520inhibitors%2520of%2520human%2520sirtuin%2520type%25202%2520%2528SIRT2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2789%26epage%3D2793%26doi%3D10.1016%2Fj.bmcl.2012.02.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khanfar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ejmech.2014.02.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=414-426&author=M.+A.+Khanfarauthor=L.+Quintiauthor=H.+Wangauthor=S.+H.+Choiauthor=A.+G.+Kazantsevauthor=R.+B.+Silverman&title=Development+and+characterization+of+3-%28benzylsulfonamido%29benzamides+as+potent+and+selective+SIRT2+inhibitors&doi=10.1016%2Fj.ejmech.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDevelopment%2520and%2520characterization%2520of%25203-%2528benzylsulfonamido%2529benzamides%2520as%2520potent%2520and%2520selective%2520SIRT2%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D76%26spage%3D414%26epage%3D426%26doi%3D10.1016%2Fj.ejmech.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Khanfar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Design and evaluation of 3-(benzylthio)benzamide derivatives as potent and selective SIRT2 inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=607-611&author=M.+A.+Khanfarauthor=L.+Quintiauthor=H.+Wangauthor=J.+Noblesauthor=A.+G.+Kazantsevauthor=R.+B.+Silverman&title=Design+and+evaluation+of+3-%28benzylthio%29benzamide+derivatives+as+potent+and+selective+SIRT2+inhibitors&doi=10.1021%2Facsmedchemlett.5b00075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00075%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNobles%26aufirst%3DJ.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDesign%2520and%2520evaluation%2520of%25203-%2528benzylthio%2529benzamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520SIRT2%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D607%26epage%3D611%26doi%3D10.1021%2Facsmedchemlett.5b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5760</span><span class="NLM_x">–</span> <span class="NLM_lpage">5773</span><span class="refDoi"> DOI: 10.1021/jm3002108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2ns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5760-5773&author=T.+Suzukiauthor=M.+N.+Khanauthor=H.+Sawadaauthor=E.+Imaiauthor=Y.+Itohauthor=K.+Yamatsutaauthor=N.+Tokudaauthor=J.+Takeuchiauthor=T.+Sekoauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+synthesis%2C+and+biological+activity+of+a+novel+series+of+human+sirtuin-2-selective+inhibitors&doi=10.1021%2Fjm3002108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors</span></div><div class="casAuthors">Suzuki, Takayoshi; Khan, Mohammed Naseer Ahmed; Sawada, Hideyuki; Imai, Erika; Itoh, Yukihiro; Yamatsuta, Katsura; Tokuda, Natsuko; Takeuchi, Jun; Seko, Takuya; Nakagawa, Hidehiko; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5760-5773</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anilinobenzamides such as I [R = H, PhNHCO, PhNMeCO, PhCH2NHCO, PhCH2NMeCO, PhCH2CONH, PhCH2CONMe, cyclohexylmethoxy, Me2CHCH2O, PhCH2O, PhCH2CH2O, R2CH2CH2O, PhCH2CH2CH2O; R2 = 2-MeC6H4, 3-MeC6H4, 4-MeC6H4, 2-F3CC6H4, 3-F3CC6H4, 4-F3CC6H4, 2-FC6H4, 3-FC6H4, 4-FC6H4, 2-ClC6H4, 3-ClC6H4, 4-ClC6H4, 2-BrC6H4, 3-BrC6H4, 4-BrC6H4; R1 = H, (E)-PhCH:CH, (Z)-PhCH:CH, PhCH2CH2, PhNMeCO, PhNHCO, PhCONMe, PhCONH, R3CONH; R3 = Me, Me2CH, cyclohexyl, 4-piperidinyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl] were prepd. as selective inhibitors of human sirtuin 2 (SIRT2), a deacetylase with potential involvement in neurodegenerative diseases such as Parkinson's and Huntington's diseases.  In particular, phenethyloxyanilinobenzamides such as I (R = R2CH2CH2O; R1 = H; R2 = Ph, 3-FC6H4) were potent and selective SIRT2 inhibitors, with 3.5-fold greater SIRT2 inhibition and more than 35-fold greater selectivity for SIRT2 over SIRT1 and SIRT3 than the previously known dichlorophenylfuranylpropenamide SIRT2 inhibitor AGK2.  I (R = PhCH2CH2; R1 = H) dose-dependently inhibited SIRT2 in human colon cancer HCT116 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrob-E8DojbhrVg90H21EOLACvtfcHk0lg4M1Nj1HHsDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2ns78%253D&md5=63c83476f2406763a50313457ec4431e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm3002108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002108%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BN.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DE.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DYamatsuta%26aufirst%3DK.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DJ.%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520novel%2520series%2520of%2520human%2520sirtuin-2-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5760%26epage%3D5773%26doi%3D10.1021%2Fjm3002108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Friden-Saxin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landergren, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7104</span><span class="NLM_x">–</span> <span class="NLM_lpage">7113</span><span class="refDoi"> DOI: 10.1021/jm3005288</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3005288" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7104-7113&author=M.+Friden-Saxinauthor=T.+Seifertauthor=M.+R.+Landergrenauthor=T.+Suuronenauthor=M.+Lahtela-Kakkonenauthor=E.+M.+Jarhoauthor=K.+Luthman&title=Synthesis+and+evaluation+of+substituted+chroman-4-one+and+chromone+derivatives+as+sirtuin+2-selective+inhibitors&doi=10.1021%2Fjm3005288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors</span></div><div class="casAuthors">Friden-Saxin, Maria; Seifert, Tina; Landergren, Marie Ryden; Suuronen, Tiina; Lahtela-Kakkonen, Maija; Jarho, Elina M.; Luthman, Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7104-7113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of substituted chromone/chroman-4-one derivs. has been synthesized and evaluated as novel inhibitors of SIRT2, an enzyme involved in aging-related diseases, e.g., neurodegenerative disorders.  The analogs were efficiently synthesized in a one-step procedure including a base-mediated aldol condensation using microwave irradn.  The most potent compds., with inhibitory concns. in the low micromolar range, were substituted in the 2-, 6-, and 8-positions.  Larger, electron-withdrawing substituents in the 6- and 8-positions were favorable.  The most potent inhibitor of SIRT2 was 6,8-dibromo-2-pentylchroman-4-one (I) with an IC50 of 1.5 μM.  The synthesized compds. show high selectivity toward SIRT2 over SIRT1 and SIRT3 and represent an important starting point for the development of novel SIRT2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5DvugJ8tbwLVg90H21EOLACvtfcHk0lg4M1Nj1HHsDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gsLk%253D&md5=d0f80ecf32a11b3ad3c5dd209db81b0b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm3005288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3005288%26sid%3Dliteratum%253Aachs%26aulast%3DFriden-Saxin%26aufirst%3DM.%26aulast%3DSeifert%26aufirst%3DT.%26aulast%3DLandergren%26aufirst%3DM.%2BR.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DJarho%26aufirst%3DE.%2BM.%26aulast%3DLuthman%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520substituted%2520chroman-4-one%2520and%2520chromone%2520derivatives%2520as%2520sirtuin%25202-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7104%26epage%3D7113%26doi%3D10.1021%2Fjm3005288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Disch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evindar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyanskaya, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquilani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graybill, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuozzo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlasuk, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3666</span><span class="NLM_x">–</span> <span class="NLM_lpage">3679</span><span class="refDoi"> DOI: 10.1021/jm400204k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400204k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3666-3679&author=J.+S.+Dischauthor=G.+Evindarauthor=C.+H.+Chiuauthor=C.+A.+Blumauthor=H.+Daiauthor=L.+Jinauthor=E.+Schumanauthor=K.+E.+Lindauthor=S.+L.+Belyanskayaauthor=J.+Dengauthor=F.+Coppoauthor=L.+Aquilaniauthor=T.+L.+Graybillauthor=J.+W.+Cuozzoauthor=S.+Lavuauthor=C.+Maoauthor=G.+P.+Vlasukauthor=R.+B.+Perni&title=Discovery+of+thieno%5B3%2C2-d%5Dpyrimidine-6-carboxamides+as+potent+inhibitors+of+SIRT1%2C+SIRT2%2C+and+SIRT3&doi=10.1021%2Fjm400204k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3</span></div><div class="casAuthors">Disch, Jeremy S.; Evindar, Ghotas; Chiu, Cynthia H.; Blum, Charles A.; Dai, Han; Jin, Lei; Schuman, Eli; Lind, Kenneth E.; Belyanskaya, Svetlana L.; Deng, Jianghe; Coppo, Frank; Aquilani, Leah; Graybill, Todd L.; Cuozzo, John W.; Lavu, Siva; Mao, Cheney; Vlasuk, George P.; Perni, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3666-3679</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sirtuins SIRT1, SIRT2, and SIRT3 are NAD+ dependent deacetylases that are considered potential targets for metabolic, inflammatory, oncol., and neurodegenerative disorders.  Encoded library technol. (ELT) was used to affinity screen a 1.2 million heterocycle enriched library of DNA encoded small mols., which identified pan-inhibitors of SIRT1/2/3 with nanomolar potency.  Subsequent SAR studies to improve physiochem. properties identified the potent drug like analogs 4-(4-(2-Pivalamidoethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide and 4-(4-(2-(Methylsulfonamido)ethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide.  Crystallog. studies of N2-(2-(1-(6-Carbamoylthieno[3,2-d]pyrimidin-4-yl)piperidin-4-yl)ethyl)-N5-ethylthiophene-2,5-dicarboxamide, 4-(4-(2-Pivalamidoethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide, and 4-(4-(2-(Methylsulfonamido)ethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide bound in the SIRT3 active site revealed that the common carboxamide binds in the nicotinamide C-pocket and the aliph. portions of the inhibitors extend through the substrate channel, explaining the observable SAR.  These pan SIRT1/2/3 inhibitors, representing a novel chemotype, are significantly more potent than currently available inhibitors, which makes them valuable tools for sirtuin research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxOC0cS5NuHbVg90H21EOLACvtfcHk0lg4M1Nj1HHsDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gtrs%253D&md5=447a6bcce0f47173a42e4ac5d95c3ec6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm400204k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400204k%26sid%3Dliteratum%253Aachs%26aulast%3DDisch%26aufirst%3DJ.%2BS.%26aulast%3DEvindar%26aufirst%3DG.%26aulast%3DChiu%26aufirst%3DC.%2BH.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DSchuman%26aufirst%3DE.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DCoppo%26aufirst%3DF.%26aulast%3DAquilani%26aufirst%3DL.%26aulast%3DGraybill%26aufirst%3DT.%2BL.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DLavu%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DVlasuk%26aufirst%3DG.%2BP.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520of%2520thieno%255B3%252C2-d%255Dpyrimidine-6-carboxamides%2520as%2520potent%2520inhibitors%2520of%2520SIRT1%252C%2520SIRT2%252C%2520and%2520SIRT3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3666%26epage%3D3679%26doi%3D10.1021%2Fjm400204k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Di Fruscia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharioudakis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laohasinnarong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khongkow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltsida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexter, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span> </span><span class="NLM_article-title">The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson’s disease model</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1002/cmdc.201402431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fcmdc.201402431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25395356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=69-82&author=P.+Di+Frusciaauthor=E.+Zacharioudakisauthor=C.+Liuauthor=S.+Moniotauthor=S.+Laohasinnarongauthor=M.+Khongkowauthor=I.+F.+Harrisonauthor=K.+Koltsidaauthor=C.+R.+Reynoldsauthor=K.+Schmidtkunzauthor=M.+Jungauthor=K.+L.+Chapmanauthor=C.+Steegbornauthor=D.+T.+Dexterauthor=M.+J.+Sternbergauthor=E.+W.+Lamauthor=M.+J.+Fuchter&title=The+discovery+of+a+highly+selective+5%2C6%2C7%2C8-tetrahydrobenzo%5B4%2C5%5Dthieno%5B2%2C3-d%5Dpyrimidin-4%283H%29-one+SIRT2+inhibitor+that+is+neuroprotective+in+an+in+vitro+Parkinson%E2%80%99s+disease+model&doi=10.1002%2Fcmdc.201402431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Highly Selective 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 Inhibitor that is Neuroprotective in an in vitro Parkinson's Disease Model</span></div><div class="casAuthors">Di Fruscia, Paolo; Zacharioudakis, Emmanouil; Liu, Chang; Moniot, Sebastien; Laohasinnarong, Sasiwan; Khongkow, Mattaka; Harrison, Ian F.; Koltsida, Konstantina; Reynolds, Christopher R.; Schmidtkunz, Karin; Jung, Manfred; Chapman, Kathryn L.; Steegborn, Clemens; Dexter, David T.; Sternberg, Michael J. E.; Lam, Eric W.-F.; Fuchter, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-82</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sirtuins, NAD+-dependent histone deacetylases (HDACs), have recently emerged as potential therapeutic targets for the treatment of a variety of diseases.  The discovery of potent and isoform-selective inhibitors of this enzyme family should provide chem. tools to help det. the roles of these targets and validate their therapeutic value.  Herein, the authors report the discovery of a novel class of highly selective SIRT2 inhibitors, identified by pharmacophore screening.  The authors report the identification and validation of I (ICL-SIRT078), a substrate-competitive SIRT2 inhibitor with a Ki value of 0.62±0.15 μM and more than 50-fold selectivity against SIRT1, 3 and 5.  Treatment of MCF-7 breast cancer cells with ICL-SIRT078 results in hyperacetylation of α-tubulin, an established SIRT2 biomarker, at doses comparable with the biochem. IC50 data, while suppressing MCF-7 proliferation at higher concns.  In concordance with the recent reports that suggest SIRT2 inhibition is a potential strategy for the treatment of Parkinson's disease, the authors find that compd. ICL-SIRT078 has a significant neuroprotective effect in a lactacystin-induced model of Parkinsonian neuronal cell death in the N27 cell line.  These results encourage further investigation into the effects of ICL-SIRT078, or an optimized deriv. thereof, as a candidate neuroprotective agent in in vivo models of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhBvCt3DxtybVg90H21EOLACvtfcHk0lhrXdb4VHcG9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7bE&md5=86cc1270a96ecc3a3e61e9bb2782e8a3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402431%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DZacharioudakis%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMoniot%26aufirst%3DS.%26aulast%3DLaohasinnarong%26aufirst%3DS.%26aulast%3DKhongkow%26aufirst%3DM.%26aulast%3DHarrison%26aufirst%3DI.%2BF.%26aulast%3DKoltsida%26aufirst%3DK.%26aulast%3DReynolds%26aufirst%3DC.%2BR.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DChapman%26aufirst%3DK.%2BL.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26aulast%3DSternberg%26aufirst%3DM.%2BJ.%26aulast%3DLam%26aufirst%3DE.%2BW.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520a%2520highly%2520selective%25205%252C6%252C7%252C8-tetrahydrobenzo%255B4%252C5%255Dthieno%255B2%252C3-d%255Dpyrimidin-4%25283H%2529-one%2520SIRT2%2520inhibitor%2520that%2520is%2520neuroprotective%2520in%2520an%2520in%2520vitro%2520Parkinson%25E2%2580%2599s%2520disease%2520model%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D69%26epage%3D82%26doi%3D10.1002%2Fcmdc.201402431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roessler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladwein, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Selective Sirt2 inhibition by ligand-induced rearrangement of the active site</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6263</span><span class="refDoi"> DOI: 10.1038/ncomms7263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fncomms7263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25672491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6263&author=T.+Rumpfauthor=M.+Schiedelauthor=B.+Karamanauthor=C.+Roesslerauthor=B.+J.+Northauthor=A.+Lehotzkyauthor=J.+Olahauthor=K.+I.+Ladweinauthor=K.+Schmidtkunzauthor=M.+Gajerauthor=M.+Pannekauthor=C.+Steegbornauthor=D.+A.+Sinclairauthor=S.+Gerhardtauthor=J.+Ovadiauthor=M.+Schutkowskiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Selective+Sirt2+inhibition+by+ligand-induced+rearrangement+of+the+active+site&doi=10.1038%2Fncomms7263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Sirt2 inhibition by ligand-induced rearrangement of the active site</span></div><div class="casAuthors">Rumpf, Tobias; Schiedel, Matthias; Karaman, Berin; Roessler, Claudia; North, Brian J.; Lehotzky, Attila; Olah, Judit; Ladwein, Kathrin I.; Schmidtkunz, Karin; Gajer, Markus; Pannek, Martin; Steegborn, Clemens; Sinclair, David A.; Gerhardt, Stefan; Ovadi, Judit; Schutkowski, Mike; Sippl, Wolfgang; Einsle, Oliver; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6263</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sirtuins are a highly conserved class of NAD-dependent lysine deacylases.  Human isotype Sirt2 has been implicated in the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of Sirt2 activity a promising strategy for pharmaceutical intervention.  However, a rational basis for the development of optimized Sirt2 inhibitors is lacking so far.  Here, the authors present high-resoln. structures of human Sirt2 in complex with highly selective drug-like inhibitors that show a unique inhibitory mechanism.  The potency and the unprecedented Sirt2 selectivity were based on a ligand-induced structural rearrangement of the active site unveiling a yet-unexploited binding pocket.  The application of the most potent sirtuin-rearranging ligand, termed SirReal2, led to tubulin hyperacetylation in HeLa cells and induced destabilization of checkpoint protein BubR1, consistent with Sirt2 inhibition in vivo.  The structural insights into this unique mechanism of selective sirtuin inhibition provide the basis for further inhibitor development and selective tools for sirtuin biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN2LzipheDFLVg90H21EOLACvtfcHk0lixCzgHE9wlDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D&md5=bc3c61af5e456f4483746a588db91643</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1038%2Fncomms7263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7263%26sid%3Dliteratum%253Aachs%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DRoessler%26aufirst%3DC.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DLadwein%26aufirst%3DK.%2BI.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DGajer%26aufirst%3DM.%26aulast%3DPannek%26aufirst%3DM.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DSelective%2520Sirt2%2520inhibition%2520by%2520ligand-induced%2520rearrangement%2520of%2520the%2520active%2520site%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6263%26doi%3D10.1038%2Fncomms7263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Aminothiazoles as potent and selective Sirt2 inhibitors: a structure-sctivity relationship study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01517</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01517" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1599-1612&author=M.+Schiedelauthor=T.+Rumpfauthor=B.+Karamanauthor=A.+Lehotzkyauthor=J.+Olahauthor=S.+Gerhardtauthor=J.+Ovadiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Aminothiazoles+as+potent+and+selective+Sirt2+inhibitors%3A+a+structure-sctivity+relationship+study&doi=10.1021%2Facs.jmedchem.5b01517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01517%26sid%3Dliteratum%253Aachs%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DAminothiazoles%2520as%2520potent%2520and%2520selective%2520Sirt2%2520inhibitors%253A%2520a%2520structure-sctivity%2520relationship%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1599%26epage%3D1612%26doi%3D10.1021%2Facs.jmedchem.5b01517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollick, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staples, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoubala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleyard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1016/j.ccr.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ccr.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=18455128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFelsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=454-463&author=S.+Lainauthor=J.+J.+Hollickauthor=J.+Campbellauthor=O.+D.+Staplesauthor=M.+Higginsauthor=M.+Aoubalaauthor=A.+McCarthyauthor=V.+Appleyardauthor=K.+E.+Murrayauthor=L.+Bakerauthor=A.+Thompsonauthor=J.+Mathersauthor=S.+J.+Hollandauthor=M.+J.+Starkauthor=G.+Passauthor=J.+Woodsauthor=D.+P.+Laneauthor=N.+J.+Westwood&title=Discovery%2C+in+vivo+activity%2C+and+mechanism+of+action+of+a+small-molecule+p53+activator&doi=10.1016%2Fj.ccr.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator</span></div><div class="casAuthors">Lain, Sonia; Hollick, Jonathan J.; Campbell, Johanna; Staples, Oliver D.; Higgins, Maureen; Aoubala, Mustapha; McCarthy, Anna; Appleyard, Virginia; Murray, Karen E.; Baker, Lee; Thompson, Alastair; Mathers, Joanne; Holland, Stephen J.; Stark, Michael J. R.; Pass, Georgia; Woods, Julie; Lane, David P.; Westwood, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">454-463</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have carried out a cell-based screen aimed at discovering small mols. that activate p53 and have the potential to decrease tumor growth.  Here, we describe one of our hit compds., tenovin-1, along with a more water-sol. analog, tenovin-6.  Via a yeast genetic screen, biochem. assays, and target validation studies in mammalian cells, we show that tenovins act through inhibition of the protein-deacetylating activities of SirT1 and SirT2, two important members of the sirtuin family.  Tenovins are active on mammalian cells at one-digit micromolar concns. and decrease tumor growth in vivo as single agents.  This underscores the utility of these compds. as biol. tools for the study of sirtuin function as well as their potential therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOaSyIs0EPErVg90H21EOLACvtfcHk0lh3puRKUv_W2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFelsr4%253D&md5=cc43822431826afa40e17fd68a86647a</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DLain%26aufirst%3DS.%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DStaples%26aufirst%3DO.%2BD.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DAoubala%26aufirst%3DM.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DAppleyard%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DK.%2BE.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DMathers%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DS.%2BJ.%26aulast%3DStark%26aufirst%3DM.%2BJ.%26aulast%3DPass%26aufirst%3DG.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%252C%2520in%2520vivo%2520activity%252C%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520small-molecule%2520p53%2520activator%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D454%26epage%3D463%26doi%3D10.1016%2Fj.ccr.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCarthy, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollick, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronseaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staples, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.bmc.2012.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22304848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFaqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1779-1793&author=A.+R.+McCarthyauthor=L.+Pirrieauthor=J.+J.+Hollickauthor=S.+Ronseauxauthor=J.+Campbellauthor=M.+Higginsauthor=O.+D.+Staplesauthor=F.+Tranauthor=A.+M.+Slawinauthor=S.+Lainauthor=N.+J.+Westwood&title=Synthesis+and+biological+characterisation+of+sirtuin+inhibitors+based+on+the+tenovins&doi=10.1016%2Fj.bmc.2012.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins</span></div><div class="casAuthors">McCarthy, Anna R.; Pirrie, Lisa; Hollick, Jonathan J.; Ronseaux, Sebastien; Campbell, Johanna; Higgins, Maureen; Staples, Oliver D.; Tran, Fanny; Slawin, Alexandra M. Z.; Lain, Sonia; Westwood, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1779-1793</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The tenovins are small mol. inhibitors of the NAD+-dependent family of protein deacetylases known as the sirtuins.  There remains considerable interest in inhibitors of this enzyme family due to possible applications in both cancer and neurodegenerative disease therapy.  Through the synthesis of novel tenovin analogs, further insights into the structural requirements for activity against the sirtuins in vitro are provided.  In addn., the activity of one of the analogs in cells led to an improved understanding of the function of SirT1 in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVQbzCITDMgbVg90H21EOLACvtfcHk0lh3puRKUv_W2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFaqt74%253D&md5=726af22730cdcc2162d75c3663534c88</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DA.%2BR.%26aulast%3DPirrie%26aufirst%3DL.%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DRonseaux%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DStaples%26aufirst%3DO.%2BD.%26aulast%3DTran%26aufirst%3DF.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520characterisation%2520of%2520sirtuin%2520inhibitors%2520based%2520on%2520the%2520tenovins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1779%26epage%3D1793%26doi%3D10.1016%2Fj.bmc.2012.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Morimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, H.</span><span> </span><span class="NLM_article-title">Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3423</span><span class="NLM_x">–</span> <span class="NLM_lpage">3427</span><span class="refDoi"> DOI: 10.1002/anie.201108118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fanie.201108118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XivV2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=3423-3427&author=J.+Morimotoauthor=Y.+Hayashiauthor=H.+Suga&title=Discovery+of+macrocyclic+peptides+armed+with+a+mechanism-based+warhead%3A+isoform-selective+inhibition+of+human+deacetylase+SIRT2&doi=10.1002%2Fanie.201108118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Macrocyclic Peptides Armed with a Mechanism-Based Warhead: Isoform-Selective Inhibition of Human Deacetylase SIRT2</span></div><div class="casAuthors">Morimoto, Jumpei; Hayashi, Yuuki; Suga, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3423-3427, S3423/1-S3423/17</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A short communication reports discovery of macrocyclic peptide armed with a mechanism-based warhead, isoform-selective inhibition of human deacetylase SIRT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4HWN1fpAF_LVg90H21EOLACvtfcHk0ljaxt1tW_3fNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivV2qs7g%253D&md5=92d7ab54fa0da63a570cc8328b7111d5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fanie.201108118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201108118%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DJ.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DSuga%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520macrocyclic%2520peptides%2520armed%2520with%2520a%2520mechanism-based%2520warhead%253A%2520isoform-selective%2520inhibition%2520of%2520human%2520deacetylase%2520SIRT2%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D3423%26epage%3D3427%26doi%3D10.1002%2Fanie.201108118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mahajan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sripathy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posakony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loe, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalhofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J. A.</span><span> </span><span class="NLM_article-title">Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3283</span><span class="NLM_x">–</span> <span class="NLM_lpage">3294</span><span class="refDoi"> DOI: 10.1021/jm4018064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4018064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3283-3294&author=S.+S.+Mahajanauthor=M.+Scianauthor=S.+Sripathyauthor=J.+Posakonyauthor=U.+Laoauthor=T.+K.+Loeauthor=V.+Lekoauthor=A.+Thalhoferauthor=A.+D.+Schulerauthor=A.+Bedalovauthor=J.+A.+Simon&title=Development+of+pyrazolone+and+isoxazol-5-one+cambinol+analogues+as+sirtuin+inhibitors&doi=10.1021%2Fjm4018064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm4018064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4018064%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DScian%26aufirst%3DM.%26aulast%3DSripathy%26aufirst%3DS.%26aulast%3DPosakony%26aufirst%3DJ.%26aulast%3DLao%26aufirst%3DU.%26aulast%3DLoe%26aufirst%3DT.%2BK.%26aulast%3DLeko%26aufirst%3DV.%26aulast%3DThalhofer%26aufirst%3DA.%26aulast%3DSchuler%26aufirst%3DA.%2BD.%26aulast%3DBedalov%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520pyrazolone%2520and%2520isoxazol-5-one%2520cambinol%2520analogues%2520as%2520sirtuin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3283%26epage%3D3294%26doi%3D10.1021%2Fjm4018064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, M. L.</span><span> </span><span class="NLM_article-title">Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ejmech.2014.12.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=145-155&author=T.+Yangauthor=X.+Chenauthor=H.+X.+Jinauthor=G.+Sethiauthor=M.+L.+Go&title=Functionalized+tetrahydro-1H-pyrido%5B4%2C3-b%5Dindoles%3A+a+novel+chemotype+with+Sirtuin+2+inhibitory+activity&doi=10.1016%2Fj.ejmech.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DH.%2BX.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DFunctionalized%2520tetrahydro-1H-pyrido%255B4%252C3-b%255Dindoles%253A%2520a%2520novel%2520chemotype%2520with%2520Sirtuin%25202%2520inhibitory%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D145%26epage%3D155%26doi%3D10.1016%2Fj.ejmech.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">More, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8340</span><span class="NLM_x">–</span> <span class="NLM_lpage">8357</span><span class="refDoi"> DOI: 10.1021/jm500777s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500777s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8340-8357&author=H.+Cuiauthor=Z.+Kamalauthor=T.+Aiauthor=Y.+Xuauthor=S.+S.+Moreauthor=D.+J.+Wilsonauthor=L.+Chen&title=Discovery+of+potent+and+selective+sirtuin+2+%28SIRT2%29+inhibitors+using+a+fragment-based+approach&doi=10.1021%2Fjm500777s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Cui, Huaqing; Kamal, Zeeshan; Ai, Teng; Xu, Yanli; More, Swati S.; Wilson, Daniel J.; Chen, Liqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8340-8357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuin 2 (SIRT2) is one of the sirtuins, a family of NAD+-dependent deacetylases that act on a variety of histone and non-histone substrates.  Accumulating biol. functions and potential therapeutic applications have drawn interest in the discovery and development of SIRT2 inhibitors.  Herein we report our discovery of novel SIRT2 inhibitors using a fragment-based approach.  Inspired by the purported close binding proximity of suramin and nicotinamide, we prepd. two sets of fragments, namely, the naphthylamide sulfonic acids and the naphthalene-benzamides and -nicotinamides.  Biochem. evaluation of these two series provided structure-activity relationship (SAR) information, which led to the design of (5-benzamidonaphthalen-1/2-yloxy)nicotinamide derivs.  Among these inhibitors, one compd. exhibited high anti-SIRT2 activity (48 nM) and excellent selectivity for SIRT2 over SIRT1 and SIRT3.  In vitro, it also increased the acetylation level of α-tubulin, a well-established SIRT2 substrate, in both concn.- and time-dependent manners.  Further kinetic studies revealed that this compd. behaves as a competitive inhibitor against the peptide substrate and most likely as a noncompetitive inhibitor against NAD+.  Taken together, these results indicate that we have discovered a potent and selective SIRT2 inhibitor whose novel structure merits further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdLtR3ic38bVg90H21EOLACvtfcHk0ljaxt1tW_3fNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL&md5=6831830798aa6518ca02e3780c49b4cd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm500777s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500777s%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.%26aulast%3DKamal%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMore%26aufirst%3DS.%2BS.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520sirtuin%25202%2520%2528SIRT2%2529%2520inhibitors%2520using%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8340%26epage%3D8357%26doi%3D10.1021%2Fjm500777s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Parenti, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rio, A.</span><span> </span><span class="NLM_article-title">Selectivity hot-spots of sirtuin catalytic cores</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2263</span><span class="NLM_x">–</span> <span class="NLM_lpage">2272</span><span class="refDoi"> DOI: 10.1039/C5MB00205B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1039%2FC5MB00205B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=26061123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFSiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=2263-2272&author=M.+D.+Parentiauthor=S.+Bruzzoneauthor=A.+Nencioniauthor=A.+Del+Rio&title=Selectivity+hot-spots+of+sirtuin+catalytic+cores&doi=10.1039%2FC5MB00205B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity hot-spots of sirtuin catalytic cores</span></div><div class="casAuthors">Parenti, Marco Daniele; Bruzzone, Santina; Nencioni, Alessio; Del Rio, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2263-2272</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent deacetylases with several biol. roles in DNA regulation, genomic stability, metab., longevity and immune cell functions.  Numerous disease conditions are linked to sirtuins including metabolic disorders, inflammatory and autoimmune processes and cancer.  Although few specific small mol. modulators have been reported to date, the need to identify selective ligands would be crucial not only for the development of active pharmaceutical ingredients for new targeted therapies but also as a tool for dissecting the biol. roles of sirtuin family members.  Herein, we report a comprehensive study aimed to classify and identify the selectivity hot-spots for targeting the catalytic cores of human sirtuins using small mol. modulators.  Our selectivity anal. suggests that catalytic cores can be divided into different clusters that can constitute the basis for the development of selective ligands.  The ensemble of hot-spot information is expected to be helpful to devise new selective chems. targeting sirtuin family members.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJp_S4bMfrlLVg90H21EOLACvtfcHk0lhIY_eFa6w2Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFSiur8%253D&md5=20e51ccba48f639934973e570cea5d07</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC5MB00205B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MB00205B%26sid%3Dliteratum%253Aachs%26aulast%3DParenti%26aufirst%3DM.%2BD.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DDel%2BRio%26aufirst%3DA.%26atitle%3DSelectivity%2520hot-spots%2520of%2520sirtuin%2520catalytic%2520cores%26jtitle%3DMol.%2520BioSyst.%26date%3D2015%26volume%3D11%26spage%3D2263%26epage%3D2272%26doi%3D10.1039%2FC5MB00205B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settles, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallows, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">SIRT3 substrate specificity determined by peptide arrays and machine learning</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span><span class="refDoi"> DOI: 10.1021/cb100218d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100218d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGkt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=146-157&author=B.+C.+Smithauthor=B.+Settlesauthor=W.+C.+Hallowsauthor=M.+W.+Cravenauthor=J.+M.+Denu&title=SIRT3+substrate+specificity+determined+by+peptide+arrays+and+machine+learning&doi=10.1021%2Fcb100218d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT3 Substrate Specificity Determined by Peptide Arrays and Machine Learning</span></div><div class="casAuthors">Smith, Brian C.; Settles, Burr; Hallows, William C.; Craven, Mark W.; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-157</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that reversible protein acetylation may be a major regulatory mechanism that rivals phosphorylation.  With the recent cataloging of thousands of acetylation sites on hundreds of proteins comes the challenge of identifying the acetyltransferases and deacetylases that regulate acetylation levels.  Sirtuins are a conserved family of NAD+-dependent protein deacetylases that are implicated in genome maintenance, metab., cell survival, and lifespan.  SIRT3 is the dominant protein deacetylase in mitochondria, and emerging evidence suggests that SIRT3 may control major pathways by deacetylation of central metabolic enzymes.  Here, to identify potential SIRT3 substrates, we have developed an unbiased screening strategy that involves a novel acetyl-lysine analog (thiotrifluoroacetyl-lysine), SPOT-peptide libraries, machine learning, and kinetic validation.  SPOT peptide libraries based on known and potential mitochondrial acetyl-lysine sites were screened for SIRT3 binding and then analyzed using machine learning to establish binding trends.  These trends were then applied to the mitochondrial proteome as a whole to predict binding affinity of all lysine sites within human mitochondria.  Machine learning prediction of SIRT3 binding correlated with steady-state kinetic kcat/Km values for 24 acetyl-lysine peptides that possessed a broad range of predicted binding.  Thus, SPOT peptide-binding screens and machine learning prediction provides an accurate and efficient method to evaluate sirtuin substrate specificity from a relatively small learning set.  These analyses suggest potential SIRT3 substrates involved in several metabolic pathways such as the urea cycle, ATP synthesis, and fatty acid oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZ8i2tCKgDLVg90H21EOLACvtfcHk0lhIY_eFa6w2Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGkt7fP&md5=bfdf78cdd6f6129a3663d2409b15986b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcb100218d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100218d%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DSettles%26aufirst%3DB.%26aulast%3DHallows%26aufirst%3DW.%2BC.%26aulast%3DCraven%26aufirst%3DM.%2BW.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DSIRT3%2520substrate%2520specificity%2520determined%2520by%2520peptide%2520arrays%2520and%2520machine%2520learning%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D146%26epage%3D157%26doi%3D10.1021%2Fcb100218d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery: a Guide for Medicinal Chemists and Pharmacologists</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Chapter 7.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2F9781118540398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery%3A+a+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F9781118540398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%253A%2520a%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the histone deacetylase SIRT2</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span><span class="refDoi"> DOI: 10.1038/89668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2F89668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=11427894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=621-625&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=N.+P.+Pavletich&title=Structure+of+the+histone+deacetylase+SIRT2&doi=10.1038%2F89668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the histone deacetylase SIRT2</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Sir2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres, and ribosomal gene clusters, and plays a crit. role in the detn. of life span in yeast and Caenorhabditis elegans.  Here, the 1.7 Å crystal structure of the 323-amino-acid catalytic core of human SIRT2, a homolog of yeast Sir2, revealed an NAD-binding domain, which was a variant of the Rossmann fold, and a smaller domain composed of a helical module and a Zn-binding module.  A conserved large groove at the interface of the 2 domains was the likely site of catalysis based on mutagenesis.  Intersecting this large groove, there was a pocket formed by the helical module.  The pocket was lined with hydrophobic residues conserved within each of the 5 Sir2 classes, suggesting that it is a class-specific protein-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNi1R8KPeQ7Vg90H21EOLACvtfcHk0lhIY_eFa6w2Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D&md5=6d305c420bff2690da780fc23938c22f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2F89668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89668%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520histone%2520deacetylase%2520SIRT2%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D621%26epage%3D625%26doi%3D10.1038%2F89668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span><span class="refDoi"> DOI: 10.1038/nrd2999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fnrd2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=19876042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders&doi=10.1038%2Fnrd2999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases in central nervous system disorders</span></div><div class="casAuthors">Chico, Laura K.; Van Eldik, Linda J.; Watterson, D. Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">892-909</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a growing drug target class in disorders in peripheral tissues, but the development of kinase-targeted therapies for central nervous system (CNS) diseases remains a challenge, largely owing to issues assocd. specifically with CNS drug discovery.  However, several candidate therapeutics that target CNS protein kinases are now in various stages of preclin. and clin. development.  We review candidate compds. and discuss selected CNS protein kinases that are emerging as important therapeutic targets.  In addn., we analyze trends in small-mol. properties that correlate with key challenges in CNS drug discovery, such as blood-brain barrier penetrance and cytochrome P 450-mediated metab., and discuss the potential of future approaches that will integrate mol.-fragment expansion with pharmacoinformatics to address these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzQo2JmuPNlrVg90H21EOLACvtfcHk0lhG0oJAM87imQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO&md5=4dc1f6b7542e59c99f91525d37c49973</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2999%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909%26doi%3D10.1038%2Fnrd2999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1021/cn100007x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes&doi=10.1021%2Fcn100007x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lhG0oJAM87imQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434%26doi%3D10.1021%2Fcn100007x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Gumbleton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audus, K. L.</span><span> </span><span class="NLM_article-title">Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1681</span><span class="NLM_x">–</span> <span class="NLM_lpage">1698</span><span class="refDoi"> DOI: 10.1002/jps.1119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fjps.1119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=11745727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=1681-1698&author=M.+Gumbletonauthor=K.+L.+Audus&title=Progress+and+limitations+in+the+use+of+in+vitro+cell+cultures+to+serve+as+a+permeability+screen+for+the+blood-brain+barrier&doi=10.1002%2Fjps.1119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Gumbleton, Mark; Audus, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1681-1698</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  A relatively simple, widely applicable, and robust in vitro method of predicting blood-brain barrier (BBB) permeability to central nervous system-acting drugs is an increasing need.  A cell-based model offers the potential to account for transcellular and paracellular drug diffusional processes, metab., and active transport processes, as well as nondefined interactions between a drug and cellular material that may impact upon a membrane's overall permeability profile.  Any in vitro BBB cell model to be utilized for the transendothelial BBB permeability screening of potential central nervous system drugs must display reproducible solute permeability, and a no. of other general criteria including: a restrictive paracellular barrier; a physiol. realistic cell architecture; the functional expression of key transporter mechanisms; and allow case of culture to meet the tech. and time constraints of a screening program.  This article reviews the range of in vitro cell-based BBB models available, including the primary/low passage bovine and porcine brain endothelial cultures as well as the spectrum of immortalized brain endothelial cell lines that have been established.  The article further discusses the benefits and limitations of exploiting such systems as in vitro BBB permeability screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfQGmXBBqLF7Vg90H21EOLACvtfcHk0ljSRc9jHr_3xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKltrw%253D&md5=b4e729da5775cfa74dd5d00e8ce2a3bc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.1119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.1119%26sid%3Dliteratum%253Aachs%26aulast%3DGumbleton%26aufirst%3DM.%26aulast%3DAudus%26aufirst%3DK.%2BL.%26atitle%3DProgress%2520and%2520limitations%2520in%2520the%2520use%2520of%2520in%2520vitro%2520cell%2520cultures%2520to%2520serve%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D90%26spage%3D1681%26epage%3D1698%26doi%3D10.1002%2Fjps.1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddapati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierks, M. R.</span><span> </span><span class="NLM_article-title">Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson’s disease cell model</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1186/1471-2202-11-57</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1186%2F1471-2202-11-57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20433710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A280%3ADC%252BC3czns12ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=57-66&author=M.+S.+Wangauthor=S.+Boddapatiauthor=S.+Emadiauthor=M.+R.+Sierks&title=Curcumin+reduces+alpha-synuclein+induced+cytotoxicity+in+Parkinson%E2%80%99s+disease+cell+model&doi=10.1186%2F1471-2202-11-57"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model</span></div><div class="casAuthors">Wang Min S; Boddapati Shanta; Emadi Sharareh; Sierks Michael R</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Overexpression and abnormal accumulation of aggregated alpha-synuclein (alphaS) have been linked to Parkinson's disease (PD) and other synucleinopathies. alphaS can misfold and adopt a variety of morphologies but recent studies implicate oligomeric forms as the most cytotoxic species.  Both genetic mutations and chronic exposure to neurotoxins increase alphaS aggregation and intracellular reactive oxygen species (ROS), leading to mitochondrial dysfunction and oxidative damage in PD cell models.  RESULTS:  Here we show that curcumin can alleviate alphaS-induced toxicity, reduce ROS levels and protect cells against apoptosis.  We also show that both intracellular overexpression of alphaS and extracellular addition of oligomeric alphaS increase ROS which induces apoptosis, suggesting that aggregated alphaS may induce similar toxic effects whether it is generated intra- or extracellulary.  CONCLUSIONS:  Since curcumin is a natural food pigment that can cross the blood brain barrier and has widespread medicinal uses, it has potential therapeutic value for treating PD and other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzpoo8du5T1Ph3YQQtAhNufW6udTcc2eYnExsFzED4bLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czns12ksw%253D%253D&md5=351eb6a5dab5145c025cd295f9aee6a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-11-57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-11-57%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DBoddapati%26aufirst%3DS.%26aulast%3DEmadi%26aufirst%3DS.%26aulast%3DSierks%26aufirst%3DM.%2BR.%26atitle%3DCurcumin%2520reduces%2520alpha-synuclein%2520induced%2520cytotoxicity%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520cell%2520model%26jtitle%3DBMC%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D57%26epage%3D66%26doi%3D10.1186%2F1471-2202-11-57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. C.</span><span> </span><span class="NLM_article-title">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1038/nature12481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fnature12481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=24005412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=45-51&author=M.+Juckerauthor=L.+C.+Walker&title=Self-propagation+of+pathogenic+protein+aggregates+in+neurodegenerative+diseases&doi=10.1038%2Fnature12481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span></div><div class="casAuthors">Jucker, Mathias; Walker, Lary C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">7465</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biol. of the prion diseases.  Recently, owing largely to the advent of new disease models, this hypothesis has gained exptl. momentum.  In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid.  Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease.  Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin.  However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function.  As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCZxraDJnKbbVg90H21EOLACvtfcHk0ljSRc9jHr_3xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP&md5=6e10e4c3d25f9a907b7af8944cb1ba69</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature12481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12481%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DL.%2BC.%26atitle%3DSelf-propagation%2520of%2520pathogenic%2520protein%2520aggregates%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D45%26epage%3D51%26doi%3D10.1038%2Fnature12481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Marques, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outeiro, T. F.</span><span> </span><span class="NLM_article-title">Alpha-synuclein: from secretion to dysfunction and death</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e350</span><span class="refDoi"> DOI: 10.1038/cddis.2012.94</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fcddis.2012.94" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e350&author=O.+Marquesauthor=T.+F.+Outeiro&title=Alpha-synuclein%3A+from+secretion+to+dysfunction+and+death&doi=10.1038%2Fcddis.2012.94"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.94%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DO.%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26atitle%3DAlpha-synuclein%253A%2520from%2520secretion%2520to%2520dysfunction%2520and%2520death%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De350%26doi%3D10.1038%2Fcddis.2012.94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Emadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkhordarian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierks, M. R.</span><span> </span><span class="NLM_article-title">Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span><span class="refDoi"> DOI: 10.1016/j.jmb.2007.02.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.jmb.2007.02.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=17391701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFahsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2007&pages=1132-1144&author=S.+Emadiauthor=H.+Barkhordarianauthor=M.+S.+Wangauthor=P.+Schulzauthor=M.+R.+Sierks&title=Isolation+of+a+human+single+chain+antibody+fragment+against+oligomeric+alpha-synuclein+that+inhibits+aggregation+and+prevents+alpha-synuclein-induced+toxicity&doi=10.1016%2Fj.jmb.2007.02.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced Toxicity</span></div><div class="casAuthors">Emadi, Sharareh; Barkhordarian, Hedieh; Wang, Min S.; Schulz, Philip; Sierks, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1132-1144</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein misfolding and aggregation are pathol. aspects of numerous neurodegenerative diseases.  Aggregates of α-synuclein are major components of the Lewy bodies and Lewy neurites assocd. with Parkinson's Disease (PD).  A natively unfolded protein, α-synuclein, can adopt different aggregated morphologies, including oligomers, protofibrils and fibrils.  The small oligomeric aggregates have been shown to be particularly toxic.  Antibodies that neutralize the neurotoxic aggregates without interfering with beneficial functions of monomeric α-synuclein can be useful therapeutics.  We were able to isolate single chain antibody fragments (scFvs) from a phage displayed antibody library against the target antigen morphol. using a novel biopanning technique that utilizes at. force microscopy (AFM) to image and immobilize specific morphologies of α-synuclein.  The scFv described here binds only to an oligomeric form of α-synuclein and inhibits both aggregation and toxicity of α-synuclein in vitro.  This scFv can have potential therapeutic value in controlling misfolding and aggregation of α-synuclein in vivo when expressed intracellularly in dopaminergic neurons as an intrabody.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN5ZomX-Lmj7Vg90H21EOLACvtfcHk0lhTgeFYWRhAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFahsr8%253D&md5=fb85f6ee8f66ca4b66e0cfa0fc06628a</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DEmadi%26aufirst%3DS.%26aulast%3DBarkhordarian%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DSchulz%26aufirst%3DP.%26aulast%3DSierks%26aufirst%3DM.%2BR.%26atitle%3DIsolation%2520of%2520a%2520human%2520single%2520chain%2520antibody%2520fragment%2520against%2520oligomeric%2520alpha-synuclein%2520that%2520inhibits%2520aggregation%2520and%2520prevents%2520alpha-synuclein-induced%2520toxicity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D368%26spage%3D1132%26epage%3D1144%26doi%3D10.1016%2Fj.jmb.2007.02.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Emadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasturirangan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierks, M. R.</span><span> </span><span class="NLM_article-title">Detecting morphologically distinct oligomeric forms of alpha-synuclein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">11048</span><span class="NLM_x">–</span> <span class="NLM_lpage">11058</span><span class="refDoi"> DOI: 10.1074/jbc.M806559200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1074%2Fjbc.M806559200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=11048-11058&author=S.+Emadiauthor=S.+Kasturiranganauthor=M.+S.+Wangauthor=P.+Schulzauthor=M.+R.+Sierks&title=Detecting+morphologically+distinct+oligomeric+forms+of+alpha-synuclein&doi=10.1074%2Fjbc.M806559200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806559200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806559200%26sid%3Dliteratum%253Aachs%26aulast%3DEmadi%26aufirst%3DS.%26aulast%3DKasturirangan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DSchulz%26aufirst%3DP.%26aulast%3DSierks%26aufirst%3DM.%2BR.%26atitle%3DDetecting%2520morphologically%2520distinct%2520oligomeric%2520forms%2520of%2520alpha-synuclein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D11048%26epage%3D11058%26doi%3D10.1074%2Fjbc.M806559200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehm, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span><span class="refDoi"> DOI: 10.1126/science.1227157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1126%2Fscience.1227157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=23161999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GntL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2012&pages=949-953&author=K.+C.+Lukauthor=V.+Kehmauthor=J.+Carrollauthor=B.+Zhangauthor=P.+O%E2%80%99Brienauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Pathological+alpha-synuclein+transmission+initiates+Parkinson-like+neurodegeneration+in+nontransgenic+mice&doi=10.1126%2Fscience.1227157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice</span></div><div class="casAuthors">Luk, Kelvin C.; Kehm, Victoria; Carroll, Jenna; Zhang, Bin; O'Brien, Patrick; Trojanowski, John Q.; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">6109</span>),
    <span class="NLM_cas:pages">949-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Parkinson's disease is characterized by abundant α-synuclein (α-Syn) neuronal inclusions, known as Lewy bodies and Lewy neurites, and the massive loss of midbrain dopamine neurons.  However, a cause-and-effect relationship between Lewy inclusion formation and neurodegeneration remains unclear.  Here, we found that in wild-type nontransgenic mice, a single intrastriatal inoculation of synthetic α-Syn fibrils led to the cell-to-cell transmission of pathol. α-Syn and Parkinson's-like Lewy pathol. in anatomically interconnected regions.  Lewy pathol. accumulation resulted in progressive loss of dopamine neurons in the substantia nigra pars compacta, but not in the adjacent ventral tegmental area, and was accompanied by reduced dopamine levels culminating in motor deficits.  This recapitulation of a neurodegenerative cascade thus establishes a mechanistic link between transmission of pathol. α-Syn and the cardinal features of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMkqmC5V3XW7Vg90H21EOLACvtfcHk0lhTgeFYWRhAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GntL7L&md5=33e42d401479dc4d07aae9e808611017</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1227157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1227157%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DKehm%26aufirst%3DV.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DPathological%2520alpha-synuclein%2520transmission%2520initiates%2520Parkinson-like%2520neurodegeneration%2520in%2520nontransgenic%2520mice%26jtitle%3DScience%26date%3D2012%26volume%3D338%26spage%3D949%26epage%3D953%26doi%3D10.1126%2Fscience.1227157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehm, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span><span class="refDoi"> DOI: 10.1084/jem.20112457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1084%2Fjem.20112457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22508839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmsl2itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=975-986&author=K.+C.+Lukauthor=V.+M.+Kehmauthor=B.+Zhangauthor=P.+O%E2%80%99Brienauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Intracerebral+inoculation+of+pathological+alpha-synuclein+initiates+a+rapidly+progressive+neurodegenerative+alpha-synucleinopathy+in+mice&doi=10.1084%2Fjem.20112457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice</span></div><div class="casAuthors">Luk, Kelvin C.; Kehm, Victoria M.; Zhang, Bin; O'Brien, Patrick; Trojanowski, John Q.; Lee, Virginia M. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-986</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The accumulation of misfolded proteins is a fundamental pathogenic process in neurodegenerative diseases.  However, the factors that trigger aggregation of α-Synuclein (α-Syn), the principal component of the intraneuronal inclusions known as Lewy bodies (LBs), and Lewy neurites (LNs), which characterize Parkinson's disease (PD) and dementia with LBs (DLB), are poorly understood.  We show here that in young asymptomatic α-Syn transgenic (Tg) mice, intracerebral injections of brain homogenates derived from older Tg mice exhibiting α-Syn pathol. accelerate both the formation of intracellular LB/LN-like inclusions and the onset of neurol. symptoms in recipient animals.  Pathol. α-Syn propagated along major central nervous system (CNS) pathways to regions far beyond injection sites and reduced survival with a highly reproducible interval from injection to death in inoculated animals.  Importantly, inoculation with α-Syn amyloid fibrils assembled from recombinant human α-Syn induced identical consequences.  Furthermore, we show for the first time that synthetic α-Syn fibrils are wholly sufficient to initiate PD-like LBs/LNs and to transmit disease in vivo.  Thus, our data point to a prion-like cascade in synucleinopathies whereby cell-cell transmission and propagation of misfolded α-Syn underlie the CNS spread of LBs/LNs.  These findings open up new avenues for understanding the progression of PD and for developing novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMEAs-_zzl1rVg90H21EOLACvtfcHk0lj1Gy-GEGNIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmsl2itb8%253D&md5=f225d6d7c8c78df53a54c634a3d68cfc</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1084%2Fjem.20112457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20112457%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DKehm%26aufirst%3DV.%2BM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DIntracerebral%2520inoculation%2520of%2520pathological%2520alpha-synuclein%2520initiates%2520a%2520rapidly%2520progressive%2520neurodegenerative%2520alpha-synucleinopathy%2520in%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26spage%3D975%26epage%3D986%26doi%3D10.1084%2Fjem.20112457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Volpicelli-Daley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanik, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1016/j.neuron.2011.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.neuron.2011.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=21982369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12kt7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2011&pages=57-71&author=L.+A.+Volpicelli-Daleyauthor=K.+C.+Lukauthor=T.+P.+Patelauthor=S.+A.+Tanikauthor=D.+M.+Riddleauthor=A.+Stieberauthor=D.+F.+Meaneyauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Exogenous+alpha-synuclein+fibrils+induce+Lewy+body+pathology+leading+to+synaptic+dysfunction+and+neuron+death&doi=10.1016%2Fj.neuron.2011.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39cR"><div class="casContent"><span class="casTitleNuber">39c</span><div class="casTitle"><span class="NLM_cas:atitle">Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death</span></div><div class="casAuthors">Volpicelli-Daley, Laura A.; Luk, Kelvin C.; Patel, Tapan P.; Tanik, Selcuk A.; Riddle, Dawn M.; Stieber, Anna; Meaney, David F.; Trojanowski, John Q.; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-71</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inclusions composed of α-synuclein (α-syn), i.e., Lewy bodies (LBs) and Lewy neurites (LNs), define synucleinopathies including Parkinson's disease (PD) and dementia with Lewy bodies (DLB).  Here, we demonstrate that preformed fibrils generated from full-length and truncated recombinant α-syn enter primary neurons, probably by adsorptive-mediated endocytosis, and promote recruitment of sol. endogenous α-syn into insol. PD-like LBs and LNs.  Remarkably, endogenous α-syn was sufficient for formation of these aggregates, and overexpression of wild-type or mutant α-syn was not required.  LN-like pathol. first developed in axons and propagated to form LB-like inclusions in perikarya.  Accumulation of pathol. α-syn led to selective decreases in synaptic proteins, progressive impairments in neuronal excitability and connectivity, and, eventually, neuron death.  Thus, our data contribute important insights into the etiol. and pathogenesis of PD-like α-syn inclusions and their impact on neuronal functions, and they provide a model for discovering therapeutics targeting pathol. α-syn-mediated neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi33SV7tReNbVg90H21EOLACvtfcHk0lj1Gy-GEGNIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12kt7bP&md5=771dc7412f14fc4d30d15db30cf96309</span></div><a href="/servlet/linkout?suffix=cit39c&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2011.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2011.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DVolpicelli-Daley%26aufirst%3DL.%2BA.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DPatel%26aufirst%3DT.%2BP.%26aulast%3DTanik%26aufirst%3DS.%2BA.%26aulast%3DRiddle%26aufirst%3DD.%2BM.%26aulast%3DStieber%26aufirst%3DA.%26aulast%3DMeaney%26aufirst%3DD.%2BF.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DExogenous%2520alpha-synuclein%2520fibrils%2520induce%2520Lewy%2520body%2520pathology%2520leading%2520to%2520synaptic%2520dysfunction%2520and%2520neuron%2520death%26jtitle%3DNeuron%26date%3D2011%26volume%3D72%26spage%3D57%26epage%3D71%26doi%3D10.1016%2Fj.neuron.2011.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">20051</span><span class="NLM_x">–</span> <span class="NLM_lpage">20056</span><span class="refDoi"> DOI: 10.1073/pnas.0908005106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.0908005106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20051-20056&author=K.+C.+Lukauthor=C.+Songauthor=P.+O%E2%80%99Brienauthor=A.+Stieberauthor=J.+R.+Branchauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Exogenous+alpha-synuclein+fibrils+seed+the+formation+of+Lewy+body-like+intracellular+inclusions+in+cultured+cells&doi=10.1073%2Fpnas.0908005106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39d&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908005106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908005106%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DStieber%26aufirst%3DA.%26aulast%3DBranch%26aufirst%3DJ.%2BR.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DExogenous%2520alpha-synuclein%2520fibrils%2520seed%2520the%2520formation%2520of%2520Lewy%2520body-like%2520intracellular%2520inclusions%2520in%2520cultured%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D20051%26epage%3D20056%26doi%3D10.1073%2Fpnas.0908005106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Recasens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Carbajal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Villalba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernagut, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span> </span><span class="NLM_article-title">Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1002/ana.24066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fana.24066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=24243558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=351-362&author=A.+Recasensauthor=B.+Dehayauthor=J.+Boveauthor=I.+Carballo-Carbajalauthor=S.+Doveroauthor=A.+Perez-Villalbaauthor=P.+O.+Fernagutauthor=J.+Blesaauthor=A.+Parentauthor=C.+Perierauthor=I.+Farinasauthor=J.+A.+Obesoauthor=E.+Bezardauthor=M.+Vila&title=Lewy+body+extracts+from+Parkinson+disease+brains+trigger+alpha-synuclein+pathology+and+neurodegeneration+in+mice+and+monkeys&doi=10.1002%2Fana.24066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys</span></div><div class="casAuthors">Recasens, Ariadna; Dehay, Benjamin; Bove, Jordi; Carballo-Carbajal, Iria; Dovero, Sandra; Perez-Villalba, Ana; Fernagut, Pierre-Olivier; Blesa, Javier; Parent, Annabelle; Perier, Celine; Farinas, Isabel; Obeso, Jose A.; Bezard, Erwan; Vila, Miquel</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">351-362</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective : Mounting evidence suggests that α-synuclein, a major protein component of Lewy bodies (LB), may be responsible for initiating and spreading the pathol. process in Parkinson disease (PD).  Supporting this concept, intracerebral inoculation of synthetic recombinant α-synuclein fibrils can trigger α-synuclein pathol. in mice.  However, it remains uncertain whether the pathogenic effects of recombinant synthetic α-synuclein may apply to PD-linked pathol. α-synuclein and occur in species closer to humans.  Methods : Nigral LB-enriched fractions contg. pathol. α-synuclein were purified from postmortem PD brains by sucrose gradient fractionation and subsequently inoculated into the substantia nigra or striatum of wild-type mice and macaque monkeys.  Control animals received non-LB fractions contg. sol. α-synuclein derived from the same nigral PD tissue.  Results : In both mice and monkeys, intranigral or intrastriatal inoculations of PD-derived LB exts. resulted in progressive nigrostriatal neurodegeneration starting at striatal dopaminergic terminals.  No neurodegeneration was obsd. in animals receiving non-LB fractions from the same patients.  In LB-injected animals, exogenous human α-synuclein was quickly internalized within host neurons and triggered the pathol. conversion of endogenous α-synuclein.  At the onset of LB-induced degeneration, host pathol. α-synuclein diffusely accumulated within nigral neurons and anatomically interconnected regions, both anterogradely and retrogradely.  LB-induced pathogenic effects required both human α-synuclein present in LB exts. and host expression of α-synuclein.  Interpretation : α-Synuclein species contained in PD-derived LB are pathogenic and have the capacity to initiate a PD-like pathol. process, including intracellular and presynaptic accumulations of pathol. α-synuclein in different brain areas and slowly progressive axon-initiated dopaminergic nigrostriatal neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-2AzyZDzd7Vg90H21EOLACvtfcHk0li8y3hNRJS1SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSjt7k%253D&md5=bf14c11708b633689898b9093f101acf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fana.24066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24066%26sid%3Dliteratum%253Aachs%26aulast%3DRecasens%26aufirst%3DA.%26aulast%3DDehay%26aufirst%3DB.%26aulast%3DBove%26aufirst%3DJ.%26aulast%3DCarballo-Carbajal%26aufirst%3DI.%26aulast%3DDovero%26aufirst%3DS.%26aulast%3DPerez-Villalba%26aufirst%3DA.%26aulast%3DFernagut%26aufirst%3DP.%2BO.%26aulast%3DBlesa%26aufirst%3DJ.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DFarinas%26aufirst%3DI.%26aulast%3DObeso%26aufirst%3DJ.%2BA.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DVila%26aufirst%3DM.%26atitle%3DLewy%2520body%2520extracts%2520from%2520Parkinson%2520disease%2520brains%2520trigger%2520alpha-synuclein%2520pathology%2520and%2520neurodegeneration%2520in%2520mice%2520and%2520monkeys%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D75%26spage%3D351%26epage%3D362%26doi%3D10.1002%2Fana.24066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hallows, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">10230</span><span class="NLM_x">–</span> <span class="NLM_lpage">10235</span><span class="refDoi"> DOI: 10.1073/pnas.0604392103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.0604392103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=16790548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10230-10235&author=W.+C.+Hallowsauthor=S.+Leeauthor=J.+M.+Denu&title=Sirtuins+deacetylate+and+activate+mammalian+acetyl-CoA+synthetases&doi=10.1073%2Fpnas.0604392103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases</span></div><div class="casAuthors">Hallows, William C.; Lee, Susan; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">10230-10235</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Silent Information Regulator 2 (Sir2) enzymes (or sirtuins) are NAD+-dependent deacetylases that modulate gene silencing, aging and energy metab.  Previous work has implicated several transcription factors as sirtuin targets.  Here, we investigated whether mammalian sirtuins could directly control the activity of metabolic enzymes.  We demonstrate that mammalian Acetyl-CoA synthetases (AceCSs) are regulated by reversible acetylation and that sirtuins activate AceCSs by deacetylation.  Site-specific acetylation of mouse AceCS1 on Lys-661 was identified by using mass spectrometry and a specific anti-acetyl-AceCS antibody.  SIRT1 was the only member of seven human Sir2 homologs capable of deacetylating AceCS1 in cellular coexpression expts.  SIRT1 expression also led to a pronounced increase in AceCS1-dependent fatty-acid synthesis from acetate.  Using purified enzymes, only SIRT1 and SIRT3 exhibited high catalytic efficiency against acetylated AceCS1.  In mammals, two AceCSs have been identified: cytoplasmic AceCS1 and mitochondrial AceCS2.  Because SIRT3 is localized to the mitochondria, we investigated whether AceCS2 also might be regulated by acetylation, and specifically deacetylated by mitochondrial SIRT3.  AceCS2 was completely inactivated upon acetylation and was rapidly reactivated by SIRT3 deacetylation.  Lys-635 of mouse AceCS2 was identified as the targeted residue.  Using reversible acetylation to modulate enzyme activity, we propose a model for the control of AceCS1 by SIRT1 and of AceCS2 by SIRT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptbmWATBB41bVg90H21EOLACvtfcHk0li8y3hNRJS1SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlKmt74%253D&md5=20e40562f9d9c133e7ba21261e2339ff</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604392103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604392103%26sid%3Dliteratum%253Aachs%26aulast%3DHallows%26aufirst%3DW.%2BC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DSirtuins%2520deacetylate%2520and%2520activate%2520mammalian%2520acetyl-CoA%2520synthetases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10230%26epage%3D10235%26doi%3D10.1073%2Fpnas.0604392103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38a','cit38b'],'ref39':['cit39a','cit39b','cit39c','cit39d'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Moniot</span>, <span class="hlFld-ContribAuthor ">Mariantonietta  Forgione</span>, <span class="hlFld-ContribAuthor ">Alessia  Lucidi</span>, <span class="hlFld-ContribAuthor ">Gebremedhin S.  Hailu</span>, <span class="hlFld-ContribAuthor ">Angela  Nebbioso</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Carafa</span>, <span class="hlFld-ContribAuthor ">Francesca  Baratta</span>, <span class="hlFld-ContribAuthor ">Lucia  Altucci</span>, <span class="hlFld-ContribAuthor ">Nicola  Giacché</span>, <span class="hlFld-ContribAuthor ">Daniela  Passeri</span>, <span class="hlFld-ContribAuthor ">Roberto  Pellicciari</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>, <span class="hlFld-ContribAuthor ">Clemens  Steegborn</span>, and <span class="hlFld-ContribAuthor ">Dante  Rotili</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure–Activity Relationship, X-ray Crystal Structure, and Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2344-2360. <a href="https://doi.org/10.1021/acs.jmedchem.6b01609" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01609%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252B1%25252C2%25252C4-Oxadiazoles%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252Bthe%252BHuman%252BDeacetylase%252BSirtuin%252B2%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%25252C%252BX-ray%252BCrystal%252BStructure%25252C%252Band%252BAnticancer%252BActivity%26aulast%3DMoniot%26aufirst%3DS%25C3%25A9bastien%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D02112016%26date%3D14032017%26date%3D23032017%26date%3D27022017%26volume%3D60%26issue%3D6%26spage%3D2344%26epage%3D2360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Sundriyal</span>, <span class="hlFld-ContribAuthor ">Sébastien  Moniot</span>, <span class="hlFld-ContribAuthor ">Zimam  Mahmud</span>, <span class="hlFld-ContribAuthor ">Shang  Yao</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Reynolds</span>, <span class="hlFld-ContribAuthor ">David T.  Dexter</span>, <span class="hlFld-ContribAuthor ">Michael J. E.  Sternberg</span>, <span class="hlFld-ContribAuthor ">Eric W.-F.  Lam</span>, <span class="hlFld-ContribAuthor ">Clemens  Steegborn</span>, and <span class="hlFld-ContribAuthor ">Matthew J.  Fuchter</span>  . </span><span class="cited-content_cbyCitation_article-title">Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1928-1945. <a href="https://doi.org/10.1021/acs.jmedchem.6b01690" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01690%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThienopyrimidinone%252BBased%252BSirtuin-2%252B%252528SIRT2%252529-Selective%252BInhibitors%252BBind%252Bin%252Bthe%252BLigand%252BInduced%252BSelectivity%252BPocket%26aulast%3DSundriyal%26aufirst%3DSandeep%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D17112016%26date%3D15022017%26date%3D09032017%26date%3D30012017%26volume%3D60%26issue%3D5%26spage%3D1928%26epage%3D1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuqi  Chen</span>, <span class="hlFld-ContribAuthor ">Wenmei  Lu</span>, <span class="hlFld-ContribAuthor ">Danhong  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.3389/fnins.2021.614107" title="DOI URL">https://doi.org/10.3389/fnins.2021.614107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2021.614107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2021.614107%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DSirtuin%252B2%252B%252528SIRT2%252529%25253A%252BConfusing%252BRoles%252Bin%252Bthe%252BPathophysiology%252Bof%252BNeurological%252BDisorders%26aulast%3DChen%26aufirst%3DXiuqi%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenyu  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Huilin  Su</span>, <span class="hlFld-ContribAuthor ">Rong  Li</span>, <span class="hlFld-ContribAuthor ">Chen  Song</span>, <span class="hlFld-ContribAuthor ">Zhouyu  Wang</span>, <span class="hlFld-ContribAuthor ">Lingling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of histone deacylase SIRT2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (61)
                                     , 37382-37390. <a href="https://doi.org/10.1039/D0RA06316A" title="DOI URL">https://doi.org/10.1039/D0RA06316A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA06316A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA06316A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252Bhistone%252Bdeacylase%252BSIRT2%252Binhibitors%26aulast%3DYang%26aufirst%3DWenyu%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D61%26spage%3D37382%26epage%3D37390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph W.  Grathwol</span>, <span class="hlFld-ContribAuthor ">Nathalie  Wössner</span>, <span class="hlFld-ContribAuthor ">Steven  Behnisch‐Cornwell</span>, <span class="hlFld-ContribAuthor ">Lukas  Schulig</span>, <span class="hlFld-ContribAuthor ">Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Oliver  Einsle</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Andreas  Link</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of Sirtuin 2 Inhibitors Employing Photoswitchable Geometry and Aqueous Solubility. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (15)
                                     , 1480-1489. <a href="https://doi.org/10.1002/cmdc.202000148" title="DOI URL">https://doi.org/10.1002/cmdc.202000148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000148%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DActivation%252Bof%252BSirtuin%252B2%252BInhibitors%252BEmploying%252BPhotoswitchable%252BGeometry%252Band%252BAqueous%252BSolubility%26aulast%3DGrathwol%26aufirst%3DChristoph%2BW.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D15%26spage%3D1480%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yumei  Liu</span>, <span class="hlFld-ContribAuthor ">Yingying  Zhang</span>, <span class="hlFld-ContribAuthor ">Konghua  Zhu</span>, <span class="hlFld-ContribAuthor ">Song  Chi</span>, <span class="hlFld-ContribAuthor ">Chong  Wang</span>, <span class="hlFld-ContribAuthor ">Anmu  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Role of Sirtuin 2 in Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fnagi.2019.00372" title="DOI URL">https://doi.org/10.3389/fnagi.2019.00372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2019.00372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2019.00372%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DEmerging%252BRole%252Bof%252BSirtuin%252B2%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DLiu%26aufirst%3DYumei%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gokcen  Eren</span>, <span class="hlFld-ContribAuthor ">Agostino  Bruno</span>, <span class="hlFld-ContribAuthor ">Sezen  Guntekin-Ergun</span>, <span class="hlFld-ContribAuthor ">Rengul  Cetin-Atalay</span>, <span class="hlFld-ContribAuthor ">Fikriye  Ozgencil</span>, <span class="hlFld-ContribAuthor ">Yesim  Ozkan</span>, <span class="hlFld-ContribAuthor ">Mahmut  Gozelle</span>, <span class="hlFld-ContribAuthor ">Selen Gozde  Kaya</span>, <span class="hlFld-ContribAuthor ">Gabriele  Costantino</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>89 </em>, 60-73. <a href="https://doi.org/10.1016/j.jmgm.2019.02.014" title="DOI URL">https://doi.org/10.1016/j.jmgm.2019.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2019.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2019.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Bmodeling%252Band%252Bvirtual%252Bscreening%252Bstudies%252Bto%252Bidentify%252Bnovel%252Bselective%252BSIRT2%252Binhibitors%26aulast%3DEren%26aufirst%3DGokcen%26date%3D2019%26volume%3D89%26spage%3D60%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Jie  Yan</span>, <span class="hlFld-ContribAuthor ">Hui-Lin  Su</span>, <span class="hlFld-ContribAuthor ">Chen  Yuan</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Xing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhu-Jun  Yu</span>, <span class="hlFld-ContribAuthor ">Yu-Hang  Yan</span>, <span class="hlFld-ContribAuthor ">Yamei  Yu</span>, <span class="hlFld-ContribAuthor ">Qiang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhouyu  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Shan  Qian</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Crystallographic and SAR analyses reveal the high requirements needed to selectively and potently inhibit SIRT2 deacetylase and decanoylase. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 164-168. <a href="https://doi.org/10.1039/C8MD00462E" title="DOI URL">https://doi.org/10.1039/C8MD00462E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00462E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00462E%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DCrystallographic%252Band%252BSAR%252Banalyses%252Breveal%252Bthe%252Bhigh%252Brequirements%252Bneeded%252Bto%252Bselectively%252Band%252Bpotently%252Binhibit%252BSIRT2%252Bdeacetylase%252Band%252Bdecanoylase%26aulast%3DYang%26aufirst%3DLing-Ling%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D164%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph W  Grathwol</span>, <span class="hlFld-ContribAuthor ">Nathalie  Wössner</span>, <span class="hlFld-ContribAuthor ">Sören  Swyter</span>, <span class="hlFld-ContribAuthor ">Adam C  Smith</span>, <span class="hlFld-ContribAuthor ">Enrico  Tapavicza</span>, <span class="hlFld-ContribAuthor ">Robert K  Hofstetter</span>, <span class="hlFld-ContribAuthor ">Anja  Bodtke</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Andreas  Link</span>. </span><span class="cited-content_cbyCitation_article-title">Azologization and repurposing of a hetero-stilbene-based kinase inhibitor: towards the design of photoswitchable sirtuin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>15 </em>, 2170-2183. <a href="https://doi.org/10.3762/bjoc.15.214" title="DOI URL">https://doi.org/10.3762/bjoc.15.214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.15.214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.15.214%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAzologization%252Band%252Brepurposing%252Bof%252Ba%252Bhetero-stilbene-based%252Bkinase%252Binhibitor%25253A%252Btowards%252Bthe%252Bdesign%252Bof%252Bphotoswitchable%252Bsirtuin%252Binhibitors%26aulast%3DGrathwol%26aufirst%3DChristoph%2BW%26date%3D2019%26date%3D2019%26volume%3D15%26spage%3D2170%26epage%3D2183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Chen  Yuan</span>, <span class="hlFld-ContribAuthor ">Si-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Zhu-Jun  Yu</span>, <span class="hlFld-ContribAuthor ">Sha  Liu</span>, <span class="hlFld-ContribAuthor ">Yu-Hang  Yan</span>, <span class="hlFld-ContribAuthor ">Chengyong  Wu</span>, <span class="hlFld-ContribAuthor ">Yuxi  Wang</span>, <span class="hlFld-ContribAuthor ">Zhouyu  Wang</span>, <span class="hlFld-ContribAuthor ">Yamei  Yu</span>, <span class="hlFld-ContribAuthor ">Qiang  Chen</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 806-823. <a href="https://doi.org/10.1016/j.ejmech.2018.06.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.06.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.06.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.06.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DX-ray%252Bcrystal%252Bstructure%252Bguided%252Bdiscovery%252Bof%252Bnew%252Bselective%25252C%252Bsubstrate-mimicking%252Bsirtuin%252B2%252Binhibitors%252Bthat%252Bexhibit%252Bactivities%252Bagainst%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bcells%26aulast%3DYang%26aufirst%3DLing-Ling%26date%3D2018%26volume%3D155%26spage%3D806%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Tianfang  Ma</span>, <span class="hlFld-ContribAuthor ">Qihua  Zhu</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in inhibitors of sirtuin1/2: an update and perspective. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (8)
                                     , 907-934. <a href="https://doi.org/10.4155/fmc-2017-0207" title="DOI URL">https://doi.org/10.4155/fmc-2017-0207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0207%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Binhibitors%252Bof%252Bsirtuin1%25252F2%25253A%252Ban%252Bupdate%252Band%252Bperspective%26aulast%3DZhou%26aufirst%3DZiyan%26date%3D2018%26volume%3D10%26issue%3D8%26spage%3D907%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Wenwen  Zang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Liu</span>, <span class="hlFld-ContribAuthor ">Weiping  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Bivalent SIRT1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (2)
                                     , 180-186. <a href="https://doi.org/10.1016/j.bmcl.2016.11.082" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.082%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBivalent%252BSIRT1%252Binhibitors%26aulast%3DWang%26aufirst%3DJuan%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D180%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0020.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected SIRT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of SIRT2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of SIRT2 by compound <b>86</b>. IC<sub>50</sub> values are plotted against either NAD<sup>+</sup> (A) or the peptide substrate (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed binding mode and interactions of compound <b>86</b> docked into the crystal structure of human SIRT2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f">1j8f</a>). (A) A potential binding mode of compound <b>86</b> (green) in the active site of SIRT2 (surface representation). (B) Potential interactions between compound <b>86</b> and SIRT2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Protection against oligomeric α-synuclein toxicity by selected SIRT2 inhibitors. <sup>≠</sup><i>p</i> < 0.001 vs control cells without α-synuclein treatment; *** <i>p</i> < 0.0001, ** <i>p</i> < 0.001, and * <i>p</i> < 0.05 vs control cells with α-synuclein treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/medium/jm-2015-01376n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. SIRT2 Inhibitor Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01376/20160414/images/large/jm-2015-01376n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01376&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 5-hydroxynicotinate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 75%; (b) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 80%; (c) NH<sub>3</sub>, CaCl<sub>2</sub>, MeOH, 90%; (d) RCOCl, base; or RCOOH, coupling agents, 1–94%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Houtkooper, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span> </span><span class="NLM_article-title">Sirtuins as regulators of metabolism and healthspan</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span><span class="refDoi"> DOI: 10.1038/nrm3293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fnrm3293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22395773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=225-238&author=R.+H.+Houtkooperauthor=E.+Pirinenauthor=J.+Auwerx&title=Sirtuins+as+regulators+of+metabolism+and+healthspan&doi=10.1038%2Fnrm3293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins as regulators of metabolism and healthspan</span></div><div class="casAuthors">Houtkooper, Riekelt H.; Pirinen, Eija; Auwerx, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-238</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the beginning of the century, the mammalian sirtuin protein family (comprising SIRT1-SIRT7) has received much attention for its regulatory role, mainly in metab. and ageing.  Sirtuins act in different cellular compartments: they deacetylate histones and several transcriptional regulators in the nucleus, but also specific proteins in other cellular compartments, such as in the cytoplasm and in mitochondria.  As a consequence, sirtuins regulate fat and glucose metab. in response to physiol. changes in energy levels, thereby acting as crucial regulators of the network that controls energy homeostasis and as such dets. healthspan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGF2VZDiGC9LVg90H21EOLACvtfcHk0li3jOyrLRniVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOktbw%253D&md5=3e7e0a6b23e8d7d4ad7be32bdce28d96</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3293%26sid%3Dliteratum%253Aachs%26aulast%3DHoutkooper%26aufirst%3DR.%2BH.%26aulast%3DPirinen%26aufirst%3DE.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DSirtuins%2520as%2520regulators%2520of%2520metabolism%2520and%2520healthspan%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D225%26epage%3D238%26doi%3D10.1038%2Fnrm3293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pandithage, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilischkis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harting, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedamzik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscher-Firzlaff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoorts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasonder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscher, B.</span><span> </span><span class="NLM_article-title">The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span><span class="refDoi"> DOI: 10.1083/jcb.200707126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1083%2Fjcb.200707126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=18332217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlKmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=915-929&author=R.+Pandithageauthor=R.+Lilischkisauthor=K.+Hartingauthor=A.+Wolfauthor=B.+Jedamzikauthor=J.+Luscher-Firzlaffauthor=J.+Vervoortsauthor=E.+Lasonderauthor=E.+Kremmerauthor=B.+Knollauthor=B.+Luscher&title=The+regulation+of+SIRT2+function+by+cyclin-dependent+kinases+affects+cell+motility&doi=10.1083%2Fjcb.200707126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility</span></div><div class="casAuthors">Pandithage, Ruwin; Lilischkis, Richard; Harting, Kai; Wolf, Alexandra; Jedamzik, Britta; Luescher-Firzlaff, Juliane; Vervoorts, Joerg; Lasonder, Edwin; Kremmer, Elisabeth; Knoell, Bernd; Luescher, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">915-929</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (Cdks) fulfill key functions in many cellular processes, including cell cycle progression and cytoskeletal dynamics.  A limited no. of Cdk substrates have been identified with few demonstrated to be regulated by Cdk-dependent phosphorylation.  We identify on protein expression arrays novel cyclin E-Cdk2 substrates, including SIRT2, a member of the Sirtuin family of NAD+-dependent deacetylases that targets α-tubulin.  We define Ser-331 as the site phosphorylated by cyclin E-Cdk2, cyclin A-Cdk2, and p35-Cdk5 both in vitro and in cells.  Importantly, phosphorylation at Ser-331 inhibits the catalytic activity of SIRT2.  Gain- and loss-of-function studies demonstrate that SIRT2 interfered with cell adhesion and cell migration.  In postmitotic hippocampal neurons, neurite outgrowth and growth cone collapse are inhibited by SIRT2.  The effects provoked by SIRT2, but not those of a nonphosphorylatable mutant, are antagonized by Cdk-dependent phosphorylation.  Collectively, our findings identify a posttranslational mechanism that controls SIRT2 function, and they provide evidence for a novel regulatory circuitry involving Cdks, SIRT2, and microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Zr24RfU0OrVg90H21EOLACvtfcHk0ljq51IGSMCqGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlKmtbg%253D&md5=3cfb57c6e7556f30a055ddd674d61262</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200707126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200707126%26sid%3Dliteratum%253Aachs%26aulast%3DPandithage%26aufirst%3DR.%26aulast%3DLilischkis%26aufirst%3DR.%26aulast%3DHarting%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DA.%26aulast%3DJedamzik%26aufirst%3DB.%26aulast%3DLuscher-Firzlaff%26aufirst%3DJ.%26aulast%3DVervoorts%26aufirst%3DJ.%26aulast%3DLasonder%26aufirst%3DE.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DKnoll%26aufirst%3DB.%26aulast%3DLuscher%26aufirst%3DB.%26atitle%3DThe%2520regulation%2520of%2520SIRT2%2520function%2520by%2520cyclin-dependent%2520kinases%2520affects%2520cell%2520motility%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D915%26epage%3D929%26doi%3D10.1083%2Fjcb.200707126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Harting, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, B.</span><span> </span><span class="NLM_article-title">SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology</span> <span class="citation_source-journal">Eur. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1016/j.ejcb.2009.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ejcb.2009.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20004495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2010&pages=262-269&author=K.+Hartingauthor=B.+Knoll&title=SIRT2-mediated+protein+deacetylation%3A+An+emerging+key+regulator+in+brain+physiology+and+pathology&doi=10.1016%2Fj.ejcb.2009.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2-mediated protein deacetylation: an emerging key regulator in brain physiology and pathology</span></div><div class="casAuthors">Harting, Kai; Knoell, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">262-269</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Protein function is considerably altered by posttranslational modification.  In recent years, cycles of acetylation/deacetylation emerged as fundamental regulators adjusting biol. activity of many proteins.  Particularly, protein deacetylation by Sirtuins, a family of atypical histone deacetylases (HDACs), was demonstrated to regulate fundamental cell biol. processes including gene expression, genome stability, mitosis, nutrient metab., aging, mitochondrial function and cell motility.  Given this wealth of biol. functions, perhaps not unexpectedly then, pharmacol. compds. targeting Sirtuin activity are now prime therapeutic agents for alleviating severity of major diseases encompassing diabetes, cancer, cardiovascular and neurodegenerative disorders in many organs.  In this review, we will focus on the brain and its physiol. and pathol. processes governed by Sirtuin-mediated deacetylation.  Besides discussing Sirtuin function in neurodegenerative diseases, emphasis will be given on the mounting evidence deciphering key developmental brain functions for Sirtuins in neuronal motility, neuroprotection and oligodendrocyte differentiation.  In this respect, we will particularly highlight functions of the unconventional family member SIRT2 in postmitotic neurons and glial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd7fhGWNOt5bVg90H21EOLACvtfcHk0ljq51IGSMCqGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFSksbc%253D&md5=a5c27ac7529590c28162c51479aa5d2d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejcb.2009.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejcb.2009.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DHarting%26aufirst%3DK.%26aulast%3DKnoll%26aufirst%3DB.%26atitle%3DSIRT2-mediated%2520protein%2520deacetylation%253A%2520An%2520emerging%2520key%2520regulator%2520in%2520brain%2520physiology%2520and%2520pathology%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D2010%26volume%3D89%26spage%3D262%26epage%3D269%26doi%3D10.1016%2Fj.ejcb.2009.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Pfister, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Mello, S. R.</span><span> </span><span class="NLM_article-title">Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e4090</span><span class="refDoi"> DOI: 10.1371/journal.pone.0004090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1371%2Fjournal.pone.0004090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e4090&author=J.+A.+Pfisterauthor=C.+Maauthor=B.+E.+Morrisonauthor=S.+R.+D%E2%80%99Mello&title=Opposing+effects+of+sirtuins+on+neuronal+survival%3A+SIRT1-mediated+neuroprotection+is+independent+of+its+deacetylase+activity&doi=10.1371%2Fjournal.pone.0004090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004090%26sid%3Dliteratum%253Aachs%26aulast%3DPfister%26aufirst%3DJ.%2BA.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DD%25E2%2580%2599Mello%26aufirst%3DS.%2BR.%26atitle%3DOpposing%2520effects%2520of%2520sirtuins%2520on%2520neuronal%2520survival%253A%2520SIRT1-mediated%2520neuroprotection%2520is%2520independent%2520of%2520its%2520deacetylase%2520activity%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De4090%26doi%3D10.1371%2Fjournal.pone.0004090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathearn, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1126/science.1143780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1126%2Fscience.1143780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=17588900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1143780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease</span></div><div class="casAuthors">Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5837</span>),
    <span class="NLM_cas:pages">516-519</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging.  We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued α-synuclein toxicity and modified inclusion morphol. in a cellular model of Parkinson's disease.  Genetic inhibition of SIRT2 via small interfering RNA similarly rescued α-synuclein toxicity.  Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease.  The results suggest a link between neurodegeneration and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm5psHCGzkkLVg90H21EOLACvtfcHk0lgEUIB9nM7YAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D&md5=4b8914c34ad0f45fb51b94701609bfa6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1143780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1143780%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519%26doi%3D10.1126%2Fscience.1143780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peritore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donmez, G.</span><span> </span><span class="NLM_article-title">SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway</span> <span class="citation_source-journal">Front. Aging Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="refDoi"> DOI: 10.3389/fnagi.2014.00184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.3389%2Ffnagi.2014.00184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25157229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Flt1Cisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=184&author=L.+Liuauthor=A.+Arunauthor=L.+Ellisauthor=C.+Peritoreauthor=G.+Donmez&title=SIRT2+enhances+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+%28MPTP%29-induced+nigrostriatal+damage+via+apoptotic+pathway&doi=10.3389%2Ffnagi.2014.00184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway</span></div><div class="casAuthors">Liu Lei; Arun Anirudh; Ellis Lakia; Peritore Carina; Donmez Gizem</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in aging neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">184</span>
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    </div><div class="casAbstract">Sirtuins are NAD-dependent protein deacetylases that were shown to have protective effects against different age-related diseases.  SIRT2 is a strong deacetylase that is highly expressed in brain.  It has been associated with neurodegenerative diseases.  MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a dopaminergic neurotoxin that displays clinical features of Parkinson's Disease (PD).  MPTP leads to the degeneration of nigrostriatal dopaminergic pathway after its systemic administration.  Chronic administration of MPTP induces lesion via apoptosis.  We show here that SIRT2 deacetylates Foxo3a, increases RNA and protein levels of Bim, and as a result enhances apoptosis in the MPTP model of PD.  We also show that neurodegeneration induced by chronic MPTP regimen is prevented by genetic deletion of SIRT2 in mouse.  Deletion of SIRT2 leads to the reduction of apoptosis due to an increase in acetylation of Foxo3a and a decrease in Bim levels.  We demonstrate that SIRT2 deacetylates Foxo3a, activates Bim, and induces apoptosis only in MPP(+)-treated cells.  Therefore, designing SIRT2 inhibitors might be helpful in developing effective treatments for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-tLqy8t8LFrZpSb_XWfMrfW6udTcc2eY3W-mokkPF8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Flt1Cisg%253D%253D&md5=6f00800f5c19d8c33fa8dae8dffdea25</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2014.00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2014.00184%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DArun%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DPeritore%26aufirst%3DC.%26aulast%3DDonmez%26aufirst%3DG.%26atitle%3DSIRT2%2520enhances%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520%2528MPTP%2529-induced%2520nigrostriatal%2520damage%2520via%2520apoptotic%2520pathway%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2014%26volume%3D6%26spage%3D184%26doi%3D10.3389%2Ffnagi.2014.00184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herisson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauf, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayata, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116919</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1371%2Fjournal.pone.0116919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25608039" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116919&author=X.+Chenauthor=P.+Walesauthor=L.+Quintiauthor=F.+Zuoauthor=S.+Moniotauthor=F.+Herissonauthor=N.+A.+Raufauthor=H.+Wangauthor=R.+B.+Silvermanauthor=C.+Ayataauthor=M.+M.+Maxwellauthor=C.+Steegbornauthor=M.+A.+Schwarzschildauthor=T.+F.+Outeiroauthor=A.+G.+Kazantsev&title=The+sirtuin-2+inhibitor+AK7+is+neuroprotective+in+models+of+Parkinson%E2%80%99s+disease+but+not+amyotrophic+lateral+sclerosis+and+cerebral+ischemia&doi=10.1371%2Fjournal.pone.0116919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116919%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWales%26aufirst%3DP.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DF.%26aulast%3DMoniot%26aufirst%3DS.%26aulast%3DHerisson%26aufirst%3DF.%26aulast%3DRauf%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26aulast%3DAyata%26aufirst%3DC.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DThe%2520sirtuin-2%2520inhibitor%2520AK7%2520is%2520neuroprotective%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520but%2520not%2520amyotrophic%2520lateral%2520sclerosis%2520and%2520cerebral%2520ischemia%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116919%26doi%3D10.1371%2Fjournal.pone.0116919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borra, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00038-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2FS1097-2765%2803%2900038-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=12620231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=437-444&author=B.+J.+Northauthor=B.+L.+Marshallauthor=M.+T.+Borraauthor=J.+M.+Denuauthor=E.+Verdin&title=The+human+Sir2+ortholog%2C+SIRT2%2C+is+an+NAD%2B-dependent+tubulin+deacetylase&doi=10.1016%2FS1097-2765%2803%2900038-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase</span></div><div class="casAuthors">North, Brian J.; Marshall, Brett L.; Borra, Margie T.; Denu, John M.; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The silent information regulator 2 protein (Sir2p) of Saccharomyces cerevisiae is an NAD-dependent histone deacetylase that plays a crit. role in transcriptional silencing.  Here, we report that a human ortholog of Sir2p, sirtuin type 2 (SIRT2), is a predominantly cytoplasmic protein that colocalizes with microtubules.  SIRT2 deacetylates lysine-40 of α-tubulin both in vitro and in vivo.  Knockdown of SIRT2 via siRNA results in tubulin hyperacetylation.  SIRT2 colocalizes and interacts in vivo with HDAC6, another tubulin deacetylase.  Enzymic anal. of recombinant SIRT2 in comparison to a yeast homolog of Sir2 protein (Hst2p) shows a striking preference of SIRT2 for acetylated tubulin peptide as a substrate relative to acetylated histone H3 peptide.  These observations establish SIRT2 as a bona fide tubulin deacetylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorrA4k4bpBlrVg90H21EOLACvtfcHk0ljMW2kht_JsSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D&md5=622e6bf7b48be1ec6afedf403c56350c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900038-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900038-8%26sid%3Dliteratum%253Aachs%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%2BL.%26aulast%3DBorra%26aufirst%3DM.%2BT.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DThe%2520human%2520Sir2%2520ortholog%252C%2520SIRT2%252C%2520is%2520an%2520NAD%252B-dependent%2520tubulin%2520deacetylase%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D437%26epage%3D444%26doi%3D10.1016%2FS1097-2765%2803%2900038-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Godena, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes-Hocking, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oswald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sancho, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitworth, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, K. J.</span><span> </span><span class="NLM_article-title">Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5245</span><span class="refDoi"> DOI: 10.1038/ncomms6245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fncomms6245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25316291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVersbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5245&author=V.+K.+Godenaauthor=N.+Brookes-Hockingauthor=A.+Mollerauthor=G.+Shawauthor=M.+Oswaldauthor=R.+M.+Sanchoauthor=C.+C.+Millerauthor=A.+J.+Whitworthauthor=K.+J.+De+Vos&title=Increasing+microtubule+acetylation+rescues+axonal+transport+and+locomotor+deficits+caused+by+LRRK2+Roc-COR+domain+mutations&doi=10.1038%2Fncomms6245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations</span></div><div class="casAuthors">Godena, Vinay K.; Brookes-Hocking, Nicholas; Moller, Annekathrin; Shaw, Gary; Oswald, Matthew; Sancho, Rosa M.; Miller, Christopher C. J.; Whitworth, Alexander J.; De Vos, Kurt J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5245</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of Parkinson's disease.  LRRK2 is a multifunctional protein affecting many cellular processes and has been described to bind microtubules.  Defective microtubule-based axonal transport is hypothesized to contribute to Parkinson's disease, but whether LRRK2 mutations affect this process to mediate pathogenesis is not known.  Here we find that LRRK2 contg. pathogenic Roc-COR domain mutations (R1441C, Y1699C) preferentially assocs. with deacetylated microtubules, and inhibits axonal transport in primary neurons and in Drosophila, causing locomotor deficits in vivo.  In vitro, increasing microtubule acetylation using deacetylase inhibitors or the tubulin acetylase αTAT1 prevents assocn. of mutant LRRK2 with microtubules, and the deacetylase inhibitor trichostatin A (TSA) restores axonal transport.  In vivo knockdown of the deacetylases HDAC6 and Sirt2, or administration of TSA rescues both axonal transport and locomotor behavior.  Thus, this study reveals a pathogenic mechanism and a potential intervention for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW55dshiT0xbVg90H21EOLACvtfcHk0lg1x1fBn4tbKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVersbk%253D&md5=c4ce7dd4af3f46d8e03aeadde4436705</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fncomms6245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6245%26sid%3Dliteratum%253Aachs%26aulast%3DGodena%26aufirst%3DV.%2BK.%26aulast%3DBrookes-Hocking%26aufirst%3DN.%26aulast%3DMoller%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DG.%26aulast%3DOswald%26aufirst%3DM.%26aulast%3DSancho%26aufirst%3DR.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BC.%26aulast%3DWhitworth%26aufirst%3DA.%2BJ.%26aulast%3DDe%2BVos%26aufirst%3DK.%2BJ.%26atitle%3DIncreasing%2520microtubule%2520acetylation%2520rescues%2520axonal%2520transport%2520and%2520locomotor%2520deficits%2520caused%2520by%2520LRRK2%2520Roc-COR%2520domain%2520mutations%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5245%26doi%3D10.1038%2Fncomms6245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugeno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span> </span><span class="NLM_article-title">Role of TPPP/p25 on alpha-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span><span class="refDoi"> DOI: 10.1016/j.neuint.2010.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.neuint.2010.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20849899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2010&pages=857-866&author=T.+Hasegawaauthor=T.+Babaauthor=M.+Kobayashiauthor=M.+Konnoauthor=N.+Sugenoauthor=A.+Kikuchiauthor=Y.+Itoyamaauthor=A.+Takeda&title=Role+of+TPPP%2Fp25+on+alpha-synuclein-mediated+oligodendroglial+degeneration+and+the+protective+effect+of+SIRT2+inhibition+in+a+cellular+model+of+multiple+system+atrophy&doi=10.1016%2Fj.neuint.2010.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy</span></div><div class="casAuthors">Hasegawa, Takafumi; Baba, Toru; Kobayashi, Michiko; Konno, Masatoshi; Sugeno, Naoto; Kikuchi, Akio; Itoyama, Yasuto; Takeda, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">857-866</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Multiple system atrophy (MSA) is a progressive neurodegenerative disorder presenting variable combinations of parkinsonism, cerebellar ataxia, corticospinal and autonomic dysfunction.  Alpha-synuclein (α-SYN)-immunopos. glial cytoplasmic inclusions (GCIs) represent the neuropathol. hallmark of MSA, and tubulin polymn. promoting protein (TPPP)/p25 in oligodendroglia has been known as a potent stimulator of α-SYN aggregation.  To gain insight into the mol. pathomechanisms of GCI formation and subsequent oligodendroglial degeneration, we ectopically expressed α-SYN and TPPP in HEK293T and oligodendroglial KG1C cell lines.  Here we showed that TPPP specifically accelerated α-SYN oligomer formation and co-immunopptn. anal. revealed the specific interaction of TPPP and α-SYN.  Moreover, phosphorylation of α-SYN at Ser-129 facilitated the TPPP-mediated α-SYN oligomerization.  TPPP facilitated α-SYN-pos. cytoplasmic perinuclear inclusions mimicking GCI in both cell lines; however, apoptotic cell death was only obsd. in KG1C cells.  This apoptotic cell death was partly rescued by sirtuin 2 (SIRT2) inhibition.  Together, our results provide further insight into the mol. pathogenesis of MSA and potential therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphVqU7ySXle7Vg90H21EOLACvtfcHk0lg1x1fBn4tbKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLvF&md5=87d077904be8f19f325e5f525628465b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DKonno%26aufirst%3DM.%26aulast%3DSugeno%26aufirst%3DN.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DItoyama%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26atitle%3DRole%2520of%2520TPPP%252Fp25%2520on%2520alpha-synuclein-mediated%2520oligodendroglial%2520degeneration%2520and%2520the%2520protective%2520effect%2520of%2520SIRT2%2520inhibition%2520in%2520a%2520cellular%2520model%2520of%2520multiple%2520system%2520atrophy%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D57%26spage%3D857%26epage%3D866%26doi%3D10.1016%2Fj.neuint.2010.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span> </span><span class="NLM_article-title">Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.04.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.neuroscience.2007.04.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2007&pages=599-612&author=K.+Suzukiauthor=T.+Koike&title=Mammalian+Sir2-related+protein+%28SIRT%29+2-mediated+modulation+of+resistance+to+axonal+degeneration+in+slow+Wallerian+degeneration+mice%3A+a+crucial+role+of+tubulin+deacetylation&doi=10.1016%2Fj.neuroscience.2007.04.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.04.059%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DT.%26atitle%3DMammalian%2520Sir2-related%2520protein%2520%2528SIRT%2529%25202-mediated%2520modulation%2520of%2520resistance%2520to%2520axonal%2520degeneration%2520in%2520slow%2520Wallerian%2520degeneration%2520mice%253A%2520a%2520crucial%2520role%2520of%2520tubulin%2520deacetylation%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D147%26spage%3D599%26epage%3D612%26doi%3D10.1016%2Fj.neuroscience.2007.04.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffitt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokce, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7927</span><span class="NLM_x">–</span> <span class="NLM_lpage">7932</span><span class="refDoi"> DOI: 10.1073/pnas.1002924107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.1002924107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20378838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7927-7932&author=R.+Luthi-Carterauthor=D.+M.+Taylorauthor=J.+Pallosauthor=E.+Lambertauthor=A.+Amoreauthor=A.+Parkerauthor=H.+Moffittauthor=D.+L.+Smithauthor=H.+Runneauthor=O.+Gokceauthor=A.+Kuhnauthor=Z.+Xiangauthor=M.+M.+Maxwellauthor=S.+A.+Reevesauthor=G.+P.+Batesauthor=C.+Neriauthor=L.+M.+Thompsonauthor=J.+L.+Marshauthor=A.+G.+Kazantsev&title=SIRT2+inhibition+achieves+neuroprotection+by+decreasing+sterol+biosynthesis&doi=10.1073%2Fpnas.1002924107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis</span></div><div class="casAuthors">Luthi-Carter, Ruth; Taylor, David M.; Pallos, Judit; Lambert, Emmanuel; Amore, Allison; Parker, Alex; Moffitt, Hilary; Smith, Donna L.; Runne, Heike; Gokce, Ozgun; Kuhn, Alexandre; Xiang, Zhongmin; Maxwell, Michele M.; Reeves, Steven A.; Bates, Gillian P.; Neri, Christian; Thompson, Leslie M.; Marsh, J. Lawrence; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7927-7932, S7927/1-S7927/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Huntington's disease (HD), an incurable neurodegenerative disorder, has a complex pathogenesis including protein aggregation and the dysregulation of neuronal transcription and metab.  Here, we demonstrate that inhibition of sirtuin 2 (SIRT2) achieves neuroprotection in cellular and invertebrate models of HD.  Genetic or pharmacol. inhibition of SIRT2 in a striatal neuron model of HD resulted in gene expression changes including significant down-regulation of RNAs responsible for sterol biosynthesis.  Whereas mutant huntingtin fragments increased sterols in neuronal cells, SIRT2 inhibition reduced sterol levels via decreased nuclear trafficking of SREBP-2.  Importantly, manipulation of sterol biosynthesis at the transcriptional level mimicked SIRT2 inhibition, demonstrating that the metabolic effects of SIRT2 inhibition are sufficient to diminish mutant huntingtin toxicity.  These data identify SIRT2 inhibition as a promising avenue for HD therapy and elucidate a unique mechanism of SIRT2-inhibitor-mediated neuroprotection.  Furthermore, the ascertainment of SIRT2's role in regulating cellular metab. demonstrates a central function shared with other sirtuin proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl8YT_ra15oLVg90H21EOLACvtfcHk0lh1y08Unq-ZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFymur0%253D&md5=8b4798da04f14888acbcd64d1670d503</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002924107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002924107%26sid%3Dliteratum%253Aachs%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DPallos%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DE.%26aulast%3DAmore%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DMoffitt%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRunne%26aufirst%3DH.%26aulast%3DGokce%26aufirst%3DO.%26aulast%3DKuhn%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DReeves%26aufirst%3DS.%2BA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DNeri%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DMarsh%26aufirst%3DJ.%2BL.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSIRT2%2520inhibition%2520achieves%2520neuroprotection%2520by%2520decreasing%2520sterol%2520biosynthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D7927%26epage%3D7932%26doi%3D10.1073%2Fpnas.1002924107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Taylor, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balabadra, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthi-Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowden, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1021/cb100376q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100376q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVCgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=540-546&author=D.+M.+Taylorauthor=U.+Balabadraauthor=Z.+Xiangauthor=B.+Woodmanauthor=S.+Meadeauthor=A.+Amoreauthor=M.+M.+Maxwellauthor=S.+Reevesauthor=G.+P.+Batesauthor=R.+Luthi-Carterauthor=P.+A.+Lowdenauthor=A.+G.+Kazantsev&title=A+brain-permeable+small+molecule+reduces+neuronal+cholesterol+by+inhibiting+activity+of+sirtuin+2+deacetylase&doi=10.1021%2Fcb100376q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase</span></div><div class="casAuthors">Taylor, David M.; Balabadra, Uma; Xiang, Zhongmin; Woodman, Ben; Meade, Sarah; Amore, Allison; Maxwell, Michele M.; Reeves, Steven; Bates, Gillian P.; Luthi-Carter, Ruth; Lowden, Philip A. S.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuin 2 (SIRT2) deacetylase-dependent inhibition mediates neuroprotective redn. of cholesterol biosynthesis in an in vitro Huntington's disease model.  This study sought to identify the first brain-permeable SIRT2 inhibitor and to characterize its cholesterol-reducing properties in neuronal models.  Using biochem. sirtuin deacetylation assays, we screened a brain-permeable in silico compd. library, yielding 3-(1-azepanylsulfonyl)-N-(3-bromphenyl)benzamide as the most potent and selective SIRT2 inhibitor.  Pharmacokinetic studies demonstrated brain-permeability but limited metabolic stability of the selected candidate.  In accordance with previous observations, this SIRT2 inhibitor stimulated cytoplasmic retention of sterol regulatory element binding protein-2 and subsequent transcriptional downregulation of cholesterol biosynthesis genes, resulting in reduced total cholesterol in primary striatal neurons.  Furthermore, the identified inhibitor reduced cholesterol in cultured naive neuronal cells and brain slices from wild-type mice.  The outcome of this study provides a clear opportunity for lead optimization and drug development, targeting metabolic dysfunctions in CNS disorders where abnormal cholesterol homeostasis is implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0djexnD8mDLVg90H21EOLACvtfcHk0lhN2h2565GpQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVCgsrc%253D&md5=2b04e3894350051c26a8ee24399774c3</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fcb100376q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100376q%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DD.%2BM.%26aulast%3DBalabadra%26aufirst%3DU.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DMeade%26aufirst%3DS.%26aulast%3DAmore%26aufirst%3DA.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DReeves%26aufirst%3DS.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DLowden%26aufirst%3DP.%2BA.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DA%2520brain-permeable%2520small%2520molecule%2520reduces%2520neuronal%2520cholesterol%2520by%2520inhibiting%2520activity%2520of%2520sirtuin%25202%2520deacetylase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D540%26epage%3D546%26doi%3D10.1021%2Fcb100376q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Green, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Coria, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Nicotinamide restores cognition in Alzheimer’s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">11500</span><span class="NLM_x">–</span> <span class="NLM_lpage">11510</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3203-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1523%2FJNEUROSCI.3203-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=18987186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=11500-11510&author=K.+N.+Greenauthor=J.+S.+Steffanauthor=H.+Martinez-Coriaauthor=X.+Sunauthor=S.+S.+Schreiberauthor=L.+M.+Thompsonauthor=F.+M.+LaFerla&title=Nicotinamide+restores+cognition+in+Alzheimer%E2%80%99s+disease+transgenic+mice+via+a+mechanism+involving+sirtuin+inhibition+and+selective+reduction+of+Thr231-phosphotau&doi=10.1523%2FJNEUROSCI.3203-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau</span></div><div class="casAuthors">Green, Kim N.; Steffan, Joan S.; Martinez-Coria, Hilda; Sun, Xuemin; Schreiber, Steven S.; Thompson, Leslie Michels; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11500-11510</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or delay its onset are urgently needed.  Effective preventive strategies likely offer the greatest and most widespread benefits.  Histone deacetylase (HDAC) inhibitors increase histone acetylation and enhance memory and synaptic plasticity.  We evaluated the efficacy of nicotinamide, a competitive inhibitor of the sirtuins or class III NAD+-dependent HDACs in 3xTg-AD mice, and found that it restored cognitive deficits assocd. with pathol.  Nicotinamide selectively reduces a specific phospho-species of tau (Thr231) that is assocd. with microtubule depolymn., in a manner similar to inhibition of SirT1.  Nicotinamide also dramatically increased acetylated α-tubulin, a primary substrate of SirT2, and MAP2c, both of which are linked to increased microtubule stability.  Reduced phospho Thr231-tau was related to a redn. of monoubiquitin-conjugated tau, suggesting that this posttranslationally modified form of tau may be rapidly degraded.  Overexpression of a Thr231-phospho-mimic tau in vitro increased clearance and decreased accumulation of tau compared with wild-type tau.  These preclin. findings suggest that oral nicotinamide may represent a safe treatment for AD and other tauopathies, and that phosphorylation of tau at Thr231 may regulate tau stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Lz--7nBKTrVg90H21EOLACvtfcHk0lhN2h2565GpQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOgt77N&md5=f1e2b0d0da681f441eec1be2cb62baa3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3203-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3203-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DSteffan%26aufirst%3DJ.%2BS.%26aulast%3DMartinez-Coria%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DSchreiber%26aufirst%3DS.%2BS.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DNicotinamide%2520restores%2520cognition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520mice%2520via%2520a%2520mechanism%2520involving%2520sirtuin%2520inhibition%2520and%2520selective%2520reduction%2520of%2520Thr231-phosphotau%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D11500%26epage%3D11510%26doi%3D10.1523%2FJNEUROSCI.3203-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Spires-Jones, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozkalne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitstick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="refDoi"> DOI: 10.3389/fphar.2012.00042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.3389%2Ffphar.2012.00042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22416232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=42&author=T.+L.+Spires-Jonesauthor=L.+M.+Foxauthor=A.+Rozkalneauthor=R.+Pitstickauthor=G.+A.+Carlsonauthor=A.+G.+Kazantsev&title=Inhibition+of+sirtuin+2+with+sulfobenzoic+acid+derivative+AK1+is+non-toxic+and+potentially+neuroprotective+in+a+mouse+model+of+frontotemporal+dementia&doi=10.3389%2Ffphar.2012.00042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of Frontotemporal dementia</span></div><div class="casAuthors">Spires-Jones, Tara L.; Fox, Leora M.; Rozkalne, Anete; Pitstick, Rose; Carlson, George A.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">42</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Tauopathies including tau-assocd. Frontotemporal dementia (FTD) and Alzheimer's disease are characterized pathol. by the formation of tau-contg. neurofibrillary aggregates and neuronal loss, which contribute to cognitive decline.  There are currently no effective treatments to prevent or slow this neural systems failure.  The rTg4510 mouse model, which expresses a mutant form of the tau protein assocd. with FTD with Parkinsonism-17, undergoes dramatic hippocampal and cortical neuronal loss making it an ideal model to study treatments for FTD-related neuronal loss.  Sirtuins are a family of proteins involved in cell survival that have the potential to modulate neuronal loss in neurodegenerative disorders.  Here we tested the hypothesis that sirtuin 2 (SIRT2) inhibition would be non-toxic and prevent neurodegeneration in rTg4510 brain.  In this study we delivered SIRT2 inhibitor AK1 directly to the hippocampus with an osmotic minipump and confirmed that it reached the target region both with histol. assessment of delivery of a dye and with a pharmacodynamic marker, ABCA1 transcription, which was upregulated with AK1 treatment.  AK1 treatment was found to be safe in wild-type mice and in the rTg4510 mouse model and further, it provided some neuroprotection in the rTg4510 hippocampal circuitry.  This study provides proof-of-concept for therapeutic benefits of SIRT2 inhibitors in both tau-assocd. FTD and Alzheimer's disease and suggests that development of potent, brain permeable SIRT2 inhibitors is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxj4KrfzR49rVg90H21EOLACvtfcHk0livz8Bm4nr_og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qt78%253D&md5=54aefece47f5189e19b61cafed6d9e34</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00042%26sid%3Dliteratum%253Aachs%26aulast%3DSpires-Jones%26aufirst%3DT.%2BL.%26aulast%3DFox%26aufirst%3DL.%2BM.%26aulast%3DRozkalne%26aufirst%3DA.%26aulast%3DPitstick%26aufirst%3DR.%26aulast%3DCarlson%26aufirst%3DG.%2BA.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DInhibition%2520of%2520sirtuin%25202%2520with%2520sulfobenzoic%2520acid%2520derivative%2520AK1%2520is%2520non-toxic%2520and%2520potentially%2520neuroprotective%2520in%2520a%2520mouse%2520model%2520of%2520frontotemporal%2520dementia%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D42%26doi%3D10.3389%2Ffphar.2012.00042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Theendakara, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters Libeu, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpot, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Descamps, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poksay, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cailing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredesen, D. E.</span><span> </span><span class="NLM_article-title">Neuroprotective Sirtuin ratio reversed by ApoE4</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">18303</span><span class="NLM_x">–</span> <span class="NLM_lpage">18308</span><span class="refDoi"> DOI: 10.1073/pnas.1314145110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.1314145110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=18303-18308&author=V.+Theendakaraauthor=A.+Patentauthor=C.+A.+Peters+Libeuauthor=B.+Philpotauthor=S.+Floresauthor=O.+Descampsauthor=K.+S.+Poksayauthor=Q.+Zhangauthor=G.+Cailingauthor=M.+Hartauthor=V.+Johnauthor=R.+V.+Raoauthor=D.+E.+Bredesen&title=Neuroprotective+Sirtuin+ratio+reversed+by+ApoE4&doi=10.1073%2Fpnas.1314145110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314145110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314145110%26sid%3Dliteratum%253Aachs%26aulast%3DTheendakara%26aufirst%3DV.%26aulast%3DPatent%26aufirst%3DA.%26aulast%3DPeters%2BLibeu%26aufirst%3DC.%2BA.%26aulast%3DPhilpot%26aufirst%3DB.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DDescamps%26aufirst%3DO.%26aulast%3DPoksay%26aufirst%3DK.%2BS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DCailing%26aufirst%3DG.%26aulast%3DHart%26aufirst%3DM.%26aulast%3DJohn%26aufirst%3DV.%26aulast%3DRao%26aufirst%3DR.%2BV.%26aulast%3DBredesen%26aufirst%3DD.%2BE.%26atitle%3DNeuroprotective%2520Sirtuin%2520ratio%2520reversed%2520by%2520ApoE4%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D18303%26epage%3D18308%26doi%3D10.1073%2Fpnas.1314145110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span> </span><span class="NLM_article-title">Sirtuin inhibitors as anticancer agents</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span><span class="refDoi"> DOI: 10.4155/fmc.14.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.4155%2Ffmc.14.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=24962284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=945-966&author=J.+Huauthor=H.+Jingauthor=H.+Lin&title=Sirtuin+inhibitors+as+anticancer+agents&doi=10.4155%2Ffmc.14.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin inhibitors as anticancer agents</span></div><div class="casAuthors">Hu, Jing; Jing, Hui; Lin, Hening</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">945-966</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Sirtuins are a class of enzymes with NAD (NAD)-dependent protein lysine deacylase function.  By deacylating various substrate proteins, including histones, transcription factors, and metabolic enzymes, sirtuins regulate various biol. processes, such as transcription, cell survival, DNA damage and repair, and longevity.  Small mols. that can inhibit sirtuins have been developed and many of them have shown anticancer activity.  Here, we summarize the major biol. findings that connect sirtuins to cancer and the different types of sirtuin inhibitors developed.  Interestingly, biol. data suggest that sirtuins have both tumor-suppressing and tumor-promoting roles.  However, most pharmacol. studies with small-mol. inhibitors suggest that inhibiting sirtuins has anticancer effects.  We discuss possible explanations for this discrepancy and suggest possible future directions to further establish sirtuin inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosZVnK8lSr27Vg90H21EOLACvtfcHk0livz8Bm4nr_og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemsr3O&md5=1ec5a806a221048984a0c5e18b7d9f12</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.44%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%26atitle%3DSirtuin%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D945%26epage%3D966%26doi%3D10.4155%2Ffmc.14.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of sirtuin inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.2174/092986711795590057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.2174%2F092986711795590057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=21517778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1936-1946&author=L.+Chen&title=Medicinal+chemistry+of+sirtuin+inhibitors&doi=10.2174%2F092986711795590057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of sirtuin inhibitors</span></div><div class="casAuthors">Chen, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1936-1946</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As members of Class III histone deacetylases (HDACs), sirtuins use stoichiometric NAD (NAD+) to remove the acetyl group from N-acetyl-lysines of histones or non-histone proteins.  Sirtuins have been implicated in metabolic diseases, cancer, and neurodegenerative diseases, constituting a promising target for drug discovery.  While the early sirtuin inhibitors mimicked NAD+ or substrate peptides, high-throughput and in silico screenings have identified a wide range of core structures, many of which have been subjected to medicinal chem. efforts.  This review outlines inhibitor chemotypes, and their chem. modifications and biol. evaluations, highlighting strategies to enhance inhibitory activity and selectivity among isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfXcQnFvuWkLVg90H21EOLACvtfcHk0lhpxIP7rjgJbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFehuro%253D&md5=13b27b3be14e31b97d501f4a06a7c408</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.2174%2F092986711795590057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795590057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26atitle%3DMedicinal%2520chemistry%2520of%2520sirtuin%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1936%26epage%3D1946%26doi%3D10.2174%2F092986711795590057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cen, Y.</span><span> </span><span class="NLM_article-title">Sirtuins inhibitors: the approach to affinity and selectivity</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1644</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2009.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.bbapap.2009.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=19931429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlaltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=1635-1644&author=Y.+Cen&title=Sirtuins+inhibitors%3A+the+approach+to+affinity+and+selectivity&doi=10.1016%2Fj.bbapap.2009.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins inhibitors: The approach to affinity and selectivity</span></div><div class="casAuthors">Cen, Yana</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1635-1644</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence has indicated the importance of sirtuins (class III histone deacetylases) in various biol. processes.  Their potential roles in metabolic and neurodegenerative diseases have encouraged scientists to seek potent and selective sirtuin inhibitors to investigate their biol. functions with a view to eventual new therapeutic treatments.  Here, the author surveys current knowledge of sirtuin inhibitors including those discovered via high-throughput screening or via mechanism-based drug design from synthetic or natural sources.  Their inhibitory affinity, selectivities, and possible inhibition mechanisms are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkOq-kDRaJbVg90H21EOLACvtfcHk0lhpxIP7rjgJbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlaltbw%253D&md5=3eb521cf151c8e3772244e2e4e3b861a</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DCen%26aufirst%3DY.%26atitle%3DSirtuins%2520inhibitors%253A%2520the%2520approach%2520to%2520affinity%2520and%2520selectivity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D1635%26epage%3D1644%26doi%3D10.1016%2Fj.bbapap.2009.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2789</span><span class="NLM_x">–</span> <span class="NLM_lpage">2793</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.bmcl.2012.02.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2789-2793&author=S.+H.+Choiauthor=L.+Quintiauthor=A.+G.+Kazantsevauthor=R.+B.+Silverman&title=3-%28N-arylsulfamoyl%29benzamides%2C+inhibitors+of+human+sirtuin+type+2+%28SIRT2%29&doi=10.1016%2Fj.bmcl.2012.02.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3D3-%2528N-arylsulfamoyl%2529benzamides%252C%2520inhibitors%2520of%2520human%2520sirtuin%2520type%25202%2520%2528SIRT2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2789%26epage%3D2793%26doi%3D10.1016%2Fj.bmcl.2012.02.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khanfar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ejmech.2014.02.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=414-426&author=M.+A.+Khanfarauthor=L.+Quintiauthor=H.+Wangauthor=S.+H.+Choiauthor=A.+G.+Kazantsevauthor=R.+B.+Silverman&title=Development+and+characterization+of+3-%28benzylsulfonamido%29benzamides+as+potent+and+selective+SIRT2+inhibitors&doi=10.1016%2Fj.ejmech.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDevelopment%2520and%2520characterization%2520of%25203-%2528benzylsulfonamido%2529benzamides%2520as%2520potent%2520and%2520selective%2520SIRT2%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D76%26spage%3D414%26epage%3D426%26doi%3D10.1016%2Fj.ejmech.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Khanfar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Design and evaluation of 3-(benzylthio)benzamide derivatives as potent and selective SIRT2 inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=607-611&author=M.+A.+Khanfarauthor=L.+Quintiauthor=H.+Wangauthor=J.+Noblesauthor=A.+G.+Kazantsevauthor=R.+B.+Silverman&title=Design+and+evaluation+of+3-%28benzylthio%29benzamide+derivatives+as+potent+and+selective+SIRT2+inhibitors&doi=10.1021%2Facsmedchemlett.5b00075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00075%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26aulast%3DQuinti%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNobles%26aufirst%3DJ.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDesign%2520and%2520evaluation%2520of%25203-%2528benzylthio%2529benzamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520SIRT2%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D607%26epage%3D611%26doi%3D10.1021%2Facsmedchemlett.5b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5760</span><span class="NLM_x">–</span> <span class="NLM_lpage">5773</span><span class="refDoi"> DOI: 10.1021/jm3002108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2ns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5760-5773&author=T.+Suzukiauthor=M.+N.+Khanauthor=H.+Sawadaauthor=E.+Imaiauthor=Y.+Itohauthor=K.+Yamatsutaauthor=N.+Tokudaauthor=J.+Takeuchiauthor=T.+Sekoauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+synthesis%2C+and+biological+activity+of+a+novel+series+of+human+sirtuin-2-selective+inhibitors&doi=10.1021%2Fjm3002108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors</span></div><div class="casAuthors">Suzuki, Takayoshi; Khan, Mohammed Naseer Ahmed; Sawada, Hideyuki; Imai, Erika; Itoh, Yukihiro; Yamatsuta, Katsura; Tokuda, Natsuko; Takeuchi, Jun; Seko, Takuya; Nakagawa, Hidehiko; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5760-5773</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anilinobenzamides such as I [R = H, PhNHCO, PhNMeCO, PhCH2NHCO, PhCH2NMeCO, PhCH2CONH, PhCH2CONMe, cyclohexylmethoxy, Me2CHCH2O, PhCH2O, PhCH2CH2O, R2CH2CH2O, PhCH2CH2CH2O; R2 = 2-MeC6H4, 3-MeC6H4, 4-MeC6H4, 2-F3CC6H4, 3-F3CC6H4, 4-F3CC6H4, 2-FC6H4, 3-FC6H4, 4-FC6H4, 2-ClC6H4, 3-ClC6H4, 4-ClC6H4, 2-BrC6H4, 3-BrC6H4, 4-BrC6H4; R1 = H, (E)-PhCH:CH, (Z)-PhCH:CH, PhCH2CH2, PhNMeCO, PhNHCO, PhCONMe, PhCONH, R3CONH; R3 = Me, Me2CH, cyclohexyl, 4-piperidinyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl] were prepd. as selective inhibitors of human sirtuin 2 (SIRT2), a deacetylase with potential involvement in neurodegenerative diseases such as Parkinson's and Huntington's diseases.  In particular, phenethyloxyanilinobenzamides such as I (R = R2CH2CH2O; R1 = H; R2 = Ph, 3-FC6H4) were potent and selective SIRT2 inhibitors, with 3.5-fold greater SIRT2 inhibition and more than 35-fold greater selectivity for SIRT2 over SIRT1 and SIRT3 than the previously known dichlorophenylfuranylpropenamide SIRT2 inhibitor AGK2.  I (R = PhCH2CH2; R1 = H) dose-dependently inhibited SIRT2 in human colon cancer HCT116 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrob-E8DojbhrVg90H21EOLACvtfcHk0lh_rIEpgn_wsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2ns78%253D&md5=63c83476f2406763a50313457ec4431e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm3002108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002108%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BN.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DE.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DYamatsuta%26aufirst%3DK.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DJ.%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520novel%2520series%2520of%2520human%2520sirtuin-2-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5760%26epage%3D5773%26doi%3D10.1021%2Fjm3002108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Friden-Saxin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landergren, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suuronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7104</span><span class="NLM_x">–</span> <span class="NLM_lpage">7113</span><span class="refDoi"> DOI: 10.1021/jm3005288</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3005288" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7104-7113&author=M.+Friden-Saxinauthor=T.+Seifertauthor=M.+R.+Landergrenauthor=T.+Suuronenauthor=M.+Lahtela-Kakkonenauthor=E.+M.+Jarhoauthor=K.+Luthman&title=Synthesis+and+evaluation+of+substituted+chroman-4-one+and+chromone+derivatives+as+sirtuin+2-selective+inhibitors&doi=10.1021%2Fjm3005288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors</span></div><div class="casAuthors">Friden-Saxin, Maria; Seifert, Tina; Landergren, Marie Ryden; Suuronen, Tiina; Lahtela-Kakkonen, Maija; Jarho, Elina M.; Luthman, Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7104-7113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of substituted chromone/chroman-4-one derivs. has been synthesized and evaluated as novel inhibitors of SIRT2, an enzyme involved in aging-related diseases, e.g., neurodegenerative disorders.  The analogs were efficiently synthesized in a one-step procedure including a base-mediated aldol condensation using microwave irradn.  The most potent compds., with inhibitory concns. in the low micromolar range, were substituted in the 2-, 6-, and 8-positions.  Larger, electron-withdrawing substituents in the 6- and 8-positions were favorable.  The most potent inhibitor of SIRT2 was 6,8-dibromo-2-pentylchroman-4-one (I) with an IC50 of 1.5 μM.  The synthesized compds. show high selectivity toward SIRT2 over SIRT1 and SIRT3 and represent an important starting point for the development of novel SIRT2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5DvugJ8tbwLVg90H21EOLACvtfcHk0lj-_JKO1Eqjlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gsLk%253D&md5=d0f80ecf32a11b3ad3c5dd209db81b0b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm3005288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3005288%26sid%3Dliteratum%253Aachs%26aulast%3DFriden-Saxin%26aufirst%3DM.%26aulast%3DSeifert%26aufirst%3DT.%26aulast%3DLandergren%26aufirst%3DM.%2BR.%26aulast%3DSuuronen%26aufirst%3DT.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DJarho%26aufirst%3DE.%2BM.%26aulast%3DLuthman%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520substituted%2520chroman-4-one%2520and%2520chromone%2520derivatives%2520as%2520sirtuin%25202-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7104%26epage%3D7113%26doi%3D10.1021%2Fjm3005288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Disch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evindar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyanskaya, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquilani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graybill, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuozzo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlasuk, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3666</span><span class="NLM_x">–</span> <span class="NLM_lpage">3679</span><span class="refDoi"> DOI: 10.1021/jm400204k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400204k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3666-3679&author=J.+S.+Dischauthor=G.+Evindarauthor=C.+H.+Chiuauthor=C.+A.+Blumauthor=H.+Daiauthor=L.+Jinauthor=E.+Schumanauthor=K.+E.+Lindauthor=S.+L.+Belyanskayaauthor=J.+Dengauthor=F.+Coppoauthor=L.+Aquilaniauthor=T.+L.+Graybillauthor=J.+W.+Cuozzoauthor=S.+Lavuauthor=C.+Maoauthor=G.+P.+Vlasukauthor=R.+B.+Perni&title=Discovery+of+thieno%5B3%2C2-d%5Dpyrimidine-6-carboxamides+as+potent+inhibitors+of+SIRT1%2C+SIRT2%2C+and+SIRT3&doi=10.1021%2Fjm400204k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3</span></div><div class="casAuthors">Disch, Jeremy S.; Evindar, Ghotas; Chiu, Cynthia H.; Blum, Charles A.; Dai, Han; Jin, Lei; Schuman, Eli; Lind, Kenneth E.; Belyanskaya, Svetlana L.; Deng, Jianghe; Coppo, Frank; Aquilani, Leah; Graybill, Todd L.; Cuozzo, John W.; Lavu, Siva; Mao, Cheney; Vlasuk, George P.; Perni, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3666-3679</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sirtuins SIRT1, SIRT2, and SIRT3 are NAD+ dependent deacetylases that are considered potential targets for metabolic, inflammatory, oncol., and neurodegenerative disorders.  Encoded library technol. (ELT) was used to affinity screen a 1.2 million heterocycle enriched library of DNA encoded small mols., which identified pan-inhibitors of SIRT1/2/3 with nanomolar potency.  Subsequent SAR studies to improve physiochem. properties identified the potent drug like analogs 4-(4-(2-Pivalamidoethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide and 4-(4-(2-(Methylsulfonamido)ethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide.  Crystallog. studies of N2-(2-(1-(6-Carbamoylthieno[3,2-d]pyrimidin-4-yl)piperidin-4-yl)ethyl)-N5-ethylthiophene-2,5-dicarboxamide, 4-(4-(2-Pivalamidoethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide, and 4-(4-(2-(Methylsulfonamido)ethyl)piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide bound in the SIRT3 active site revealed that the common carboxamide binds in the nicotinamide C-pocket and the aliph. portions of the inhibitors extend through the substrate channel, explaining the observable SAR.  These pan SIRT1/2/3 inhibitors, representing a novel chemotype, are significantly more potent than currently available inhibitors, which makes them valuable tools for sirtuin research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxOC0cS5NuHbVg90H21EOLACvtfcHk0lhdxp-t_0UhaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gtrs%253D&md5=447a6bcce0f47173a42e4ac5d95c3ec6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm400204k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400204k%26sid%3Dliteratum%253Aachs%26aulast%3DDisch%26aufirst%3DJ.%2BS.%26aulast%3DEvindar%26aufirst%3DG.%26aulast%3DChiu%26aufirst%3DC.%2BH.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DSchuman%26aufirst%3DE.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DCoppo%26aufirst%3DF.%26aulast%3DAquilani%26aufirst%3DL.%26aulast%3DGraybill%26aufirst%3DT.%2BL.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DLavu%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DVlasuk%26aufirst%3DG.%2BP.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520of%2520thieno%255B3%252C2-d%255Dpyrimidine-6-carboxamides%2520as%2520potent%2520inhibitors%2520of%2520SIRT1%252C%2520SIRT2%252C%2520and%2520SIRT3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3666%26epage%3D3679%26doi%3D10.1021%2Fjm400204k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Di Fruscia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharioudakis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laohasinnarong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khongkow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltsida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexter, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span> </span><span class="NLM_article-title">The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson’s disease model</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1002/cmdc.201402431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fcmdc.201402431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25395356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=69-82&author=P.+Di+Frusciaauthor=E.+Zacharioudakisauthor=C.+Liuauthor=S.+Moniotauthor=S.+Laohasinnarongauthor=M.+Khongkowauthor=I.+F.+Harrisonauthor=K.+Koltsidaauthor=C.+R.+Reynoldsauthor=K.+Schmidtkunzauthor=M.+Jungauthor=K.+L.+Chapmanauthor=C.+Steegbornauthor=D.+T.+Dexterauthor=M.+J.+Sternbergauthor=E.+W.+Lamauthor=M.+J.+Fuchter&title=The+discovery+of+a+highly+selective+5%2C6%2C7%2C8-tetrahydrobenzo%5B4%2C5%5Dthieno%5B2%2C3-d%5Dpyrimidin-4%283H%29-one+SIRT2+inhibitor+that+is+neuroprotective+in+an+in+vitro+Parkinson%E2%80%99s+disease+model&doi=10.1002%2Fcmdc.201402431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Highly Selective 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 Inhibitor that is Neuroprotective in an in vitro Parkinson's Disease Model</span></div><div class="casAuthors">Di Fruscia, Paolo; Zacharioudakis, Emmanouil; Liu, Chang; Moniot, Sebastien; Laohasinnarong, Sasiwan; Khongkow, Mattaka; Harrison, Ian F.; Koltsida, Konstantina; Reynolds, Christopher R.; Schmidtkunz, Karin; Jung, Manfred; Chapman, Kathryn L.; Steegborn, Clemens; Dexter, David T.; Sternberg, Michael J. E.; Lam, Eric W.-F.; Fuchter, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-82</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sirtuins, NAD+-dependent histone deacetylases (HDACs), have recently emerged as potential therapeutic targets for the treatment of a variety of diseases.  The discovery of potent and isoform-selective inhibitors of this enzyme family should provide chem. tools to help det. the roles of these targets and validate their therapeutic value.  Herein, the authors report the discovery of a novel class of highly selective SIRT2 inhibitors, identified by pharmacophore screening.  The authors report the identification and validation of I (ICL-SIRT078), a substrate-competitive SIRT2 inhibitor with a Ki value of 0.62±0.15 μM and more than 50-fold selectivity against SIRT1, 3 and 5.  Treatment of MCF-7 breast cancer cells with ICL-SIRT078 results in hyperacetylation of α-tubulin, an established SIRT2 biomarker, at doses comparable with the biochem. IC50 data, while suppressing MCF-7 proliferation at higher concns.  In concordance with the recent reports that suggest SIRT2 inhibition is a potential strategy for the treatment of Parkinson's disease, the authors find that compd. ICL-SIRT078 has a significant neuroprotective effect in a lactacystin-induced model of Parkinsonian neuronal cell death in the N27 cell line.  These results encourage further investigation into the effects of ICL-SIRT078, or an optimized deriv. thereof, as a candidate neuroprotective agent in in vivo models of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhBvCt3DxtybVg90H21EOLACvtfcHk0lhdxp-t_0UhaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7bE&md5=86cc1270a96ecc3a3e61e9bb2782e8a3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402431%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DZacharioudakis%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMoniot%26aufirst%3DS.%26aulast%3DLaohasinnarong%26aufirst%3DS.%26aulast%3DKhongkow%26aufirst%3DM.%26aulast%3DHarrison%26aufirst%3DI.%2BF.%26aulast%3DKoltsida%26aufirst%3DK.%26aulast%3DReynolds%26aufirst%3DC.%2BR.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DChapman%26aufirst%3DK.%2BL.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26aulast%3DSternberg%26aufirst%3DM.%2BJ.%26aulast%3DLam%26aufirst%3DE.%2BW.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520a%2520highly%2520selective%25205%252C6%252C7%252C8-tetrahydrobenzo%255B4%252C5%255Dthieno%255B2%252C3-d%255Dpyrimidin-4%25283H%2529-one%2520SIRT2%2520inhibitor%2520that%2520is%2520neuroprotective%2520in%2520an%2520in%2520vitro%2520Parkinson%25E2%2580%2599s%2520disease%2520model%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D69%26epage%3D82%26doi%3D10.1002%2Fcmdc.201402431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roessler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladwein, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Selective Sirt2 inhibition by ligand-induced rearrangement of the active site</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6263</span><span class="refDoi"> DOI: 10.1038/ncomms7263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fncomms7263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=25672491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6263&author=T.+Rumpfauthor=M.+Schiedelauthor=B.+Karamanauthor=C.+Roesslerauthor=B.+J.+Northauthor=A.+Lehotzkyauthor=J.+Olahauthor=K.+I.+Ladweinauthor=K.+Schmidtkunzauthor=M.+Gajerauthor=M.+Pannekauthor=C.+Steegbornauthor=D.+A.+Sinclairauthor=S.+Gerhardtauthor=J.+Ovadiauthor=M.+Schutkowskiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Selective+Sirt2+inhibition+by+ligand-induced+rearrangement+of+the+active+site&doi=10.1038%2Fncomms7263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Sirt2 inhibition by ligand-induced rearrangement of the active site</span></div><div class="casAuthors">Rumpf, Tobias; Schiedel, Matthias; Karaman, Berin; Roessler, Claudia; North, Brian J.; Lehotzky, Attila; Olah, Judit; Ladwein, Kathrin I.; Schmidtkunz, Karin; Gajer, Markus; Pannek, Martin; Steegborn, Clemens; Sinclair, David A.; Gerhardt, Stefan; Ovadi, Judit; Schutkowski, Mike; Sippl, Wolfgang; Einsle, Oliver; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6263</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sirtuins are a highly conserved class of NAD-dependent lysine deacylases.  Human isotype Sirt2 has been implicated in the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of Sirt2 activity a promising strategy for pharmaceutical intervention.  However, a rational basis for the development of optimized Sirt2 inhibitors is lacking so far.  Here, the authors present high-resoln. structures of human Sirt2 in complex with highly selective drug-like inhibitors that show a unique inhibitory mechanism.  The potency and the unprecedented Sirt2 selectivity were based on a ligand-induced structural rearrangement of the active site unveiling a yet-unexploited binding pocket.  The application of the most potent sirtuin-rearranging ligand, termed SirReal2, led to tubulin hyperacetylation in HeLa cells and induced destabilization of checkpoint protein BubR1, consistent with Sirt2 inhibition in vivo.  The structural insights into this unique mechanism of selective sirtuin inhibition provide the basis for further inhibitor development and selective tools for sirtuin biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN2LzipheDFLVg90H21EOLACvtfcHk0lgY3AYgkQcldA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D&md5=bc3c61af5e456f4483746a588db91643</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1038%2Fncomms7263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7263%26sid%3Dliteratum%253Aachs%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DRoessler%26aufirst%3DC.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DLadwein%26aufirst%3DK.%2BI.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DGajer%26aufirst%3DM.%26aulast%3DPannek%26aufirst%3DM.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DSelective%2520Sirt2%2520inhibition%2520by%2520ligand-induced%2520rearrangement%2520of%2520the%2520active%2520site%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6263%26doi%3D10.1038%2Fncomms7263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Aminothiazoles as potent and selective Sirt2 inhibitors: a structure-sctivity relationship study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01517</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01517" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1599-1612&author=M.+Schiedelauthor=T.+Rumpfauthor=B.+Karamanauthor=A.+Lehotzkyauthor=J.+Olahauthor=S.+Gerhardtauthor=J.+Ovadiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Aminothiazoles+as+potent+and+selective+Sirt2+inhibitors%3A+a+structure-sctivity+relationship+study&doi=10.1021%2Facs.jmedchem.5b01517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01517%26sid%3Dliteratum%253Aachs%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DAminothiazoles%2520as%2520potent%2520and%2520selective%2520Sirt2%2520inhibitors%253A%2520a%2520structure-sctivity%2520relationship%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1599%26epage%3D1612%26doi%3D10.1021%2Facs.jmedchem.5b01517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollick, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staples, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoubala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleyard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1016/j.ccr.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ccr.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=18455128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFelsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=454-463&author=S.+Lainauthor=J.+J.+Hollickauthor=J.+Campbellauthor=O.+D.+Staplesauthor=M.+Higginsauthor=M.+Aoubalaauthor=A.+McCarthyauthor=V.+Appleyardauthor=K.+E.+Murrayauthor=L.+Bakerauthor=A.+Thompsonauthor=J.+Mathersauthor=S.+J.+Hollandauthor=M.+J.+Starkauthor=G.+Passauthor=J.+Woodsauthor=D.+P.+Laneauthor=N.+J.+Westwood&title=Discovery%2C+in+vivo+activity%2C+and+mechanism+of+action+of+a+small-molecule+p53+activator&doi=10.1016%2Fj.ccr.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator</span></div><div class="casAuthors">Lain, Sonia; Hollick, Jonathan J.; Campbell, Johanna; Staples, Oliver D.; Higgins, Maureen; Aoubala, Mustapha; McCarthy, Anna; Appleyard, Virginia; Murray, Karen E.; Baker, Lee; Thompson, Alastair; Mathers, Joanne; Holland, Stephen J.; Stark, Michael J. R.; Pass, Georgia; Woods, Julie; Lane, David P.; Westwood, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">454-463</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have carried out a cell-based screen aimed at discovering small mols. that activate p53 and have the potential to decrease tumor growth.  Here, we describe one of our hit compds., tenovin-1, along with a more water-sol. analog, tenovin-6.  Via a yeast genetic screen, biochem. assays, and target validation studies in mammalian cells, we show that tenovins act through inhibition of the protein-deacetylating activities of SirT1 and SirT2, two important members of the sirtuin family.  Tenovins are active on mammalian cells at one-digit micromolar concns. and decrease tumor growth in vivo as single agents.  This underscores the utility of these compds. as biol. tools for the study of sirtuin function as well as their potential therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOaSyIs0EPErVg90H21EOLACvtfcHk0lgt5Yi6MsyrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFelsr4%253D&md5=cc43822431826afa40e17fd68a86647a</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DLain%26aufirst%3DS.%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DStaples%26aufirst%3DO.%2BD.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DAoubala%26aufirst%3DM.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DAppleyard%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DK.%2BE.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DMathers%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DS.%2BJ.%26aulast%3DStark%26aufirst%3DM.%2BJ.%26aulast%3DPass%26aufirst%3DG.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%252C%2520in%2520vivo%2520activity%252C%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520small-molecule%2520p53%2520activator%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D454%26epage%3D463%26doi%3D10.1016%2Fj.ccr.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCarthy, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollick, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronseaux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staples, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.bmc.2012.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22304848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFaqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1779-1793&author=A.+R.+McCarthyauthor=L.+Pirrieauthor=J.+J.+Hollickauthor=S.+Ronseauxauthor=J.+Campbellauthor=M.+Higginsauthor=O.+D.+Staplesauthor=F.+Tranauthor=A.+M.+Slawinauthor=S.+Lainauthor=N.+J.+Westwood&title=Synthesis+and+biological+characterisation+of+sirtuin+inhibitors+based+on+the+tenovins&doi=10.1016%2Fj.bmc.2012.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins</span></div><div class="casAuthors">McCarthy, Anna R.; Pirrie, Lisa; Hollick, Jonathan J.; Ronseaux, Sebastien; Campbell, Johanna; Higgins, Maureen; Staples, Oliver D.; Tran, Fanny; Slawin, Alexandra M. Z.; Lain, Sonia; Westwood, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1779-1793</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The tenovins are small mol. inhibitors of the NAD+-dependent family of protein deacetylases known as the sirtuins.  There remains considerable interest in inhibitors of this enzyme family due to possible applications in both cancer and neurodegenerative disease therapy.  Through the synthesis of novel tenovin analogs, further insights into the structural requirements for activity against the sirtuins in vitro are provided.  In addn., the activity of one of the analogs in cells led to an improved understanding of the function of SirT1 in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVQbzCITDMgbVg90H21EOLACvtfcHk0lgt5Yi6MsyrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFaqt74%253D&md5=726af22730cdcc2162d75c3663534c88</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DA.%2BR.%26aulast%3DPirrie%26aufirst%3DL.%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DRonseaux%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DStaples%26aufirst%3DO.%2BD.%26aulast%3DTran%26aufirst%3DF.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520characterisation%2520of%2520sirtuin%2520inhibitors%2520based%2520on%2520the%2520tenovins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1779%26epage%3D1793%26doi%3D10.1016%2Fj.bmc.2012.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Morimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, H.</span><span> </span><span class="NLM_article-title">Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3423</span><span class="NLM_x">–</span> <span class="NLM_lpage">3427</span><span class="refDoi"> DOI: 10.1002/anie.201108118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fanie.201108118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38XivV2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=3423-3427&author=J.+Morimotoauthor=Y.+Hayashiauthor=H.+Suga&title=Discovery+of+macrocyclic+peptides+armed+with+a+mechanism-based+warhead%3A+isoform-selective+inhibition+of+human+deacetylase+SIRT2&doi=10.1002%2Fanie.201108118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Macrocyclic Peptides Armed with a Mechanism-Based Warhead: Isoform-Selective Inhibition of Human Deacetylase SIRT2</span></div><div class="casAuthors">Morimoto, Jumpei; Hayashi, Yuuki; Suga, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3423-3427, S3423/1-S3423/17</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A short communication reports discovery of macrocyclic peptide armed with a mechanism-based warhead, isoform-selective inhibition of human deacetylase SIRT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4HWN1fpAF_LVg90H21EOLACvtfcHk0lgt5Yi6MsyrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivV2qs7g%253D&md5=92d7ab54fa0da63a570cc8328b7111d5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fanie.201108118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201108118%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DJ.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DSuga%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520macrocyclic%2520peptides%2520armed%2520with%2520a%2520mechanism-based%2520warhead%253A%2520isoform-selective%2520inhibition%2520of%2520human%2520deacetylase%2520SIRT2%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D3423%26epage%3D3427%26doi%3D10.1002%2Fanie.201108118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mahajan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sripathy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posakony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loe, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalhofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J. A.</span><span> </span><span class="NLM_article-title">Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3283</span><span class="NLM_x">–</span> <span class="NLM_lpage">3294</span><span class="refDoi"> DOI: 10.1021/jm4018064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4018064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3283-3294&author=S.+S.+Mahajanauthor=M.+Scianauthor=S.+Sripathyauthor=J.+Posakonyauthor=U.+Laoauthor=T.+K.+Loeauthor=V.+Lekoauthor=A.+Thalhoferauthor=A.+D.+Schulerauthor=A.+Bedalovauthor=J.+A.+Simon&title=Development+of+pyrazolone+and+isoxazol-5-one+cambinol+analogues+as+sirtuin+inhibitors&doi=10.1021%2Fjm4018064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm4018064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4018064%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DScian%26aufirst%3DM.%26aulast%3DSripathy%26aufirst%3DS.%26aulast%3DPosakony%26aufirst%3DJ.%26aulast%3DLao%26aufirst%3DU.%26aulast%3DLoe%26aufirst%3DT.%2BK.%26aulast%3DLeko%26aufirst%3DV.%26aulast%3DThalhofer%26aufirst%3DA.%26aulast%3DSchuler%26aufirst%3DA.%2BD.%26aulast%3DBedalov%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520pyrazolone%2520and%2520isoxazol-5-one%2520cambinol%2520analogues%2520as%2520sirtuin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3283%26epage%3D3294%26doi%3D10.1021%2Fjm4018064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, M. L.</span><span> </span><span class="NLM_article-title">Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.ejmech.2014.12.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=145-155&author=T.+Yangauthor=X.+Chenauthor=H.+X.+Jinauthor=G.+Sethiauthor=M.+L.+Go&title=Functionalized+tetrahydro-1H-pyrido%5B4%2C3-b%5Dindoles%3A+a+novel+chemotype+with+Sirtuin+2+inhibitory+activity&doi=10.1016%2Fj.ejmech.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DH.%2BX.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DFunctionalized%2520tetrahydro-1H-pyrido%255B4%252C3-b%255Dindoles%253A%2520a%2520novel%2520chemotype%2520with%2520Sirtuin%25202%2520inhibitory%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D145%26epage%3D155%26doi%3D10.1016%2Fj.ejmech.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">More, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8340</span><span class="NLM_x">–</span> <span class="NLM_lpage">8357</span><span class="refDoi"> DOI: 10.1021/jm500777s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500777s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8340-8357&author=H.+Cuiauthor=Z.+Kamalauthor=T.+Aiauthor=Y.+Xuauthor=S.+S.+Moreauthor=D.+J.+Wilsonauthor=L.+Chen&title=Discovery+of+potent+and+selective+sirtuin+2+%28SIRT2%29+inhibitors+using+a+fragment-based+approach&doi=10.1021%2Fjm500777s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Cui, Huaqing; Kamal, Zeeshan; Ai, Teng; Xu, Yanli; More, Swati S.; Wilson, Daniel J.; Chen, Liqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8340-8357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuin 2 (SIRT2) is one of the sirtuins, a family of NAD+-dependent deacetylases that act on a variety of histone and non-histone substrates.  Accumulating biol. functions and potential therapeutic applications have drawn interest in the discovery and development of SIRT2 inhibitors.  Herein we report our discovery of novel SIRT2 inhibitors using a fragment-based approach.  Inspired by the purported close binding proximity of suramin and nicotinamide, we prepd. two sets of fragments, namely, the naphthylamide sulfonic acids and the naphthalene-benzamides and -nicotinamides.  Biochem. evaluation of these two series provided structure-activity relationship (SAR) information, which led to the design of (5-benzamidonaphthalen-1/2-yloxy)nicotinamide derivs.  Among these inhibitors, one compd. exhibited high anti-SIRT2 activity (48 nM) and excellent selectivity for SIRT2 over SIRT1 and SIRT3.  In vitro, it also increased the acetylation level of α-tubulin, a well-established SIRT2 substrate, in both concn.- and time-dependent manners.  Further kinetic studies revealed that this compd. behaves as a competitive inhibitor against the peptide substrate and most likely as a noncompetitive inhibitor against NAD+.  Taken together, these results indicate that we have discovered a potent and selective SIRT2 inhibitor whose novel structure merits further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdLtR3ic38bVg90H21EOLACvtfcHk0liGd9K3A-qUfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL&md5=6831830798aa6518ca02e3780c49b4cd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm500777s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500777s%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.%26aulast%3DKamal%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMore%26aufirst%3DS.%2BS.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520sirtuin%25202%2520%2528SIRT2%2529%2520inhibitors%2520using%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8340%26epage%3D8357%26doi%3D10.1021%2Fjm500777s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Parenti, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rio, A.</span><span> </span><span class="NLM_article-title">Selectivity hot-spots of sirtuin catalytic cores</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2263</span><span class="NLM_x">–</span> <span class="NLM_lpage">2272</span><span class="refDoi"> DOI: 10.1039/C5MB00205B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1039%2FC5MB00205B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=26061123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFSiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=2263-2272&author=M.+D.+Parentiauthor=S.+Bruzzoneauthor=A.+Nencioniauthor=A.+Del+Rio&title=Selectivity+hot-spots+of+sirtuin+catalytic+cores&doi=10.1039%2FC5MB00205B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity hot-spots of sirtuin catalytic cores</span></div><div class="casAuthors">Parenti, Marco Daniele; Bruzzone, Santina; Nencioni, Alessio; Del Rio, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2263-2272</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent deacetylases with several biol. roles in DNA regulation, genomic stability, metab., longevity and immune cell functions.  Numerous disease conditions are linked to sirtuins including metabolic disorders, inflammatory and autoimmune processes and cancer.  Although few specific small mol. modulators have been reported to date, the need to identify selective ligands would be crucial not only for the development of active pharmaceutical ingredients for new targeted therapies but also as a tool for dissecting the biol. roles of sirtuin family members.  Herein, we report a comprehensive study aimed to classify and identify the selectivity hot-spots for targeting the catalytic cores of human sirtuins using small mol. modulators.  Our selectivity anal. suggests that catalytic cores can be divided into different clusters that can constitute the basis for the development of selective ligands.  The ensemble of hot-spot information is expected to be helpful to devise new selective chems. targeting sirtuin family members.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJp_S4bMfrlLVg90H21EOLACvtfcHk0lgiRg9Br_dn3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFSiur8%253D&md5=20e51ccba48f639934973e570cea5d07</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC5MB00205B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MB00205B%26sid%3Dliteratum%253Aachs%26aulast%3DParenti%26aufirst%3DM.%2BD.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DDel%2BRio%26aufirst%3DA.%26atitle%3DSelectivity%2520hot-spots%2520of%2520sirtuin%2520catalytic%2520cores%26jtitle%3DMol.%2520BioSyst.%26date%3D2015%26volume%3D11%26spage%3D2263%26epage%3D2272%26doi%3D10.1039%2FC5MB00205B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Smith, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settles, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallows, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">SIRT3 substrate specificity determined by peptide arrays and machine learning</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span><span class="refDoi"> DOI: 10.1021/cb100218d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100218d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGkt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=146-157&author=B.+C.+Smithauthor=B.+Settlesauthor=W.+C.+Hallowsauthor=M.+W.+Cravenauthor=J.+M.+Denu&title=SIRT3+substrate+specificity+determined+by+peptide+arrays+and+machine+learning&doi=10.1021%2Fcb100218d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT3 Substrate Specificity Determined by Peptide Arrays and Machine Learning</span></div><div class="casAuthors">Smith, Brian C.; Settles, Burr; Hallows, William C.; Craven, Mark W.; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-157</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that reversible protein acetylation may be a major regulatory mechanism that rivals phosphorylation.  With the recent cataloging of thousands of acetylation sites on hundreds of proteins comes the challenge of identifying the acetyltransferases and deacetylases that regulate acetylation levels.  Sirtuins are a conserved family of NAD+-dependent protein deacetylases that are implicated in genome maintenance, metab., cell survival, and lifespan.  SIRT3 is the dominant protein deacetylase in mitochondria, and emerging evidence suggests that SIRT3 may control major pathways by deacetylation of central metabolic enzymes.  Here, to identify potential SIRT3 substrates, we have developed an unbiased screening strategy that involves a novel acetyl-lysine analog (thiotrifluoroacetyl-lysine), SPOT-peptide libraries, machine learning, and kinetic validation.  SPOT peptide libraries based on known and potential mitochondrial acetyl-lysine sites were screened for SIRT3 binding and then analyzed using machine learning to establish binding trends.  These trends were then applied to the mitochondrial proteome as a whole to predict binding affinity of all lysine sites within human mitochondria.  Machine learning prediction of SIRT3 binding correlated with steady-state kinetic kcat/Km values for 24 acetyl-lysine peptides that possessed a broad range of predicted binding.  Thus, SPOT peptide-binding screens and machine learning prediction provides an accurate and efficient method to evaluate sirtuin substrate specificity from a relatively small learning set.  These analyses suggest potential SIRT3 substrates involved in several metabolic pathways such as the urea cycle, ATP synthesis, and fatty acid oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZ8i2tCKgDLVg90H21EOLACvtfcHk0lgiRg9Br_dn3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGkt7fP&md5=bfdf78cdd6f6129a3663d2409b15986b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcb100218d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100218d%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BC.%26aulast%3DSettles%26aufirst%3DB.%26aulast%3DHallows%26aufirst%3DW.%2BC.%26aulast%3DCraven%26aufirst%3DM.%2BW.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DSIRT3%2520substrate%2520specificity%2520determined%2520by%2520peptide%2520arrays%2520and%2520machine%2520learning%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D146%26epage%3D157%26doi%3D10.1021%2Fcb100218d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Copeland, R. A.</span> <span class="citation_source-book">Evaluation of Enzyme Inhibitors in Drug Discovery: a Guide for Medicinal Chemists and Pharmacologists</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Chapter 7.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2F9781118540398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery%3A+a+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F9781118540398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%253A%2520a%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the histone deacetylase SIRT2</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span><span class="refDoi"> DOI: 10.1038/89668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2F89668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=11427894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=621-625&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=N.+P.+Pavletich&title=Structure+of+the+histone+deacetylase+SIRT2&doi=10.1038%2F89668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the histone deacetylase SIRT2</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Sir2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres, and ribosomal gene clusters, and plays a crit. role in the detn. of life span in yeast and Caenorhabditis elegans.  Here, the 1.7 Å crystal structure of the 323-amino-acid catalytic core of human SIRT2, a homolog of yeast Sir2, revealed an NAD-binding domain, which was a variant of the Rossmann fold, and a smaller domain composed of a helical module and a Zn-binding module.  A conserved large groove at the interface of the 2 domains was the likely site of catalysis based on mutagenesis.  Intersecting this large groove, there was a pocket formed by the helical module.  The pocket was lined with hydrophobic residues conserved within each of the 5 Sir2 classes, suggesting that it is a class-specific protein-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNi1R8KPeQ7Vg90H21EOLACvtfcHk0lgiRg9Br_dn3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D&md5=6d305c420bff2690da780fc23938c22f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2F89668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89668%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520histone%2520deacetylase%2520SIRT2%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D621%26epage%3D625%26doi%3D10.1038%2F89668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span><span class="refDoi"> DOI: 10.1038/nrd2999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fnrd2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=19876042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders&doi=10.1038%2Fnrd2999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein kinases in central nervous system disorders</span></div><div class="casAuthors">Chico, Laura K.; Van Eldik, Linda J.; Watterson, D. Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">892-909</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases are a growing drug target class in disorders in peripheral tissues, but the development of kinase-targeted therapies for central nervous system (CNS) diseases remains a challenge, largely owing to issues assocd. specifically with CNS drug discovery.  However, several candidate therapeutics that target CNS protein kinases are now in various stages of preclin. and clin. development.  We review candidate compds. and discuss selected CNS protein kinases that are emerging as important therapeutic targets.  In addn., we analyze trends in small-mol. properties that correlate with key challenges in CNS drug discovery, such as blood-brain barrier penetrance and cytochrome P 450-mediated metab., and discuss the potential of future approaches that will integrate mol.-fragment expansion with pharmacoinformatics to address these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzQo2JmuPNlrVg90H21EOLACvtfcHk0ljXnXkPkMeJ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtrzO&md5=4dc1f6b7542e59c99f91525d37c49973</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2999%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909%26doi%3D10.1038%2Fnrd2999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1021/cn100007x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes&doi=10.1021%2Fcn100007x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljXnXkPkMeJ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434%26doi%3D10.1021%2Fcn100007x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Gumbleton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audus, K. L.</span><span> </span><span class="NLM_article-title">Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1681</span><span class="NLM_x">–</span> <span class="NLM_lpage">1698</span><span class="refDoi"> DOI: 10.1002/jps.1119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fjps.1119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=11745727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=1681-1698&author=M.+Gumbletonauthor=K.+L.+Audus&title=Progress+and+limitations+in+the+use+of+in+vitro+cell+cultures+to+serve+as+a+permeability+screen+for+the+blood-brain+barrier&doi=10.1002%2Fjps.1119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Gumbleton, Mark; Audus, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1681-1698</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  A relatively simple, widely applicable, and robust in vitro method of predicting blood-brain barrier (BBB) permeability to central nervous system-acting drugs is an increasing need.  A cell-based model offers the potential to account for transcellular and paracellular drug diffusional processes, metab., and active transport processes, as well as nondefined interactions between a drug and cellular material that may impact upon a membrane's overall permeability profile.  Any in vitro BBB cell model to be utilized for the transendothelial BBB permeability screening of potential central nervous system drugs must display reproducible solute permeability, and a no. of other general criteria including: a restrictive paracellular barrier; a physiol. realistic cell architecture; the functional expression of key transporter mechanisms; and allow case of culture to meet the tech. and time constraints of a screening program.  This article reviews the range of in vitro cell-based BBB models available, including the primary/low passage bovine and porcine brain endothelial cultures as well as the spectrum of immortalized brain endothelial cell lines that have been established.  The article further discusses the benefits and limitations of exploiting such systems as in vitro BBB permeability screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfQGmXBBqLF7Vg90H21EOLACvtfcHk0ljXnXkPkMeJ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKltrw%253D&md5=b4e729da5775cfa74dd5d00e8ce2a3bc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.1119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.1119%26sid%3Dliteratum%253Aachs%26aulast%3DGumbleton%26aufirst%3DM.%26aulast%3DAudus%26aufirst%3DK.%2BL.%26atitle%3DProgress%2520and%2520limitations%2520in%2520the%2520use%2520of%2520in%2520vitro%2520cell%2520cultures%2520to%2520serve%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D90%26spage%3D1681%26epage%3D1698%26doi%3D10.1002%2Fjps.1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddapati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierks, M. R.</span><span> </span><span class="NLM_article-title">Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson’s disease cell model</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1186/1471-2202-11-57</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1186%2F1471-2202-11-57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=20433710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A280%3ADC%252BC3czns12ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=57-66&author=M.+S.+Wangauthor=S.+Boddapatiauthor=S.+Emadiauthor=M.+R.+Sierks&title=Curcumin+reduces+alpha-synuclein+induced+cytotoxicity+in+Parkinson%E2%80%99s+disease+cell+model&doi=10.1186%2F1471-2202-11-57"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model</span></div><div class="casAuthors">Wang Min S; Boddapati Shanta; Emadi Sharareh; Sierks Michael R</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Overexpression and abnormal accumulation of aggregated alpha-synuclein (alphaS) have been linked to Parkinson's disease (PD) and other synucleinopathies. alphaS can misfold and adopt a variety of morphologies but recent studies implicate oligomeric forms as the most cytotoxic species.  Both genetic mutations and chronic exposure to neurotoxins increase alphaS aggregation and intracellular reactive oxygen species (ROS), leading to mitochondrial dysfunction and oxidative damage in PD cell models.  RESULTS:  Here we show that curcumin can alleviate alphaS-induced toxicity, reduce ROS levels and protect cells against apoptosis.  We also show that both intracellular overexpression of alphaS and extracellular addition of oligomeric alphaS increase ROS which induces apoptosis, suggesting that aggregated alphaS may induce similar toxic effects whether it is generated intra- or extracellulary.  CONCLUSIONS:  Since curcumin is a natural food pigment that can cross the blood brain barrier and has widespread medicinal uses, it has potential therapeutic value for treating PD and other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzpoo8du5T1Ph3YQQtAhNufW6udTcc2eaSiRhNVQlMvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czns12ksw%253D%253D&md5=351eb6a5dab5145c025cd295f9aee6a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-11-57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-11-57%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DBoddapati%26aufirst%3DS.%26aulast%3DEmadi%26aufirst%3DS.%26aulast%3DSierks%26aufirst%3DM.%2BR.%26atitle%3DCurcumin%2520reduces%2520alpha-synuclein%2520induced%2520cytotoxicity%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520cell%2520model%26jtitle%3DBMC%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D57%26epage%3D66%26doi%3D10.1186%2F1471-2202-11-57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. C.</span><span> </span><span class="NLM_article-title">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1038/nature12481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fnature12481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=24005412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=45-51&author=M.+Juckerauthor=L.+C.+Walker&title=Self-propagation+of+pathogenic+protein+aggregates+in+neurodegenerative+diseases&doi=10.1038%2Fnature12481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span></div><div class="casAuthors">Jucker, Mathias; Walker, Lary C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">7465</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biol. of the prion diseases.  Recently, owing largely to the advent of new disease models, this hypothesis has gained exptl. momentum.  In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid.  Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease.  Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin.  However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function.  As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCZxraDJnKbbVg90H21EOLACvtfcHk0lhkP0RIycZhag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP&md5=6e10e4c3d25f9a907b7af8944cb1ba69</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature12481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12481%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DL.%2BC.%26atitle%3DSelf-propagation%2520of%2520pathogenic%2520protein%2520aggregates%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D45%26epage%3D51%26doi%3D10.1038%2Fnature12481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Marques, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outeiro, T. F.</span><span> </span><span class="NLM_article-title">Alpha-synuclein: from secretion to dysfunction and death</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e350</span><span class="refDoi"> DOI: 10.1038/cddis.2012.94</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1038%2Fcddis.2012.94" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e350&author=O.+Marquesauthor=T.+F.+Outeiro&title=Alpha-synuclein%3A+from+secretion+to+dysfunction+and+death&doi=10.1038%2Fcddis.2012.94"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.94%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DO.%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26atitle%3DAlpha-synuclein%253A%2520from%2520secretion%2520to%2520dysfunction%2520and%2520death%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De350%26doi%3D10.1038%2Fcddis.2012.94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Emadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkhordarian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierks, M. R.</span><span> </span><span class="NLM_article-title">Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span><span class="refDoi"> DOI: 10.1016/j.jmb.2007.02.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.jmb.2007.02.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=17391701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFahsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2007&pages=1132-1144&author=S.+Emadiauthor=H.+Barkhordarianauthor=M.+S.+Wangauthor=P.+Schulzauthor=M.+R.+Sierks&title=Isolation+of+a+human+single+chain+antibody+fragment+against+oligomeric+alpha-synuclein+that+inhibits+aggregation+and+prevents+alpha-synuclein-induced+toxicity&doi=10.1016%2Fj.jmb.2007.02.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced Toxicity</span></div><div class="casAuthors">Emadi, Sharareh; Barkhordarian, Hedieh; Wang, Min S.; Schulz, Philip; Sierks, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1132-1144</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Protein misfolding and aggregation are pathol. aspects of numerous neurodegenerative diseases.  Aggregates of α-synuclein are major components of the Lewy bodies and Lewy neurites assocd. with Parkinson's Disease (PD).  A natively unfolded protein, α-synuclein, can adopt different aggregated morphologies, including oligomers, protofibrils and fibrils.  The small oligomeric aggregates have been shown to be particularly toxic.  Antibodies that neutralize the neurotoxic aggregates without interfering with beneficial functions of monomeric α-synuclein can be useful therapeutics.  We were able to isolate single chain antibody fragments (scFvs) from a phage displayed antibody library against the target antigen morphol. using a novel biopanning technique that utilizes at. force microscopy (AFM) to image and immobilize specific morphologies of α-synuclein.  The scFv described here binds only to an oligomeric form of α-synuclein and inhibits both aggregation and toxicity of α-synuclein in vitro.  This scFv can have potential therapeutic value in controlling misfolding and aggregation of α-synuclein in vivo when expressed intracellularly in dopaminergic neurons as an intrabody.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN5ZomX-Lmj7Vg90H21EOLACvtfcHk0lhd32GFLYtjJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFahsr8%253D&md5=fb85f6ee8f66ca4b66e0cfa0fc06628a</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DEmadi%26aufirst%3DS.%26aulast%3DBarkhordarian%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DSchulz%26aufirst%3DP.%26aulast%3DSierks%26aufirst%3DM.%2BR.%26atitle%3DIsolation%2520of%2520a%2520human%2520single%2520chain%2520antibody%2520fragment%2520against%2520oligomeric%2520alpha-synuclein%2520that%2520inhibits%2520aggregation%2520and%2520prevents%2520alpha-synuclein-induced%2520toxicity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D368%26spage%3D1132%26epage%3D1144%26doi%3D10.1016%2Fj.jmb.2007.02.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Emadi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasturirangan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierks, M. R.</span><span> </span><span class="NLM_article-title">Detecting morphologically distinct oligomeric forms of alpha-synuclein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">11048</span><span class="NLM_x">–</span> <span class="NLM_lpage">11058</span><span class="refDoi"> DOI: 10.1074/jbc.M806559200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1074%2Fjbc.M806559200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=11048-11058&author=S.+Emadiauthor=S.+Kasturiranganauthor=M.+S.+Wangauthor=P.+Schulzauthor=M.+R.+Sierks&title=Detecting+morphologically+distinct+oligomeric+forms+of+alpha-synuclein&doi=10.1074%2Fjbc.M806559200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806559200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806559200%26sid%3Dliteratum%253Aachs%26aulast%3DEmadi%26aufirst%3DS.%26aulast%3DKasturirangan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%2BS.%26aulast%3DSchulz%26aufirst%3DP.%26aulast%3DSierks%26aufirst%3DM.%2BR.%26atitle%3DDetecting%2520morphologically%2520distinct%2520oligomeric%2520forms%2520of%2520alpha-synuclein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D11048%26epage%3D11058%26doi%3D10.1074%2Fjbc.M806559200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehm, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span><span class="refDoi"> DOI: 10.1126/science.1227157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1126%2Fscience.1227157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=23161999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GntL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2012&pages=949-953&author=K.+C.+Lukauthor=V.+Kehmauthor=J.+Carrollauthor=B.+Zhangauthor=P.+O%E2%80%99Brienauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Pathological+alpha-synuclein+transmission+initiates+Parkinson-like+neurodegeneration+in+nontransgenic+mice&doi=10.1126%2Fscience.1227157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice</span></div><div class="casAuthors">Luk, Kelvin C.; Kehm, Victoria; Carroll, Jenna; Zhang, Bin; O'Brien, Patrick; Trojanowski, John Q.; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">6109</span>),
    <span class="NLM_cas:pages">949-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Parkinson's disease is characterized by abundant α-synuclein (α-Syn) neuronal inclusions, known as Lewy bodies and Lewy neurites, and the massive loss of midbrain dopamine neurons.  However, a cause-and-effect relationship between Lewy inclusion formation and neurodegeneration remains unclear.  Here, we found that in wild-type nontransgenic mice, a single intrastriatal inoculation of synthetic α-Syn fibrils led to the cell-to-cell transmission of pathol. α-Syn and Parkinson's-like Lewy pathol. in anatomically interconnected regions.  Lewy pathol. accumulation resulted in progressive loss of dopamine neurons in the substantia nigra pars compacta, but not in the adjacent ventral tegmental area, and was accompanied by reduced dopamine levels culminating in motor deficits.  This recapitulation of a neurodegenerative cascade thus establishes a mechanistic link between transmission of pathol. α-Syn and the cardinal features of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMkqmC5V3XW7Vg90H21EOLACvtfcHk0lhd32GFLYtjJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GntL7L&md5=33e42d401479dc4d07aae9e808611017</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1227157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1227157%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DKehm%26aufirst%3DV.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DPathological%2520alpha-synuclein%2520transmission%2520initiates%2520Parkinson-like%2520neurodegeneration%2520in%2520nontransgenic%2520mice%26jtitle%3DScience%26date%3D2012%26volume%3D338%26spage%3D949%26epage%3D953%26doi%3D10.1126%2Fscience.1227157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehm, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span><span class="refDoi"> DOI: 10.1084/jem.20112457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1084%2Fjem.20112457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=22508839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmsl2itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=975-986&author=K.+C.+Lukauthor=V.+M.+Kehmauthor=B.+Zhangauthor=P.+O%E2%80%99Brienauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Intracerebral+inoculation+of+pathological+alpha-synuclein+initiates+a+rapidly+progressive+neurodegenerative+alpha-synucleinopathy+in+mice&doi=10.1084%2Fjem.20112457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice</span></div><div class="casAuthors">Luk, Kelvin C.; Kehm, Victoria M.; Zhang, Bin; O'Brien, Patrick; Trojanowski, John Q.; Lee, Virginia M. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-986</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The accumulation of misfolded proteins is a fundamental pathogenic process in neurodegenerative diseases.  However, the factors that trigger aggregation of α-Synuclein (α-Syn), the principal component of the intraneuronal inclusions known as Lewy bodies (LBs), and Lewy neurites (LNs), which characterize Parkinson's disease (PD) and dementia with LBs (DLB), are poorly understood.  We show here that in young asymptomatic α-Syn transgenic (Tg) mice, intracerebral injections of brain homogenates derived from older Tg mice exhibiting α-Syn pathol. accelerate both the formation of intracellular LB/LN-like inclusions and the onset of neurol. symptoms in recipient animals.  Pathol. α-Syn propagated along major central nervous system (CNS) pathways to regions far beyond injection sites and reduced survival with a highly reproducible interval from injection to death in inoculated animals.  Importantly, inoculation with α-Syn amyloid fibrils assembled from recombinant human α-Syn induced identical consequences.  Furthermore, we show for the first time that synthetic α-Syn fibrils are wholly sufficient to initiate PD-like LBs/LNs and to transmit disease in vivo.  Thus, our data point to a prion-like cascade in synucleinopathies whereby cell-cell transmission and propagation of misfolded α-Syn underlie the CNS spread of LBs/LNs.  These findings open up new avenues for understanding the progression of PD and for developing novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMEAs-_zzl1rVg90H21EOLACvtfcHk0lhd32GFLYtjJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmsl2itb8%253D&md5=f225d6d7c8c78df53a54c634a3d68cfc</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1084%2Fjem.20112457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20112457%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DKehm%26aufirst%3DV.%2BM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DIntracerebral%2520inoculation%2520of%2520pathological%2520alpha-synuclein%2520initiates%2520a%2520rapidly%2520progressive%2520neurodegenerative%2520alpha-synucleinopathy%2520in%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26spage%3D975%26epage%3D986%26doi%3D10.1084%2Fjem.20112457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Volpicelli-Daley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanik, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1016/j.neuron.2011.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1016%2Fj.neuron.2011.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=21982369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12kt7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2011&pages=57-71&author=L.+A.+Volpicelli-Daleyauthor=K.+C.+Lukauthor=T.+P.+Patelauthor=S.+A.+Tanikauthor=D.+M.+Riddleauthor=A.+Stieberauthor=D.+F.+Meaneyauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Exogenous+alpha-synuclein+fibrils+induce+Lewy+body+pathology+leading+to+synaptic+dysfunction+and+neuron+death&doi=10.1016%2Fj.neuron.2011.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39cR"><div class="casContent"><span class="casTitleNuber">39c</span><div class="casTitle"><span class="NLM_cas:atitle">Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death</span></div><div class="casAuthors">Volpicelli-Daley, Laura A.; Luk, Kelvin C.; Patel, Tapan P.; Tanik, Selcuk A.; Riddle, Dawn M.; Stieber, Anna; Meaney, David F.; Trojanowski, John Q.; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-71</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inclusions composed of α-synuclein (α-syn), i.e., Lewy bodies (LBs) and Lewy neurites (LNs), define synucleinopathies including Parkinson's disease (PD) and dementia with Lewy bodies (DLB).  Here, we demonstrate that preformed fibrils generated from full-length and truncated recombinant α-syn enter primary neurons, probably by adsorptive-mediated endocytosis, and promote recruitment of sol. endogenous α-syn into insol. PD-like LBs and LNs.  Remarkably, endogenous α-syn was sufficient for formation of these aggregates, and overexpression of wild-type or mutant α-syn was not required.  LN-like pathol. first developed in axons and propagated to form LB-like inclusions in perikarya.  Accumulation of pathol. α-syn led to selective decreases in synaptic proteins, progressive impairments in neuronal excitability and connectivity, and, eventually, neuron death.  Thus, our data contribute important insights into the etiol. and pathogenesis of PD-like α-syn inclusions and their impact on neuronal functions, and they provide a model for discovering therapeutics targeting pathol. α-syn-mediated neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi33SV7tReNbVg90H21EOLACvtfcHk0liPaesZVhGq7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12kt7bP&md5=771dc7412f14fc4d30d15db30cf96309</span></div><a href="/servlet/linkout?suffix=cit39c&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2011.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2011.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DVolpicelli-Daley%26aufirst%3DL.%2BA.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DPatel%26aufirst%3DT.%2BP.%26aulast%3DTanik%26aufirst%3DS.%2BA.%26aulast%3DRiddle%26aufirst%3DD.%2BM.%26aulast%3DStieber%26aufirst%3DA.%26aulast%3DMeaney%26aufirst%3DD.%2BF.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DExogenous%2520alpha-synuclein%2520fibrils%2520induce%2520Lewy%2520body%2520pathology%2520leading%2520to%2520synaptic%2520dysfunction%2520and%2520neuron%2520death%26jtitle%3DNeuron%26date%3D2011%26volume%3D72%26spage%3D57%26epage%3D71%26doi%3D10.1016%2Fj.neuron.2011.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">20051</span><span class="NLM_x">–</span> <span class="NLM_lpage">20056</span><span class="refDoi"> DOI: 10.1073/pnas.0908005106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.0908005106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20051-20056&author=K.+C.+Lukauthor=C.+Songauthor=P.+O%E2%80%99Brienauthor=A.+Stieberauthor=J.+R.+Branchauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Exogenous+alpha-synuclein+fibrils+seed+the+formation+of+Lewy+body-like+intracellular+inclusions+in+cultured+cells&doi=10.1073%2Fpnas.0908005106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39d&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908005106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908005106%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DStieber%26aufirst%3DA.%26aulast%3DBranch%26aufirst%3DJ.%2BR.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DExogenous%2520alpha-synuclein%2520fibrils%2520seed%2520the%2520formation%2520of%2520Lewy%2520body-like%2520intracellular%2520inclusions%2520in%2520cultured%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D20051%26epage%3D20056%26doi%3D10.1073%2Fpnas.0908005106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Recasens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Carbajal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Villalba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernagut, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span> </span><span class="NLM_article-title">Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1002/ana.24066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1002%2Fana.24066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=24243558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=351-362&author=A.+Recasensauthor=B.+Dehayauthor=J.+Boveauthor=I.+Carballo-Carbajalauthor=S.+Doveroauthor=A.+Perez-Villalbaauthor=P.+O.+Fernagutauthor=J.+Blesaauthor=A.+Parentauthor=C.+Perierauthor=I.+Farinasauthor=J.+A.+Obesoauthor=E.+Bezardauthor=M.+Vila&title=Lewy+body+extracts+from+Parkinson+disease+brains+trigger+alpha-synuclein+pathology+and+neurodegeneration+in+mice+and+monkeys&doi=10.1002%2Fana.24066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys</span></div><div class="casAuthors">Recasens, Ariadna; Dehay, Benjamin; Bove, Jordi; Carballo-Carbajal, Iria; Dovero, Sandra; Perez-Villalba, Ana; Fernagut, Pierre-Olivier; Blesa, Javier; Parent, Annabelle; Perier, Celine; Farinas, Isabel; Obeso, Jose A.; Bezard, Erwan; Vila, Miquel</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">351-362</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective : Mounting evidence suggests that α-synuclein, a major protein component of Lewy bodies (LB), may be responsible for initiating and spreading the pathol. process in Parkinson disease (PD).  Supporting this concept, intracerebral inoculation of synthetic recombinant α-synuclein fibrils can trigger α-synuclein pathol. in mice.  However, it remains uncertain whether the pathogenic effects of recombinant synthetic α-synuclein may apply to PD-linked pathol. α-synuclein and occur in species closer to humans.  Methods : Nigral LB-enriched fractions contg. pathol. α-synuclein were purified from postmortem PD brains by sucrose gradient fractionation and subsequently inoculated into the substantia nigra or striatum of wild-type mice and macaque monkeys.  Control animals received non-LB fractions contg. sol. α-synuclein derived from the same nigral PD tissue.  Results : In both mice and monkeys, intranigral or intrastriatal inoculations of PD-derived LB exts. resulted in progressive nigrostriatal neurodegeneration starting at striatal dopaminergic terminals.  No neurodegeneration was obsd. in animals receiving non-LB fractions from the same patients.  In LB-injected animals, exogenous human α-synuclein was quickly internalized within host neurons and triggered the pathol. conversion of endogenous α-synuclein.  At the onset of LB-induced degeneration, host pathol. α-synuclein diffusely accumulated within nigral neurons and anatomically interconnected regions, both anterogradely and retrogradely.  LB-induced pathogenic effects required both human α-synuclein present in LB exts. and host expression of α-synuclein.  Interpretation : α-Synuclein species contained in PD-derived LB are pathogenic and have the capacity to initiate a PD-like pathol. process, including intracellular and presynaptic accumulations of pathol. α-synuclein in different brain areas and slowly progressive axon-initiated dopaminergic nigrostriatal neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-2AzyZDzd7Vg90H21EOLACvtfcHk0liPaesZVhGq7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSjt7k%253D&md5=bf14c11708b633689898b9093f101acf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fana.24066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24066%26sid%3Dliteratum%253Aachs%26aulast%3DRecasens%26aufirst%3DA.%26aulast%3DDehay%26aufirst%3DB.%26aulast%3DBove%26aufirst%3DJ.%26aulast%3DCarballo-Carbajal%26aufirst%3DI.%26aulast%3DDovero%26aufirst%3DS.%26aulast%3DPerez-Villalba%26aufirst%3DA.%26aulast%3DFernagut%26aufirst%3DP.%2BO.%26aulast%3DBlesa%26aufirst%3DJ.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DFarinas%26aufirst%3DI.%26aulast%3DObeso%26aufirst%3DJ.%2BA.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DVila%26aufirst%3DM.%26atitle%3DLewy%2520body%2520extracts%2520from%2520Parkinson%2520disease%2520brains%2520trigger%2520alpha-synuclein%2520pathology%2520and%2520neurodegeneration%2520in%2520mice%2520and%2520monkeys%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D75%26spage%3D351%26epage%3D362%26doi%3D10.1002%2Fana.24066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hallows, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span> </span><span class="NLM_article-title">Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">10230</span><span class="NLM_x">–</span> <span class="NLM_lpage">10235</span><span class="refDoi"> DOI: 10.1073/pnas.0604392103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=10.1073%2Fpnas.0604392103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=16790548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10230-10235&author=W.+C.+Hallowsauthor=S.+Leeauthor=J.+M.+Denu&title=Sirtuins+deacetylate+and+activate+mammalian+acetyl-CoA+synthetases&doi=10.1073%2Fpnas.0604392103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases</span></div><div class="casAuthors">Hallows, William C.; Lee, Susan; Denu, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">10230-10235</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Silent Information Regulator 2 (Sir2) enzymes (or sirtuins) are NAD+-dependent deacetylases that modulate gene silencing, aging and energy metab.  Previous work has implicated several transcription factors as sirtuin targets.  Here, we investigated whether mammalian sirtuins could directly control the activity of metabolic enzymes.  We demonstrate that mammalian Acetyl-CoA synthetases (AceCSs) are regulated by reversible acetylation and that sirtuins activate AceCSs by deacetylation.  Site-specific acetylation of mouse AceCS1 on Lys-661 was identified by using mass spectrometry and a specific anti-acetyl-AceCS antibody.  SIRT1 was the only member of seven human Sir2 homologs capable of deacetylating AceCS1 in cellular coexpression expts.  SIRT1 expression also led to a pronounced increase in AceCS1-dependent fatty-acid synthesis from acetate.  Using purified enzymes, only SIRT1 and SIRT3 exhibited high catalytic efficiency against acetylated AceCS1.  In mammals, two AceCSs have been identified: cytoplasmic AceCS1 and mitochondrial AceCS2.  Because SIRT3 is localized to the mitochondria, we investigated whether AceCS2 also might be regulated by acetylation, and specifically deacetylated by mitochondrial SIRT3.  AceCS2 was completely inactivated upon acetylation and was rapidly reactivated by SIRT3 deacetylation.  Lys-635 of mouse AceCS2 was identified as the targeted residue.  Using reversible acetylation to modulate enzyme activity, we propose a model for the control of AceCS1 by SIRT1 and of AceCS2 by SIRT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptbmWATBB41bVg90H21EOLACvtfcHk0lif6BkWeExbow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlKmt74%253D&md5=20e40562f9d9c133e7ba21261e2339ff</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604392103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604392103%26sid%3Dliteratum%253Aachs%26aulast%3DHallows%26aufirst%3DW.%2BC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26atitle%3DSirtuins%2520deacetylate%2520and%2520activate%2520mammalian%2520acetyl-CoA%2520synthetases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10230%26epage%3D10235%26doi%3D10.1073%2Fpnas.0604392103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1j8f','PDB','1j8f'); return false;">PDB: 1j8f</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01376">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13012"></div></div></div></div></div><hr /></hr><p class="last"> Table S1–S3 and Figure S1–S2. The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01376">10.1021/acs.jmedchem.5b01376</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Chemical characterization data of compounds <b>11−13</b>, <b>15−21</b>, <b>23−41</b>, and <b>43−117</b>; inhibitory activity of 5-((3-amidobenzyl)oxy)nicotinamides (compounds <b>33−44</b>, <b>50−55</b>, and <b>88−99</b>); inhibition of SIRT2 by compound <b>61</b>, and protection against oligomeric α-synuclein toxicity by selected SIRT2 inhibitors (<b>8</b>, <b>61</b>, <b>86</b>, and <b>102</b>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf">PDF</a>)</p></li><li><p class="inline">IC<sub>50</sub> values of the compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_001.pdf">jm5b01376_si_001.pdf (455.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01376/suppl_file/jm5b01376_si_002.csv">jm5b01376_si_002.csv (10.29 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01376&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01376%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01376" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac3133f903c52","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
